Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3027135	s-igg1	g/l (g/l)	3062	4159	0.00%
3027135	s-igg1	— (—)	1415	1878	100.00%	Distribution not available
3027135	s-immunoglobuliinig,alaluokka1	g/l (g/l)	24	26	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Asthma/COPD (KELA code 203)

1273

2562

3.46

317.58

1.5

1.3

6.22

6.94

g/l

8.88

941

1718

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

311

118

19.68

313.80

1.5

1.2

7.55

7.00

g/l

0.76

213

Asthma, including avohilmo

1525

2752

3.15

309.13

1.5

1.3

6.31

7.01

g/l

9.35

1113

1852

Second line medication for Crohn's disease

922

2394

3.94

309.02

1.6

1.3

7.07

6.64

g/l

1.81

652

1676

Undetermined asthma, excluding more controls

304

203

15.66

307.65

1.7

1.2

6.01

6.95

g/l

2.34

225

132

Asthma, unspecified (mode)

790

868

7.00

307.65

1.4

1.3

6.36

7.17

g/l

4.76

548

550

Acute pancreatitis

504

582

9.10

307.65

1.6

1.3

6.04

6.86

g/l

3.59

227

424

Bronchiectasis

288

156

20.20

307.65

1.4

7.06

7.17

g/l

0.09

214

110

All pneumoniae

1423

2784

3.47

307.65

1.4

6.72

g/l

0.02

1029

1891

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1310

1794

4.50

307.65

1.4

1.3

6.68

7.00

g/l

1.47

951

1180

Asthma (diagnoses ohter than nonallergic)

1379

2888

4.04

307.65

1.5

1.3

6.24

6.98

g/l

10.86

1008

1978

ILD medications

1932

1790

5.98

307.65

1.5

1.2

6.69

6.84

g/l

0.62

1375

1190

Inflammatory bowel disease treatment related agents

2010

1992

5.77

307.65

1.5

1.2

6.71

6.83

g/l

0.48

1434

1337

Asthma (only as main-diagnosis), excluding more controls

1242

899

8.09

307.65

1.5

1.3

6.23

7.07

g/l

6.47

909

564

Asthma-related pneumonia or sepsis

719

1135

6.53

307.65

1.5

1.3

6.33

7.10

g/l

4.54

542

776

Asthma (mode)

1212

955

6.93

307.65

1.5

1.3

6.26

7.12

g/l

6.50

886

598

Immunodeficiency with predominantly antibody defects

285

52.77

307.65

2.1

1.3

4.93

7.31

g/l

3.33

235

Systemic connective tissue disorders

703

1245

5.84

307.65

1.7

1.3

7.04

6.59

g/l

1.50

505

861

ILD medications: prednisolone, methylprednisolone, prednisone

1915

1747

6.27

307.65

1.5

1.2

6.65

6.86

g/l

1.06

1367

1160

Immunodeficiencies

361

146

30.36

307.65

2.0

1.3

5.06

7.16

g/l

5.76

289

103

Asthma, hospital admission 2, infections

1136

2106

5.43

307.65

1.5

1.3

6.19

7.02

g/l

9.65

854

1444

Fever of other and unknown origin

942

1724

4.97

307.65

1.4

1.3

6.79

6.82

g/l

0.07

672

1211

Pneumonias (Asthma/COPD co-morbidities)

1417

2775

3.48

307.65

1.4

6.73

6.71

g/l

0.05

1025

1889

Asthma, hospital admissions , main diagnosis only

1308

2926

4.02

307.65

1.5

1.3

6.24

6.97

g/l

10.12

961

1995

Influenza and pneumonia

1475

2729

3.49

307.65

1.4

1.3

6.70

6.74

g/l

0.11

1070

1849

Chronic lower respiratory diseases

1620

2573

3.40

307.65

1.4

1.3

6.48

6.93

g/l

3.84

1181

1724

Asthma-related infections

1136

2106

5.43

307.65

1.5

1.3

6.19

7.02

g/l

9.65

854

1444

Certain disorders involving the immune mechanism

598

699

9.12

307.65

1.9

1.3

5.67

6.81

g/l

7.77

439

481

Asthma, hospital admissions 3, pneumonia

719

1135

6.53

307.65

1.5

1.3

6.33

7.10

g/l

4.54

542

776

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1044

2110

4.53

307.65

1.4

7.06

6.74

g/l

1.37

730

1461

First line medication for Crohn's disease

1793

1773

5.57

307.65

1.5

1.2

6.73

6.84

g/l

0.41

1272

1187

Chronic sinusitis

775

1501

5.30

307.65

1.5

1.3

6.20

7.10

g/l

7.61

591

999

Asthma-related pneumonia

718

1133

6.53

307.65

1.5

1.3

6.33

7.10

g/l

4.54

542

775

Asthma, excluding more controls

1230

899

7.29

307.65

1.5

1.3

6.30

7.07

g/l

5.42

897

564

Acute pancreatitis (for exclusion)

504

686

7.71

307.65

1.6

1.3

6.04

6.87

g/l

3.55

227

499

Oral corticosteroids

1992

1902

6.37

307.65

1.5

1.2

6.61

6.86

g/l

1.32

1419

1269

Pneumonia, organism unspecified

1306

2526

3.69

307.65

1.4

6.74

6.73

g/l

0.03

943

1707

Asthma, unspecified (mode), excluding more controls

781

825

7.23

307.65

1.4

1.3

6.36

7.12

g/l

4.38

541

524

ILD medications: immunosuppressive drugs

1122

1620

6.60

307.65

1.5

1.2

6.96

6.80

g/l

0.52

798

1082

939

1609

5.98

307.65

1.5

1.3

6.17

6.87

g/l

6.22

711

1109

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1438

2725

3.70

307.65

1.5

1.3

6.62

6.80

g/l

0.71

1021

1897

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1376

2788

3.42

307.65

1.4

6.72

g/l

0.00

998

1896

Undetermined asthma

304

209

15.21

307.65

1.7

1.2

6.01

6.98

g/l

2.52

225

138

Abnormal findings on diagnostic imaging of lung

809

1477

5.39

307.65

1.4

7.02

6.86

g/l

0.42

587

1013

Asthma

1258

950

7.09

307.65

1.5

1.3

6.30

7.11

g/l

5.88

917

595

Asthma (only as main-diagnosis)

1262

950

7.87

307.65

1.5

1.3

6.25

7.11

g/l

6.64

922

595

1310

1794

4.50

307.65

1.4

1.3

6.68

7.00

g/l

1.47

951

1180

L04AX Other immunosuppressants

898

2321

3.95

302.98

1.6

1.3

7.04

6.67

g/l

1.47

640

1627

Other systemic involvement of connective tissue (FG)

494

792

6.36

288.77

1.8

1.3

7.30

6.70

g/l

1.54

356

538

Autoimmune diseases related-to ILD

1116

2952

3.28

274.66

1.4

7.12

6.56

g/l

3.69

767

2058

Other pulmonary diagnosis

864

958

4.57

272.82

1.3

6.60

7.11

g/l

2.19

606

601

Other systemic involvement of connective tissue

510

914

5.76

270.77

1.8

1.3

7.27

6.53

g/l

2.32

366

633

Excluding asthma or asthma-COPD overlap

855

958

4.53

266.90

1.3

6.60

7.11

g/l

2.14

598

601

ILD differential diagnosis

849

955

4.51

263.88

1.3

6.61

7.12

g/l

2.13

594

598

Asthma and opportunity respiratory infection

202

105

21.63

263.73

1.5

1.3

6.63

7.29

g/l

0.61

147

COPD differential diagnosis

848

956

4.50

262.93

1.3

6.61

7.12

g/l

2.13

594

598

Abnormalities of breathing

1115

1945

3.37

253.96

1.4

1.3

6.40

6.93

g/l

3.69

793

1299

COPD/asthma related infections

1188

1795

3.35

253.82

1.4

1.3

6.55

7.00

g/l

2.66

861

1180

COPD/asthma/ILD related infections

1188

1795

3.35

253.82

1.4

1.3

6.55

7.00

g/l

2.66

861

1180

Cough

607

1251

4.69

252.15

1.4

1.3

6.45

7.02

g/l

2.47

459

850

Other respiratory diseases principally affecting the interstitium

368

516

7.43

249.17

1.4

1.3

7.34

6.94

g/l

0.64

251

356

Disorders of gallbladder, biliary tract and pancreas

1231

2574

3.06

246.81

1.5

1.3

6.77

6.78

g/l

0.02

730

1921

Other and unspecified immunodeficiencies with predominantly antibody defects

146

54.60

245.81

2.2

1.4

4.49

6.55

g/l

4.10

121

ILD, hospital admission 2, with pulmonary infections

232

178

13.73

245.50

1.4

1.3

7.48

6.67

g/l

0.99

160

121

Acute sinusitis

771

1896

3.84

244.76

1.5

1.3

6.24

6.91

g/l

5.23

585

1275

Allergic asthma (mode), excluding more controls

346

449

7.71

242.75

1.5

1.3

6.09

7.07

g/l

4.04

283

286

Other interstitial pulmonary diseases

329

422

8.16

241.04

1.4

1.3

7.58

6.63

g/l

2.26

223

290

Interstitial lung disease endpoints

329

424

8.12

240.08

1.4

1.3

7.58

6.65

g/l

2.20

223

291

Interstitial lung disease

329

424

8.12

240.08

1.4

1.3

7.58

6.65

g/l

2.20

223

291

Allergic asthma (mode)

346

457

7.57

239.11

1.5

1.3

6.09

7.12

g/l

4.20

283

293

Non-allergic asthma (mode), excluding more controls

295

328

9.14

238.67

1.6

1.2

6.31

7.26

g/l

2.54

221

219

ILD, hospital admissions

325

418

8.14

237.60

1.4

1.3

7.55

6.65

g/l

2.04

220

285

ILD medications: azathioprine

305

365

8.68

236.30

1.8

1.2

7.16

6.83

g/l

0.54

218

255

Non-allergic asthma (mode)

295

339

8.85

232.59

1.6

1.2

6.31

7.34

g/l

2.75

221

226

Any gastric operation

889

1168

3.86

230.40

1.4

1.2

6.65

6.71

g/l

0.13

587

936

GASTRO-related operations

889

1168

3.86

230.40

1.4

1.2

6.65

6.71

g/l

0.13

587

936

1292

2283

2.96

229.71

1.4

1.3

6.45

7.07

g/l

5.37

945

1520

Reimbursement for rheumatic diseases

808

2351

3.49

227.08

1.5

1.4

7.14

6.69

g/l

1.98

585

1634

Autoimmune diseases excluding thyroid diseases

1259

2362

2.94

226.32

1.4

1.3

7.09

6.47

g/l

4.47

885

1638

Azathioprine

305

388

8.17

224.69

1.8

1.2

7.16

6.66

g/l

0.97

218

270

Autoimmune diseases excluding thyroid diseases, strict definition

1210

2286

2.93

216.55

1.4

1.3

7.09

6.48

g/l

4.20

857

1597

ILD, hospital admissions 1, main diag only

293

373

8.23

216.16

1.4

1.3

7.64

6.73

g/l

1.88

203

256

Bacterial pneumonia (organism specified)

611

1365

4.14

214.01

1.4

6.60

6.84

g/l

0.61

439

931

Bacterial pneumoniae

558

1125

4.46

213.27

1.4

6.58

6.85

g/l

0.68

406

751

Obesity related asthma

519

1163

4.57

212.26

1.4

1.3

6.23

6.98

g/l

4.13

367

785

General symptoms and signs

1219

2112

2.92

210.46

1.5

1.3

6.75

g/l

0.01

861

1449

ILD, hospital admissions 3, with pneumonia sepsis

206

171

12.72

207.91

1.2

1.4

7.64

6.79

g/l

0.95

142

119

Chronic rhinitis, nasopharyngitis and pharyngitis

493

1091

4.63

204.75

1.4

6.32

7.09

g/l

4.55

396

739

Bacterial pneumonia, not elsewhere classified

521

1044

4.48

200.34

1.3

1.4

6.58

6.87

g/l

0.71

380

700

Bronchitis

1231

2971

2.64

190.31

1.4

1.3

6.47

6.88

g/l

2.82

895

2020

Other acute lower respiratory infections

723

2087

3.36

189.76

1.5

1.4

6.43

6.82

g/l

1.65

531

1440

Bacterial infection, other or unspecified

661

1662

3.51

181.28

1.3

1.4

6.89

6.80

g/l

0.17

476

1141

Chronic pancreatitis

253

335

7.88

180.40

1.9

1.2

6.47

6.90

g/l

0.83

131

247

Nonhereditary hypogammaglobulinemia

107

52.09

179.92

2.3

1.4

4.27

7.01

g/l

4.26

Bacterial infection, other or unspecified

703

1810

3.33

177.15

1.3

1.4

6.88

6.76

g/l

0.26

511

1248

Dyspnoea

1045

2889

2.70

177.09

1.4

6.46

6.84

g/l

2.19

739

2023

Symptoms and signs involving the circulatory and respiratory systems

1083

1952

2.81

174.78

1.4

1.3

6.61

6.94

g/l

1.65

765

1300

Acute upper respiratory infections

1145

2715

2.62

174.40

1.4

1.3

6.32

6.99

g/l

6.57

846

1831

Other bacterial diseases

1076

2770

2.64

169.85

1.4

6.87

6.72

g/l

0.47

758

1920

Other diseases of pleura

555

1324

3.74

167.70

1.5

1.4

6.78

6.92

g/l

0.32

380

907

Other diseases of biliary tract

187

190

10.32

164.55

2.0

1.3

7.26

6.74

g/l

0.73

103

140

Cholangitis (primary sclerosing, PSC)

163

137

12.63

163.39

1.8

1.2

7.84

6.76

g/l

1.75

103

Examination and observation for other reasons

693

1179

3.44

162.86

1.5

1.3

6.33

7.01

g/l

3.50

581

689

Acute bronchitis

549

1518

3.61

162.41

1.4

6.42

6.82

g/l

1.31

402

1053

Other bacterial diseases

1129

2852

2.54

162.30

1.4

6.83

6.70

g/l

0.38

806

1966

Kela reimbursement Agammaglobulinemia (D80-84)

64.82

161.90

2.2

1.5

4.36

7.64

g/l

3.01

Selective deficiency of immunoglobulin G [IgG] subclasses

67.68

161.33

2.5

1.2

5.44

7.73

g/l

2.01

Autoimmune diseases

1178

2374

2.55

159.68

1.4

1.3

7.13

6.47

g/l

4.80

824

1646

Used for control exclusion in common control thyroid runs

1109

2158

2.62

158.48

1.4

1.3

7.07

6.48

g/l

3.85

753

1519

Asthma and allergy, excluding more controls

209

258

8.20

154.92

1.5

1.4

6.13

6.99

g/l

2.33

173

Pain in joint

658

1265

3.36

154.24

1.4

6.48

6.99

g/l

2.04

479

851

Asthma and allergy

209

261

8.11

153.43

1.5

1.4

6.13

7.03

g/l

2.43

173

171

Anaemias

350

417

5.59

153.29

1.4

1.3

7.07

6.66

g/l

0.77

248

303

Diseases of the respiratory system

596

799

3.77

150.48

1.4

1.3

6.50

7.18

g/l

2.74

419

501

Enlarged lymph nodes

276

486

5.85

149.44

1.5

1.2

7.25

6.57

g/l

1.38

199

348

Tramadol

861

1916

2.79

147.12

1.4

6.57

6.92

g/l

1.46

615

1315

Acute upper respiratory infections of multiple and unspecified sites

842

2301

2.74

146.92

1.4

1.3

6.32

6.94

g/l

4.87

616

1552

Suggestive for eosinophilic asthma

198

252

8.23

146.21

1.8

1.3

6.26

7.02

g/l

1.65

155

169

Other specified/unspecified systemic involvement of connective tissue

160

161

10.60

142.27

2.4

1.4

7.53

6.72

g/l

0.85

127

113

Early onset COPD, excluding more controls

222

329

6.87

142.17

1.6

1.2

6.18

7.36

g/l

3.12

156

215

Other necrotizing vasculopathies

168

182

9.75

141.27

1.4

6.03

6.92

g/l

1.45

123

134

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

172

192

9.40

141.20

1.6

1.4

8.09

6.99

g/l

1.28

110

131

Septicaemia

493

1325

3.54

140.00

1.4

7.05

6.78

g/l

0.51

338

920

Abnormal findings on examination of blood, without diagnosis

565

1624

3.25

139.46

1.6

1.4

7.25

6.84

g/l

1.20

387

1118

Diseases of oesophagus, stomach and duodenum

1124

2859

2.37

138.32

1.3

1.4

6.58

6.82

g/l

1.10

794

1981

Bacterial Sepsis

535

1386

3.35

136.37

1.4

6.92

6.85

g/l

0.10

373

954

Any reimbursement code in KELA

607

896

3.43

134.66

1.4

1.3

6.55

6.77

g/l

0.61

428

618

Ethmoidectomy

262

486

5.60

134.60

1.7

1.3

6.39

6.75

g/l

0.73

191

338

Diseases of liver

456

1299

3.58

133.87

1.3

1.4

7.92

6.63

g/l

5.41

298

915

FESS (DNB20)

257

473

5.65

133.21

1.7

1.4

6.39

6.73

g/l

0.66

187

328

Other necrotizing vasculopathies (FG)

144

140

10.87

130.98

1.4

1.3

6.18

7.05

g/l

1.05

104

101

Pain in throat and chest

828

1873

2.68

130.62

1.4

1.3

6.50

6.95

g/l

2.75

603

1244

Other diseases of upper respiratory tract

1079

2366

2.40

130.47

1.4

1.3

6.36

7.06

g/l

6.69

783

1572

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

574

1862

3.03

128.65

1.4

1.3

6.31

7.09

g/l

5.89

393

1237

Explicit Sepsis

515

1502

3.25

128.13

1.4

7.05

6.76

g/l

0.56

355

1045

Headache

682

1952

2.82

128.06

1.5

1.3

6.39

6.75

g/l

1.83

501

1354

Finngen Rheumatological endpoints

1001

2371

2.42

127.13

1.4

1.3

6.92

6.68

g/l

0.87

709

1612

Gastrointestinal diseases

578

872

3.35

124.20

1.4

1.3

6.67

6.70

g/l

0.07

395

652

Other septicaemia

429

1180

3.55

123.69

1.4

1.3

6.77

6.73

g/l

0.06

300

814

Implicit bacterial Sepsis

448

1196

3.37

116.62

1.4

6.57

6.84

g/l

0.58

316

826

Vasomotor and allergic rhinitis

445

1336

3.32

116.08

1.4

1.3

6.46

7.00

g/l

2.50

353

883

Other diseases of pancreas

152

190

8.34

113.90

1.6

1.2

6.63

6.78

g/l

0.12

138

Infections, IBD-co-morbidities

206

219

6.85

113.51

1.6

1.2

6.85

6.80

g/l

0.04

142

149

Polyarthropathies

725

1818

2.63

113.30

1.4

6.97

6.83

g/l

0.32

531

1255

Medical observation and evaluation for suspected diseases and conditions

660

1181

2.88

112.89

1.5

1.3

6.85

7.02

g/l

0.37

499

691

Certain infectious and parasitic diseases

945

2000

2.39

111.90

1.4

1.3

6.89

6.67

g/l

0.73

654

1356

Opioids

964

2149

2.35

111.69

1.4

6.65

6.89

g/l

0.93

665

1478

Symptoms and signs involving the digestive system and abdomen

964

2072

2.35

110.56

1.4

1.3

6.58

6.88

g/l

1.26

647

1467

Other immunodeficiencies

28.07

110.46

2.3

1.3

5.42

6.81

g/l

1.74

L04AA Selective immunosuppressants

344

929

3.79

109.73

1.5

1.3

6.51

6.61

g/l

0.19

249

643

Implicit bacterial Sepsis

470

1305

3.15

109.28

1.4

6.60

6.84

g/l

0.51

334

897

Other soft tissue disorders, not elsewhere classified

950

2446

2.30

108.35

1.4

1.3

6.43

6.96

g/l

4.05

686

1674

Mixed connective tissue disease

149

196

8.01

107.24

1.9

1.5

7.72

6.73

g/l

1.13

117

133

Codeine

906

2106

2.36

107.20

1.4

6.47

6.90

g/l

2.51

620

1448

Other specific joint derangements/joint disorders

778

2055

2.47

106.77

1.4

6.51

6.80

g/l

1.14

556

1409

Other and unspecified dermatitis

578

2165

2.70

105.48

1.5

1.4

6.89

6.85

g/l

0.09

416

1523

Dermatitis

660

2635

2.52

104.74

1.5

1.4

6.86

6.79

g/l

0.19

473

1848

Gastro-oesophageal reflux disease

699

2462

2.48

103.35

1.4

6.36

6.86

g/l

2.95

480

1714

Implicit viral Sepsis

349

990

3.59

103.13

1.4

6.46

6.76

g/l

0.58

250

701

Abdominal and pelvic pain

940

2072

2.30

102.67

1.4

1.3

6.57

6.88

g/l

1.33

628

1467

Malaise and fatigue

497

1364

2.96

102.47

1.4

1.3

6.62

6.85

g/l

0.53

348

956

Primary_lymphoid and hematopoietic malignant neoplasms

310

819

3.87

101.95

1.4

7.14

6.76

g/l

0.40

223

568

Implicit Sepsis

744

2341

2.42

101.73

1.4

6.62

6.76

g/l

0.39

513

1630

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

312

343

4.60

100.00

1.3

6.44

6.73

g/l

0.54

221

226

Sicca syndrome [Sjögren]

163

255

6.66

99.93

1.5

1.4

8.65

6.92

g/l

2.23

106

184

Idiopathic pulmonary fibrosis

128

156

8.52

97.89

1.4

1.2

7.85

6.85

g/l

1.24

110

Vocal cord dysfunction

176

264

6.10

96.36

1.6

1.2

6.49

6.72

g/l

0.29

116

177

Other diseases of intestines

1044

2839

2.11

96.32

1.4

1.3

6.55

6.78

g/l

1.00

735

1965

Viral Sepsis

269

671

4.09

95.90

1.4

1.3

6.36

6.64

g/l

0.42

193

482

Implicit viral Sepsis

268

668

4.10

95.64

1.4

1.3

6.36

6.65

g/l

0.42

192

480

Haemorrhage from respiratory passages

336

873

3.51

94.18

1.4

1.3

6.68

7.12

g/l

0.99

232

576

Low back pain

747

2315

2.34

93.60

1.4

1.3

6.35

6.99

g/l

4.31

527

1571

Other diseases of blood and blood-forming organs, wide

308

864

3.65

92.91

1.4

7.35

6.70

g/l

1.07

205

608

Noninfective enteritis and colitis

536

2067

2.62

92.12

1.3

1.4

6.94

6.72

g/l

0.55

361

1461

Liquid cancers, helper endpoint

422

1256

2.97

89.01

1.4

7.22

6.80

g/l

0.65

306

876

Adrenocortical insufficiency

104

111

10.04

88.76

1.7

1.4

6.33

7.24

g/l

0.73

Oedema, not elsewhere classified

321

947

3.39

87.08

1.6

1.3

6.65

6.85

g/l

0.42

233

664

Parasetamol

697

1459

2.44

87.06

1.4

1.3

6.62

7.11

g/l

2.08

488

971

Nasal polyp

240

592

4.14

86.91

1.6

1.3

6.39

7.23

g/l

2.51

197

395

Other disorders of adrenal gland

116

146

8.42

86.82

1.6

1.3

6.24

7.10

g/l

0.83

106

Codeine or tramadol medication

1058

2890

2.02

86.30

1.4

6.47

6.89

g/l

2.67

728

1994

Budesonide

170

318

5.46

86.27

1.4

1.2

7.59

6.63

g/l

1.63

115

216

Exclusions for E4_PCOS_BROAD

269

726

3.80

85.95

1.5

1.4

6.13

6.69

g/l

1.37

132

532

Cholelithiasis, broad definition with cholecystitis

768

2329

2.24

85.75

1.4

6.88

6.80

g/l

0.18

489

1735

Other special examinations and investigations of persons without complaint or reported diagnosis

602

1181

2.60

85.47

1.3

6.79

7.02

g/l

0.56

431

691

Diagnoses used for exclusion with ILD

310

922

3.42

85.33

1.4

1.3

6.88

6.90

g/l

0.02

206

658

All influenza

286

807

3.60

85.28

1.5

1.3

6.65

6.69

g/l

0.04

208

556

Respiratory disorders in diseases classified elsewhere

20.20

84.14

1.8

1.3

6.04

6.64

g/l

0.47

Drug-induced adrenocortical insufficiency

16.62

83.99

1.9

1.4

6.12

6.36

g/l

0.14

Other disorders involving the immune mechanism, not elsewhere classified

11.37

83.80

2.6

1.3

6.24

6.88

g/l

0.72

Other diseases of the respiratory system

248

646

3.91

83.29

1.5

1.4

6.30

6.96

g/l

1.24

174

453

Other respiratory disorders and diseases

248

646

3.91

83.29

1.5

1.4

6.30

6.96

g/l

1.24

174

453

Implicit Sepsis

769

2588

2.19

83.15

1.4

6.59

6.77

g/l

0.54

523

1819

Heart failure, not strict

699

2087

2.30

82.99

1.5

1.4

6.70

6.80

g/l

0.23

487

1441

Other disorders of white blood cells

116

154

7.90

82.82

1.4

6.89

6.81

g/l

0.04

109

Disorders of lacrimal system

464

1761

2.66

82.25

1.5

1.4

6.66

6.78

g/l

0.27

323

1222

Nausea and vomiting

294

845

3.46

82.12

1.4

1.3

6.53

6.89

g/l

0.83

216

627

General examination and investigation of persons without complaint and reported diagnosis

580

1181

2.58

82.10

1.4

1.3

6.40

7.02

g/l

2.91

479

691

Unspecified acute lower respiratory infection

217

519

4.28

82.03

1.5

1.3

6.73

6.75

g/l

0.02

161

361

Disorders of other endocrine glands

492

1897

2.58

81.81

1.5

1.3

6.41

6.70

g/l

0.86

283

1356

Cardiovascular diseases

637

1411

2.45

81.64

1.4

1.3

6.65

6.63

g/l

0.04

429

1016

Osteoporosis

279

745

3.56

80.27

1.5

1.3

6.37

6.88

g/l

1.24

192

512

Dermatitis and eczema

1034

3302

1.95

79.78

1.4

6.70

6.73

g/l

0.09

732

2277

Other disorders of lacrimal gland

393

1400

2.85

79.30

1.6

1.3

6.43

6.73

g/l

0.85

273

969

Pain in limb

760

2359

2.17

79.00

1.4

1.3

6.45

6.98

g/l

3.47

555

1614

Cardiovascular diseases (excluding rheumatic etc)

663

1652

2.33

77.86

1.4

1.3

6.79

6.65

g/l

0.34

444

1174

Cholangitis (primary sclerosing, PSC), with reimbursement 202

13.90

77.18

1.9

1.3

9.08

6.45

g/l

2.96

Provisional assignment of new diseases of uncertain etiology

551

2342

2.37

76.79

1.5

1.3

6.24

6.89

g/l

3.80

408

1616

Wegener granulomatosis

19.20

76.70

1.7

1.3

6.26

6.34

g/l

0.03

Pain, not elsewhere classified

289

879

3.33

76.66

1.7

1.3

6.10

6.80

g/l

3.00

227

621

Codes for special purposes

551

2344

2.37

76.64

1.5

1.3

6.24

6.89

g/l

3.81

408

1618

Cholelithiasis

718

2279

2.19

76.61

1.4

6.86

6.81

g/l

0.08

452

1698

Other heart diseases

502

1276

2.60

76.60

1.5

1.3

6.99

6.65

g/l

0.96

349

908

Sulfasalazine

255

721

3.58

75.79

1.4

1.2

6.90

6.79

g/l

0.15

178

476

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

11.42

75.72

2.7

1.3

6.27

7.06

g/l

0.84

Dorsalgia

905

2397

2.04

75.43

1.5

1.3

6.36

6.97

g/l

4.50

629

1625

COPD (mode)

214

399

4.26

75.29

1.3

1.2

6.80

7.34

g/l

0.90

152

255

Other inflammatory liver diseases

121

187

6.73

75.11

1.3

1.5

8.94

6.43

g/l

3.74

130

Oxycodone

368

1165

2.89

74.84

1.5

1.4

6.44

7.05

g/l

1.88

254

802

Irritable bowel syndrome

322

1061

3.08

74.82

1.5

1.4

6.15

6.74

g/l

2.78

227

730

Covid-19 confirmed case

389

1421

2.77

74.80

1.5

1.3

6.10

6.88

g/l

3.16

262

968

Pneumonia due to other infectious organisms, not elsewhere classified

11.45

74.45

1.4

1.3

6.88

6.96

g/l

0.03

Eosinophilic disease (BM)

21.98

73.95

1.6

1.2

7.21

9.24

g/l

0.50

Biological medicines for asthma

13.42

73.76

1.3

6.03

7.18

g/l

1.21

Viral pneumonia

171

369

4.74

73.67

1.3

6.48

6.60

g/l

0.12

120

257

Dental caries

294

886

3.24

73.61

1.5

1.3

6.92

6.78

g/l

0.19

220

594

COPD

367

1050

2.89

72.78

1.4

1.3

6.71

7.16

g/l

1.13

259

702

Aplastic and other anaemias

426

1529

2.63

72.63

1.4

6.92

6.86

g/l

0.09

268

1075

Diseases of the skin and subcutaneous tissue

899

2245

2.02

72.26

1.4

1.3

6.80

6.71

g/l

0.23

626

1519

Other arthritis (FG)

326

1107

2.98

71.81

1.4

1.3

6.67

6.71

g/l

0.06

234

752

Pleural effusion

176

397

4.52

71.73

1.5

1.4

7.28

6.85

g/l

0.62

114

281

Neurological diseases

803

1932

2.10

71.50

1.4

6.54

7.04

g/l

2.49

553

1362

15.68

71.38

1.5

1.3

7.09

7.05

g/l

0.02

Pain (limb, back, neck, head abdominally)

618

1327

2.35

71.27

1.4

6.68

6.98

g/l

0.97

432

896

Neurological diseases, wide definition

294

410

3.63

71.14

1.4

1.2

6.53

6.69

g/l

0.26

206

285

Osteopathies and chondropathies

545

2225

2.30

70.10

1.5

1.4

6.40

6.85

g/l

1.55

377

1562

Implicit fungal Sepsis

111

169

6.80

69.85

1.4

5.67

6.60

g/l

1.51

120

Condition for Implicit Sepsis (Organ dysfunction codes)

768

2667

2.05

69.54

1.3

1.4

6.59

6.74

g/l

0.46

522

1881

Lower back pain or/and sciatica

955

3294

1.91

69.44

1.4

6.31

6.88

g/l

4.85

677

2261

Other chronic obstructive pulmonary disease

350

1012

2.88

69.27

1.4

1.3

6.63

7.19

g/l

1.57

247

671

Hernia of abdominal wall, postoperative

161

349

4.68

68.80

1.5

1.3

6.42

6.78

g/l

0.60

110

293

Simple and mucopurulent chronic bronchitis

10.28

68.77

1.3

6.01

7.64

g/l

1.58

Certain infectious and parasitic diseases

635

1408

2.27

68.20

1.3

6.79

6.72

g/l

0.17

463

940

Condition for Implicit Sepsis (Organ dysfunction codes)

807

2802

2.00

68.19

1.3

1.4

6.65

6.74

g/l

0.25

555

1956

Caries of dentine

260

773

3.32

68.13

1.5

1.3

6.94

6.77

g/l

0.23

195

518

Other and unspecified anaemias

390

1419

2.65

68.03

1.4

6.97

6.89

g/l

0.12

247

994

Disorders of thyroid, IBD co-morbidities

169

244

4.93

67.69

1.4

1.2

6.42

6.82

g/l

0.76

119

167

5-aminosalicylic acid

210

564

3.78

67.48

1.4

1.2

8.05

6.60

g/l

3.91

130

372

Other anaemias

391

1430

2.63

67.12

1.4

6.96

6.90

g/l

0.09

248

1002

Other heart diseases, wide

866

2724

1.96

67.07

1.4

7.09

6.55

g/l

2.78

593

1909

Intestinal infectious diseases

870

3458

1.92

66.97

1.4

6.78

6.72

g/l

0.16

611

2399

Complications of surgical and medical care, not elsewhere classified

894

3217

1.92

66.75

1.4

6.62

6.79

g/l

0.62

644

2217

Respiratory insufficiency

8.95

65.09

1.3

5.97

6.91

g/l

0.83

Disorders of eyelid, lacrimal system and orbit

772

2981

1.98

64.88

1.5

1.4

6.56

6.83

g/l

1.19

545

2086

Symptoms and signs involving the skin and subcutaneous tissue

661

3172

2.06

64.53

1.5

1.3

6.78

6.76

g/l

0.05

502

2204

Allergic rhinitis

369

1400

2.64

64.38

1.4

1.3

6.29

6.77

g/l

2.24

300

959

ILD-related respiratory insufficiency

10.57

64.27

1.2

8.73

7.80

g/l

0.32

Diseases of salivary glands

355

1341

2.68

64.11

1.6

1.3

6.87

6.72

g/l

0.26

248

924

Other noninfective gastroenteritis and colitis

287

974

2.99

63.34

1.4

1.3

6.30

6.66

g/l

0.78

202

700

L04AD Calcineurin inhibitors

179

452

4.08

63.20

1.3

1.4

7.03

6.67

g/l

0.46

124

324

Fibrosis and cirrhosis of liver

119

216

5.69

62.74

1.2

1.4

9.82

6.72

g/l

4.57

150

Other specified/unspecified arthritis

287

981

2.97

62.58

1.4

6.75

6.89

g/l

0.23

203

675

Hypothyroidism and >3 levothyroxin purchases

256

415

3.52

62.27

1.4

1.3

7.05

6.61

g/l

0.85

169

295

Hypothyroidism, levothyroxine purchases

256

415

3.52

62.27

1.4

1.3

7.05

6.61

g/l

0.85

169

295

Rheumatoid arthritis

316

1011

2.84

62.08

1.5

1.4

6.93

6.95

g/l

0.02

236

697

Sarcoidosis

181

468

3.96

61.71

1.4

6.95

6.93

g/l

0.02

116

333

Diarrhoea and gastroenteritis of presumed infectious origin

661

2956

2.03

61.45

1.4

6.63

6.71

g/l

0.18

462

2050

Other headache syndromes

417

1733

2.43

61.38

1.4

6.29

6.88

g/l

1.92

296

1225

Candidiasis

320

1174

2.77

61.23

1.4

1.3

6.44

6.67

g/l

0.47

235

814

Other joint disorders

785

2101

1.98

60.87

1.4

6.58

6.79

g/l

0.74

558

1438

Infection due to other mycobacteria

18.08

60.60

1.5

1.4

6.95

6.56

g/l

0.26

Hypothyroidism (congenital or acquired)

254

417

3.48

60.59

1.4

1.3

6.95

6.61

g/l

0.64

166

297

Spondylopathies

673

1956

2.07

60.47

1.4

1.3

6.37

7.05

g/l

4.08

461

1319

Childhood asthma (age<16), excluding more controls

138

216

5.10

60.08

1.3

1.2

6.41

6.87

g/l

0.71

100

135

All kidney diseases

877

3246

1.86

59.75

1.4

6.97

6.69

g/l

0.92

593

2287

Soft tissue disorders

901

2481

1.88

59.64

1.4

1.3

6.45

6.97

g/l

3.57

627

1698

Diseases of the eye and adnexa

735

1832

2.02

59.30

1.4

1.3

6.43

6.92

g/l

2.73

522

1244

Episodal and paroxysmal disorders

963

2682

1.84

59.20

1.4

6.56

6.87

g/l

1.47

648

1898

Childhood asthma (age<16)

138

220

5.01

58.93

1.3

1.2

6.41

6.89

g/l

0.76

100

137

Chronic laryngitis and laryngotracheitis

161

396

4.15

58.71

1.4

1.3

6.04

7.15

g/l

3.76

114

261

Coagulation defects, purpura and other haemorrhagic conditions

237

757

3.19

58.33

1.5

1.3

6.68

6.69

g/l

0.02

178

533

Eosinophilia

13.63

57.99

1.6

1.3

7.21

7.19

g/l

0.01

Other dorsopathies, not elsewhere classified

866

2420

1.88

57.86

1.4

1.3

6.48

6.96

g/l

2.64

604

1644

Colitis, primary sclerosing

12.63

57.85

1.4

1.2

9.38

6.38

g/l

3.01

Other functional intestinal disorders

418

1649

2.37

57.73

1.5

1.3

6.30

6.83

g/l

1.78

300

1158

Dorsopathies

893

2446

1.87

57.58

1.4

1.3

6.59

6.96

g/l

1.69

617

1667

Migraine

486

1770

2.25

57.43

1.4

1.3

6.11

6.78

g/l

4.65

349

1276

Symptoms and signs concerning food and fluid intake

131

281

4.76

56.80

1.5

1.3

7.24

6.64

g/l

0.73

211

Methotrexate

139

314

4.50

56.57

1.6

1.2

6.86

6.55

g/l

0.32

100

219

Diarrhoea and gastroenteritis of presumed infectious origin

890

3240

1.82

56.57

1.4

6.59

6.75

g/l

0.55

626

2238

Diseases of the digestive system

417

1797

2.33

56.02

1.5

1.4

6.96

6.83

g/l

0.22

281

1243

Persons encountering health services for examination and investigation

528

1181

2.26

55.89

1.4

1.3

6.80

7.02

g/l

0.51

397

691

Fibromyalgia

129

279

4.74

55.59

1.6

1.4

6.20

6.81

g/l

0.93

197

Arthropathies

794

2114

1.91

55.20

1.4

6.59

6.78

g/l

0.80

575

1451

Other intervertebral disc disorders

701

2159

1.97

55.07

1.4

1.3

6.53

7.01

g/l

2.30

492

1458

COPD, hospital admission 2, with asthma infections

285

875

2.82

55.06

1.4

6.31

7.05

g/l

2.64

204

600

All chronic kidney diseases

478

1782

2.21

54.60

1.5

1.4

7.12

6.77

g/l

0.98

324

1242

Other general symptoms and signs

144

6.47

54.52

1.6

1.3

6.51

6.55

g/l

0.03

110

Intestinal infectious diseases

988

3222

1.76

54.49

1.4

6.75

6.76

g/l

0.02

698

2220

Abnormalities of heart beat

292

1062

2.72

54.33

1.3

1.4

6.54

6.95

g/l

1.18

198

716

Pneumocystosis

12.15

54.21

1.6

1.4

6.25

8.23

g/l

0.83

Voice disturbances

282

1035

2.76

54.01

1.4

6.06

6.84

g/l

3.24

203

719

Sleep disorders (combined)

962

2852

1.78

53.88

1.3

1.4

6.67

6.83

g/l

0.61

641

2000

Fungal Sepsis

8.04

53.88

1.4

1.3

6.40

6.91

g/l

0.26

Purpura and other haemorrhagic conditions

176

491

3.66

53.80

1.5

1.4

6.67

6.72

g/l

0.06

131

350

Endocrine, nutritional and metabolic diseases

723

1880

1.96

53.75

1.4

1.3

6.61

6.73

g/l

0.33

474

1357

Hypertensive diseases (excluding secondary)

483

1250

2.26

53.66

1.5

1.3

6.36

6.69

g/l

1.07

315

883

Functional dyspepsia

266

955

2.82

53.08

1.4

6.56

6.73

g/l

0.29

195

655

Complications of medical and surgical care

644

3075

1.94

52.93

1.4

6.64

6.81

g/l

0.49

464

2143

Diseases of the musculoskeletal system and connective tissue

465

1012

2.32

52.42

1.4

1.3

6.58

6.69

g/l

0.28

329

696

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

120

7.01

52.41

1.5

1.4

7.85

6.99

g/l

0.58

Protozoal diseases

8.50

52.12

1.5

1.4

6.43

7.48

g/l

0.50

Persons encountering health services in other circumstances, wide

991

2933

1.75

52.07

1.4

6.97

6.64

g/l

1.61

716

2008

Inflammatory bowel disease

339

1386

2.48

52.05

1.3

7.38

6.63

g/l

2.21

221

959

Persons encountering health services for specific procedures and health care

940

3227

1.76

51.94

1.3

1.4

6.64

6.75

g/l

0.32

665

2235

Other diseases of pericardium

103

7.55

51.94

1.4

1.3

7.17

6.72

g/l

0.26

Implicit fungal Sepsis

8.21

51.86

1.5

1.3

5.95

6.77

g/l

0.63

Mycoses

286

1085

2.67

51.36

1.5

1.3

6.81

g/l

0.00

193

753

Renal failure

382

1448

2.35

51.34

1.4

7.16

6.85

g/l

0.56

245

1000

Complications of procedures, not elsewhere classified

700

3105

1.88

51.30

1.4

6.71

6.80

g/l

0.22

512

2142

Sleep apnoea

801

2857

1.83

51.21

1.3

1.4

6.62

6.83

g/l

0.85

519

2011

Osteoporosis with pathological fracture (FG)

142

6.29

51.14

1.6

1.2

6.28

7.43

g/l

1.12

104

Other disorders of fluid, electrolyte and acid-base balance

289

1046

2.66

51.08

1.3

7.04

6.89

g/l

0.16

195

718

COPD, hospital admissions 3, with asthma pneumonia sepsis

241

701

2.97

51.03

1.5

1.4

6.41

7.18

g/l

2.30

177

487

Primary biliary cholangitis (PBC)

13.29

50.73

1.2

8.40

6.82

g/l

1.15

Cardiac arrhythmias

552

1746

2.07

50.72

1.3

1.4

7.26

6.67

g/l

1.94

368

1250

Dysphagia

222

740

3.04

50.70

1.4

1.3

6.43

7.03

g/l

1.69

151

527

Viral infections characterized by skin and mucous membrane lesions

410

1842

2.25

50.54

1.5

1.4

6.22

6.74

g/l

1.98

302

1281

Cholecystectomy

607

2698

1.95

50.52

1.4

6.83

6.79

g/l

0.07

379

1918

Depression medications

267

444

3.05

50.24

1.4

1.3

6.42

6.74

g/l

0.65

185

317

Other diseases of liver

210

683

3.13

50.21

1.3

7.19

6.52

g/l

1.29

137

485

Viral infections characterized by skin and mucous membrane lesions

756

3582

1.82

50.06

1.4

6.50

6.78

g/l

1.11

542

2485

Rheumatoid arthritis, including avohilmo

361

1547

2.36

49.90

1.4

7.00

6.73

g/l

0.50

263

1058

Urticaria and erythema

375

1634

2.32

49.86

1.4

6.66

g/l

0.01

279

1142

Hypopituitarism

124

286

4.48

49.49

1.5

1.3

5.76

6.83

g/l

1.68

217

Chronic kidney disease

262

960

2.71

48.22

1.4

7.15

6.87

g/l

0.39

171

675

Rheumatism, unspecified

156

432

3.68

48.20

1.8

1.4

6.10

7.00

g/l

1.99

112

302

Drug-induced osteoporosis with pathological fracture

14.27

48.17

1.9

1.3

6.67

7.77

g/l

0.40

Antihypertensive medication - note that there are other indications

571

1498

2.03

47.68

1.4

1.3

6.54

6.78

g/l

0.74

391

1070

Symptoms and signs involving speech and voice

320

1327

2.44

47.68

1.4

6.14

6.90

g/l

3.22

230

921

Explicit bacterial Sepsis

126

303

4.24

47.45

1.4

8.86

6.66

g/l

1.97

220

Pulmonary heart disease, diseases of pulmonary circulation

286

1129

2.56

47.30

1.4

6.87

6.93

g/l

0.06

212

778

Anxiety disorders, excluding more controls

725

2586

1.84

47.21

1.5

1.4

6.47

6.85

g/l

1.62

532

1778

Intestinal malabsorption

124

6.52

47.20

1.4

1.3

7.04

6.95

g/l

0.05

Other pleural conditions

108

231

4.77

47.16

1.5

1.4

7.13

6.97

g/l

0.14

166

Ulcerative colitis, NAS

178

545

3.33

47.13

1.3

1.4

8.12

6.68

g/l

3.12

120

388

Sleep apnoea, including avohilmo

834

2948

1.76

47.03

1.4

6.58

6.82

g/l

1.03

543

2070

Chronic hepatitis, not elsewhere classified

7.84

47.00

1.4

1.3

9.83

6.55

g/l

2.69

Persons encountering health services in other circumstances

382

1711

2.24

46.92

1.4

1.3

6.86

6.61

g/l

0.40

230

1169

Abnormal findings on diagnostic imaging of other body structures

151

418

3.68

46.70

1.5

1.3

7.00

6.75

g/l

0.30

299

Renal tubulo-interstitial diseases

731

3031

1.81

46.54

1.4

7.06

6.68

g/l

1.18

492

2127

Myalgia

239

872

2.78

46.34

1.5

1.3

6.18

6.90

g/l

2.50

171

596

Ulcerative colitis

264

1015

2.64

46.21

1.3

7.93

6.67

g/l

3.92

173

708

Bleeding

685

2660

1.84

46.08

1.4

6.90

6.75

g/l

0.36

478

1844

Constipation

743

2879

1.80

45.81

1.4

6.55

6.81

g/l

0.95

507

2041

Nutritional anaemias

424

1936

2.13

45.54

1.5

1.4

6.99

6.80

g/l

0.36

311

1345

Polymyalgia rheumatica

126

313

4.09

45.41

1.5

1.3

6.80

6.91

g/l

0.08

220

Seropositive rheumatoid arthritis

223

790

2.84

45.33

1.5

1.3

7.00

6.73

g/l

0.40

168

537

Neoplasms

679

1928

1.88

45.24

1.4

6.63

6.66

g/l

0.07

443

1358

Disorders of conjunctiva

726

3284

1.79

45.08

1.5

1.3

6.46

6.75

g/l

1.39

543

2266

Erysipelas

555

2186

1.95

45.00

1.5

1.4

6.85

6.73

g/l

0.26

402

1495

Other chronic obstructive pulmonary disease, including avohilmo

425

1654

2.14

44.99

1.4

6.58

6.99

g/l

1.32

299

1139

Other disorders of skin and subcutaneous tissue

576

2702

1.91

44.91

1.4

6.90

6.80

g/l

0.19

416

1884

Sciatica+with lumbago

431

1898

2.11

44.66

1.4

6.11

7.04

g/l

7.41

309

1290

Biological medication for rheuma

215

758

2.89

44.63

1.3

1.4

6.72

6.57

g/l

0.25

145

520

Streptococcal septicaemia

105

230

4.67

44.60

1.4

8.74

6.55

g/l

1.71

173

Early onset COPD

222

799

2.82

44.26

1.6

1.4

6.18

6.90

g/l

2.23

156

544

Lumbar disc prolapse

525

2057

1.97

43.90

1.4

6.48

7.03

g/l

2.47

363

1388

Colitis, primary sclerosing, strict definition

11.94

43.40

1.4

1.2

9.11

6.11

g/l

2.89

Other and unspecified iron deficiency

305

1292

2.38

43.28

1.4

1.3

6.90

6.73

g/l

0.28

220

898

Symptoms and signs involving the nervous and musculoskeletal systems

498

2555

1.96

43.18

1.6

1.4

6.29

6.87

g/l

3.50

361

1798

Iron deficiency anaemia

370

1677

2.19

43.07

1.4

7.00

6.81

g/l

0.32

269

1168

Benign neoplasm of colon, rectum, anus and anal canal

503

2232

1.97

43.07

1.4

6.79

6.89

g/l

0.22

374

1520

Later onset COPD, excluding more controls

121

220

4.29

42.99

1.1

1.2

7.37

7.44

g/l

0.05

143

Metabolic disorders

788

2770

1.75

42.95

1.5

1.4

6.80

g/l

0.01

546

1926

Multiple myeloma and malignant plasma cell neoplasms

108

6.60

42.38

1.4

1.3

10.95

7.34

g/l

1.51

Nerve, nerve root and plexus disorders

867

3156

1.69

42.30

1.4

6.39

6.87

g/l

3.49

592

2187

Pneumonia due to Streptococcus pneumoniae

6.89

42.20

1.4

1.2

8.27

6.92

g/l

0.61

Non-Hodgkin lymphoma, all, including Hilmo

147

430

3.48

41.88

1.5

1.4

5.90

6.87

g/l

1.79

104

302

Unspecified jaundice

6.88

41.69

1.9

1.2

7.49

7.25

g/l

0.13

Anxiety disorders

776

3155

1.72

41.61

1.5

1.3

6.47

6.76

g/l

1.23

570

2159

Hypermobility syndrome

173

5.19

41.59

1.6

1.4

6.38

6.23

g/l

0.12

124

Persons encountering health services for other counselling and medical advice, not elsewhere classified

900

2933

1.68

41.36

1.4

6.80

6.64

g/l

0.58

681

2008

Pulmonary embolism

258

1035

2.52

41.34

1.4

6.58

6.92

g/l

0.67

187

716

Polyarthrosis

187

585

3.01

41.32

1.6

1.5

7.04

6.92

g/l

0.12

125

409

Other symptoms and signs involving the nervous and musculoskeletal systems

384

1825

2.12

41.27

1.6

1.3

6.29

6.84

g/l

2.44

275

1265

Atrial fibrillation and flutter

269

680

2.59

41.20

1.3

7.87

6.83

g/l

1.98

189

471

Acute renal failure

201

714

2.85

41.09

1.4

1.3

7.22

6.91

g/l

0.36

121

501

Neurotic, stress-related and somatoform disorders

766

3132

1.72

40.88

1.5

1.3

6.47

6.76

g/l

1.19

564

2141

COPD, hospital admissions

349

1339

2.22

40.79

1.4

6.62

6.97

g/l

0.87

246

907

Other antidepressants

844

2548

1.71

40.78

1.4

6.49

6.92

g/l

2.38

571

1770

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

385

1119

2.19

40.63

1.5

1.3

6.81

6.78

g/l

0.05

253

787

Pulmonary heart disease

258

1044

2.50

40.60

1.4

6.58

6.95

g/l

0.74

187

724

Inflammatory diseases of the central nervous system

112

278

4.13

40.58

1.5

1.4

6.86

6.89

g/l

0.03

193

Benign neoplasm: Colon

428

2028

2.03

40.57

1.5

1.4

6.69

6.90

g/l

0.59

318

1393

COPD, early/later onset

350

1343

2.21

40.56

1.4

6.63

6.97

g/l

0.81

247

911

Diverticular disease of intestine

543

1824

1.91

40.10

1.6

1.4

6.53

6.91

g/l

1.51

401

1255

IBD (strict) with PSC

13.48

39.89

1.3

10.55

6.40

g/l

3.27

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

807

3132

1.69

39.50

1.4

6.82

6.71

g/l

0.28

549

2236

Abnormal results of function studies

110

275

4.09

39.46

1.5

1.3

7.37

6.67

g/l

0.59

197

Abnormal serum enzyme levels

257

1024

2.47

39.39

1.5

1.4

7.00

6.93

g/l

0.11

186

703

Other gastritis (incl. Duodenitis)

200

725

2.79

39.35

1.5

1.4

6.91

7.04

g/l

0.15

150

491

Chronic diseases of tonsils and adenoids

597

2059

1.84

39.32

1.3

6.22

6.97

g/l

4.94

447

1364

Multiple myeloma, including Hilmo

110

6.30

39.30

1.4

10.44

7.24

g/l

1.30

Ulcerative colitis (strict) with PSC

15.70

38.84

1.3

10.22

6.47

g/l

2.51

Dialysis, with operation codes

146

449

3.31

38.49

1.4

6.79

6.59

g/l

0.15

101

317

Giant cell arteritis

7.01

38.35

1.2

1.5

5.95

7.38

g/l

1.30

Drug-induced cataract

8.19

38.22

1.5

1.3

5.90

6.85

g/l

0.59

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

499

2639

1.88

37.97

1.3

1.4

6.76

6.84

g/l

0.16

363

1830

Conjunctivitis

649

3118

1.75

37.92

1.5

1.3

6.46

6.71

g/l

1.03

493

2148

Other specified/unspecified necrotizing vasculopathies

13.23

37.92

1.4

6.51

5.98

g/l

0.29

Nephropathy related operations

142

434

3.34

37.83

1.4

1.3

6.93

6.76

g/l

0.12

308

Spondyloarthritis

173

594

2.95

37.66

1.4

1.3

6.48

6.59

g/l

0.15

119

422

Syncope and collapse

319

1236

2.22

37.65

1.4

1.3

6.52

6.87

g/l

0.91

213

863

Infections of the skin and subcutaneous tissue

509

2730

1.86

37.49

1.4

1.3

6.87

6.72

g/l

0.38

379

1877

Benign neoplasms

800

2636

1.68

37.40

1.4

1.3

6.66

6.86

g/l

0.73

547

1816

Diseases of arteries, arterioles and capillaries (FINNGEN)

203

504

2.82

37.15

1.3

1.4

7.00

6.90

g/l

0.10

145

343

Transplanted organ and tissue status

125

358

3.57

36.91

1.5

1.4

6.99

6.67

g/l

0.21

272

Heart failure,strict

382

1302

2.08

36.73

1.4

7.39

6.86

g/l

1.09

255

882

Depression or dysthymia

562

1681

1.86

36.71

1.4

6.57

6.99

g/l

1.64

388

1166

Pneumonia derived septicemia

6.95

36.70

1.4

9.85

6.57

g/l

1.54

Mood disorders, excluding more controls

760

2702

1.69

36.69

1.4

6.46

6.88

g/l

2.23

533

1856

IBD patients in KELA-register

237

973

2.47

36.29

1.2

1.3

7.80

6.63

g/l

3.34

146

684

Erysipelas

407

1819

1.99

36.24

1.5

1.4

6.84

6.82

g/l

0.04

295

1238

Noninfectious colitis NAS

153

502

3.10

36.19

1.5

1.3

6.02

6.82

g/l

2.13

115

364

Diaphragmatic hernia

299

1358

2.22

36.17

1.4

6.42

6.86

g/l

1.36

225

938

Urticaria

297

1346

2.23

36.16

1.5

1.4

6.46

6.68

g/l

0.48

222

949

Collagenous colitis

110

293

3.84

36.16

1.4

6.77

6.76

g/l

0.01

203

Mycoses

700

3630

1.69

36.15

1.4

6.50

6.80

g/l

1.39

490

2513

Spondylopathies (FG)

146

468

3.17

35.91

1.5

1.3

6.33

6.74

g/l

0.71

103

314

Migraine with aura

233

954

2.47

35.83

1.4

5.89

6.73

g/l

4.55

172

686

SLE (Finngen)

7.16

35.78

1.6

1.4

7.04

6.66

g/l

0.27

Heart failure and antihypertensive medication

218

539

2.67

35.65

1.5

1.3

7.57

6.98

g/l

0.79

151

383

All influenza (not pneumonia)

147

475

3.14

35.64

1.4

1.3

6.55

6.58

g/l

0.02

327

Hypertensive diseases

660

2144

1.75

35.64

1.4

6.56

6.80

g/l

0.84

442

1503

Hypertension, essential

634

2044

1.77

35.49

1.4

6.53

6.83

g/l

1.16

424

1424

Non-invasive ventilation

192

634

2.73

35.45

1.3

1.4

6.23

6.94

g/l

1.46

438

Hypertension

658

2141

1.74

35.31

1.4

6.54

6.80

g/l

0.96

441

1501

Benign neoplasm of other and ill-defined parts of digestive system

176

633

2.82

35.28

1.5

1.3

6.16

6.83

g/l

1.80

127

436

Migraine without aura

202

779

2.62

35.27

1.4

6.28

6.80

g/l

1.48

146

569

Hypothyroidism, strict autoimmune

508

1799

1.87

35.26

1.3

6.88

6.52

g/l

1.20

349

1271

Depression

787

3267

1.64

35.05

1.4

6.44

6.80

g/l

1.82

552

2252

Care involving use of rehabilitation procedures

533

2746

1.80

34.75

1.4

6.45

6.79

g/l

1.26

372

1924

Candidiasis

149

494

3.07

34.65

1.5

1.3

7.03

6.84

g/l

0.17

102

350

Other and unspecified disorders of white blood cells

107

5.99

34.62

1.3

6.47

7.03

g/l

0.22

Glomerular diseases

182

673

2.74

34.61

1.6

1.3

6.66

6.75

g/l

0.09

119

473

Diseases of middle ear and mastoid

502

2251

1.84

34.48

1.4

6.37

6.73

g/l

1.45

349

1544

COPD related to multimorbidity

289

1101

2.23

34.38

1.4

6.59

7.07

g/l

1.10

201

740

Recurrent or chronic depression

357

1215

2.08

34.19

1.3

1.4

6.35

6.96

g/l

2.52

250

849

Disorders of sclera, cornea, iris and ciliary body

460

2491

1.86

34.04

1.4

6.75

6.74

g/l

0.02

318

1740

Crohn disease

152

517

2.99

33.82

1.2

1.3

6.91

6.64

g/l

0.30

100

367

Diseases of the ear and mastoid process

934

2978

1.58

33.67

1.4

1.3

6.53

6.83

g/l

1.61

650

2087

Pericarditis

6.96

33.67

1.2

1.3

6.74

6.90

g/l

0.08

Other bacterial intestinal infections

172

628

2.77

33.50

1.4

1.3

6.99

6.69

g/l

0.31

123

434

Pulmonary eosinophilia, not elsewhere classified

13.73

33.50

1.8

1.3

6.54

6.73

g/l

0.09

Spondylosis

402

1688

1.95

33.40

1.5

1.3

6.32

7.12

g/l

3.98

258

1142

DVT of lower extremities and pulmonary embolism

323

1553

2.09

33.38

1.4

6.56

6.90

g/l

0.82

228

1077

Temporomandibular joint disorders, including avohilmo

394

2015

1.94

33.23

1.5

1.3

6.40

6.61

g/l

0.59

272

1413

Migraine with aura and triptan purchases

175

648

2.74

33.22

1.4

5.96

6.79

g/l

3.04

131

454

Enterocolitis due to Clostridium difficile

103

278

3.76

33.17

1.5

1.4

6.65

6.76

g/l

0.07

198

Mood disorders

826

3353

1.60

33.14

1.4

6.48

6.81

g/l

1.64

576

2320

Acute suppurative otitis media

272

1145

2.24

33.11

1.4

1.3

6.30

6.65

g/l

0.86

196

794

Venous thromboembolism

411

2088

1.91

33.10

1.5

1.4

6.44

6.94

g/l

1.81

288

1447

Inflammatory bowel disease, strict (require KELA)

237

1016

2.36

33.01

1.2

1.3

7.80

6.59

g/l

3.54

146

712

Thrombocytopenia, unspecified

214

4.21

32.85

1.6

1.3

6.68

6.97

g/l

0.24

146

Tumor necrosis factor alpha inhibitors

182

692

2.67

32.83

1.3

1.4

6.73

6.66

g/l

0.10

120

472

Nonsuppurative otitis media

231

838

2.41

32.82

1.5

1.3

5.92

6.72

g/l

4.22

166

590

Unspecified chronic bronchitis

7.74

32.79

1.3

1.4

7.20

7.74

g/l

0.24

Mood [affective] disorders

823

3353

1.60

32.76

1.4

6.49

6.81

g/l

1.57

574

2319

Pollen allergy

213

863

2.47

32.64

1.4

1.3

6.45

6.51

g/l

0.13

179

611

Alcohol-induced acute pancreatitis

110

5.76

32.59

1.4

1.3

5.96

6.77

g/l

1.00

Gout

198

683

2.57

32.51

1.4

1.5

6.87

7.26

g/l

0.49

133

466

Herpesviral [herpes simplex] infections

133

429

3.16

32.47

1.4

6.49

6.76

g/l

0.30

100

305

Cholecystitis

120

364

3.34

32.32

1.9

1.2

7.00

6.82

g/l

0.25

255

Visual disturbances and blindness

424

2277

1.87

32.21

1.5

1.4

6.39

6.80

g/l

1.61

317

1579

Bacterial intestinal infections, IBD co-morbidities

171

636

2.72

32.16

1.4

1.3

7.02

6.70

g/l

0.34

123

442

Other symptoms and signs involving the digestive system and abdomen

142

481

2.99

31.76

1.4

1.3

6.07

6.95

g/l

1.66

358

Polypectomy (DHB20)

207

4.21

31.70

2.0

1.3

6.27

6.89

g/l

0.89

141

Hypothyroidism, drug reimbursement

123

255

3.44

31.54

1.7

1.3

6.84

6.65

g/l

0.24

188

Atopic dermatitis, strict definition with reimbursement

282

1275

2.15

31.48

1.4

1.3

6.77

6.67

g/l

0.15

215

890

Other reaction to severe stress, and adjustment disorders

331

1657

2.01

31.08

1.5

1.3

6.49

6.65

g/l

0.31

238

1140

Suppurative and unspecified otitis media

339

1507

2.01

30.98

1.4

1.3

6.37

6.64

g/l

0.72

242

1046

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

304

1479

2.08

30.93

1.6

1.3

6.34

6.68

g/l

0.92

167

1048

Ischemic heart diseases

639

2288

1.69

30.92

1.5

1.4

6.82

6.75

g/l

0.14

443

1588

Other ulcerative colitis

194

4.28

30.90

1.3

8.19

6.73

g/l

1.45

132

Other disorders of urethra and urinary system

540

2242

1.75

30.87

1.4

1.3

6.65

6.84

g/l

0.58

376

1572

Mucosal proctocolitis

143

498

2.92

30.53

1.3

8.64

6.66

g/l

4.98

355

Zoster [herpes zoster]

384

2000

1.90

30.53

1.4

6.44

6.85

g/l

1.21

284

1380

COPD, hospital admissions 1, only main diagnosis

251

963

2.25

30.51

1.3

1.4

6.53

7.05

g/l

1.17

179

655

Hypo-osmolality and hyponatraemia

153

549

2.81

30.48

1.3

6.86

6.79

g/l

0.05

377

Visual disturbances

398

2136

1.88

30.40

1.6

1.4

6.42

6.78

g/l

1.21

297

1477

Polyarteritis nodosa and related conditions

10.61

30.34

1.6

1.3

7.00

5.80

g/l

0.60

Disorders of lens

505

1772

1.79

30.33

1.3

1.4

6.67

6.87

g/l

0.49

348

1247

Other/unspecified dorsalgia

296

1423

2.08

30.28

1.3

1.4

6.14

7.05

g/l

4.34

205

974

Spinal stenosis

355

1371

1.98

30.23

1.4

6.24

7.22

g/l

5.53

255

920

Percutaneous Coronary Intervention

601

2179

1.70

30.10

1.4

6.84

6.77

g/l

0.13

436

1510

Other bacterial intestinal infections

202

841

2.43

30.08

1.3

6.98

6.63

g/l

0.47

147

581

Other encephalitis

6.74

30.01

1.3

6.90

7.66

g/l

0.36

Viral pneumonia (unknown virus, not influenza)

208

4.08

29.78

1.2

1.3

6.47

6.78

g/l

0.23

149

Disturbances of skin sensation

256

1185

2.18

29.69

1.3

6.49

6.75

g/l

0.48

188

808

Congenital malformations of the respiratory system

6.91

29.67

1.5

1.4

6.24

6.12

g/l

0.09

Pneumococcal septicemia

5.89

29.60

1.4

1.3

10.15

6.65

g/l

1.57

Corticotropin deficiency

12.70

29.59

2.1

1.3

6.59

7.04

g/l

0.13

Other specified/unspecified inflammatory spondylopathies

139

4.87

29.56

1.6

1.4

6.25

6.94

g/l

0.68

Coronary revascularization (ANGIO or CABG)

599

2179

1.69

29.52

1.4

6.84

6.77

g/l

0.13

434

1510

Unknown and unspecified causes of morbidity

176

4.34

29.31

1.3

5.89

6.80

g/l

1.43

132

Systemic lupus erythematosus

5.81

29.27

1.6

1.4

7.04

6.70

g/l

0.20

Encephalitis

6.25

29.10

1.3

6.86

7.35

g/l

0.23

Benzodiazepine use

782

3450

1.57

29.10

1.3

1.4

6.66

6.78

g/l

0.34

531

2396

Continuous positive airway pressure

153

467

2.79

29.08

1.3

7.05

6.82

g/l

0.20

131

329

Heart failure, strict

404

1527

1.88

29.07

1.4

7.31

6.82

g/l

1.06

271

1048

Polyneuropathies and other disorders of the peripheral nervous system

188

770

2.47

29.06

1.4

1.3

6.50

6.91

g/l

0.73

140

536

Atrial fibrillation and flutter with reimbursement

195

491

2.55

29.00

1.4

7.85

7.07

g/l

0.95

132

334

Hypoparathyroidism

5.97

28.98

2.4

1.3

6.41

7.31

g/l

0.62

Other and unspecified tonsillitis

279

1119

2.11

28.93

1.4

6.47

6.86

g/l

1.14

199

734

Weight loss

105

315

3.39

28.92

1.4

7.40

6.72

g/l

0.65

227

Zoster [herpes zoster]

161

614

2.65

28.88

1.5

1.3

6.00

6.81

g/l

1.92

127

422

Abnormal weight loss

277

3.57

28.85

1.4

7.68

6.81

g/l

0.83

199

Emergency coronary revascularization (for ACS)

632

2329

1.66

28.85

1.4

6.85

6.79

g/l

0.13

458

1603

Shoulder lesions

554

1966

1.72

28.69

1.4

1.3

6.22

7.05

g/l

6.37

399

1335

Other and unspecified polyneuropathies, also in other diseases

166

645

2.61

28.68

1.4

1.3

6.54

6.81

g/l

0.39

124

448

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

452

2501

1.77

28.30

1.6

1.3

6.36

6.72

g/l

1.66

348

1736

Intracranial trauma

431

1671

1.82

28.30

1.5

1.4

6.65

7.02

g/l

0.95

296

1173

Seropositive rheumatoid arthritis, wide

223

998

2.26

28.14

1.5

1.4

7.00

6.68

g/l

0.52

168

688

Other Crohn's disease

249

3.69

28.11

1.2

1.3

7.01

6.66

g/l

0.29

174

Any mental disorder

851

2770

1.54

27.86

1.4

6.58

6.86

g/l

1.12

598

1907

Other nutritional deficiencies

534

3007

1.68

27.82

1.4

6.31

6.82

g/l

2.94

372

2123

All-cause Heart Failure

393

1496

1.87

27.77

1.4

7.35

6.85

g/l

1.07

265

1026

COPD-related respiratory insufficiency

100

299

3.39

27.66

1.4

6.14

6.84

g/l

1.06

215

Congenital malformations of the respiratory system

6.87

27.58

1.5

1.4

6.19

6.07

g/l

0.08

Anxiety (asthma-related co-morbidities)

507

2299

1.72

27.55

1.4

6.52

6.82

g/l

0.97

387

1595

Non-follicular lymphoma

286

3.45

27.48

1.4

6.00

6.76

g/l

0.80

200

Other complications of surgical and medical care, not elsewhere classified

105

326

3.28

27.39

1.4

6.77

6.85

g/l

0.05

234

Follow-up examination after treatment for conditions other than malignant neoplasms

298

966

2.05

27.37

1.4

1.3

6.52

7.07

g/l

1.52

225

574

Concussion

376

1654

1.86

27.35

1.5

1.4

6.62

7.02

g/l

0.94

259

1164

Hard cardiovascular diseases

637

2338

1.63

27.32

1.4

6.80

6.72

g/l

0.17

458

1607

Agranulocytosis

116

383

3.08

27.29

1.3

1.4

7.07

6.76

g/l

0.28

266

Alcohol-induced chronic pancreatitis

213

3.90

27.26

1.2

6.06

6.90

g/l

1.35

149

Other diseases of lip and oral mucosa

332

1744

1.92

27.19

1.4

6.93

6.73

g/l

0.33

239

1202

Disorders of orbit

126

4.89

27.01

1.6

1.4

6.30

6.80

g/l

0.44

Valvular heart disease excluding rheumatic fever

336

1256

1.94

26.99

1.4

7.27

6.64

g/l

1.53

230

864

Other skin changes

160

630

2.57

26.93

1.7

1.3

6.48

6.81

g/l

0.50

118

439

Vasculitis limited to skin, not elsewhere classified

7.08

26.89

1.4

1.2

5.68

8.19

g/l

1.87

Non-rheumatic valve diseases

333

1242

1.95

26.87

1.4

7.30

6.65

g/l

1.64

228

852

Cerebrovascular diseases (FINNGEN)

235

752

2.23

26.86

1.3

7.11

6.82

g/l

0.36

169

519

All anxiety disorders

516

2422

1.69

26.83

1.4

1.3

6.52

6.79

g/l

0.84

393

1663

Symptoms and signs involving cognition, perception, emotional state and behaviour

740

3254

1.56

26.77

1.4

6.57

6.79

g/l

0.91

520

2265

Cystitis

642

2366

1.62

26.76

1.4

1.3

6.68

6.83

g/l

0.44

461

1661

Lung cancer and mesothelioma

247

3.42

26.59

1.2

1.3

6.75

7.31

g/l

0.58

160

Insulin, combination of fast acting with intermediate-acting or long-acting

462

2456

1.73

26.57

1.5

1.4

6.70

6.84

g/l

0.25

295

1715

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

439

2527

1.75

26.48

1.4

6.77

6.82

g/l

0.08

317

1755

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

7.14

26.45

1.3

12.60

7.26

g/l

1.60

Multiple myeloma

7.14

26.45

1.3

12.60

7.26

g/l

1.60

Disorders of oesophagus in diseases classified elsewhere

9.02

26.45

1.5

1.1

6.85

8.09

g/l

0.47

Hypokalaemia

114

380

3.04

26.37

1.3

7.08

6.82

g/l

0.24

264

Congenital malformations, deformations and chromosomal abnormalities

529

2950

1.66

26.27

1.4

1.3

6.57

6.70

g/l

0.35

361

2054

Suppurative and necrotic conditions of lower respiratory tract

149

4.46

26.27

1.4

1.3

6.74

7.00

g/l

0.20

102

Personal history of allergy to drugs, medicaments and biological substances

9.50

26.25

1.6

1.1

5.90

6.38

g/l

0.43

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

138

513

2.73

26.13

1.3

1.4

9.57

6.90

g/l

3.83

359

Adalimumab

115

388

3.02

26.11

1.3

6.61

6.63

g/l

0.03

271

Presence of other functional implants

413

1599

1.80

26.07

1.4

6.55

6.89

g/l

0.87

225

1144

Cirrhosis of liver, NAS

146

4.49

26.04

1.2

1.3

10.69

6.65

g/l

3.58

Papulosquamous disorders

316

1657

1.92

26.04

1.4

6.55

6.84

g/l

0.84

230

1139

Disorders of skin appendages

397

2233

1.79

26.00

1.3

1.4

6.34

6.76

g/l

1.71

286

1544

Asthma mixed form (mode), excluding more controls

6.09

25.93

1.7

1.3

6.19

7.35

g/l

1.01

Other/unspecified seropositive rheumatoid arthritis

216

988

2.21

25.89

1.5

1.4

7.01

6.68

g/l

0.53

164

682

Deviated nasal septum

241

1150

2.11

25.81

1.3

6.49

7.18

g/l

2.33

156

747

Pain in thoracic spine

136

506

2.72

25.67

1.4

1.3

5.77

6.82

g/l

3.58

106

344

Other and unspecified vasculitis limited to skin

7.11

25.63

1.4

1.2

5.69

8.19

g/l

1.83

Lymphoid leukaemia

144

4.48

25.56

1.4

1.2

6.39

7.19

g/l

0.46

101

Thyroiditis, ILD-related definition

114

389

2.97

25.33

1.5

1.3

7.00

6.58

g/l

0.56

276

Gout, FINNGEN

198

879

2.26

25.32

1.4

6.87

7.13

g/l

0.31

133

601

Allergic conjunctivitis

468

2707

1.69

25.28

1.6

1.3

6.35

6.71

g/l

1.73

362

1879

Congenital malformations, deformations and chromosomal abnormalities

484

2759

1.68

25.24

1.5

1.4

6.53

6.69

g/l

0.45

331

1919

Temporal arteritis

6.11

25.23

1.2

1.5

5.97

7.23

g/l

0.91

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

213

980

2.19

25.18

1.5

1.4

6.98

6.69

g/l

0.45

161

679

Paralytic ileus and intestinal obstruction

190

834

2.30

25.10

1.4

1.3

6.71

7.02

g/l

0.38

123

571

Other (seronegative) rheumatoid arthritis, wide

162

664

2.47

25.08

1.5

1.3

6.87

6.68

g/l

0.19

121

456

Dentofacial anomalies [including malocclusion]

566

2817

1.62

25.06

1.4

6.50

6.73

g/l

0.85

385

1979

Major coronary heart disease event

611

2299

1.61

25.01

1.4

6.86

6.78

g/l

0.16

440

1583

Other diseases of urinary system

749

2743

1.54

24.98

1.4

6.79

6.82

g/l

0.07

521

1923

Glomerulonephritis

105

345

3.10

24.97

1.7

1.4

6.78

6.62

g/l

0.10

244

Cervicobrachial syndrome

182

788

2.33

24.90

1.6

1.3

6.11

6.99

g/l

2.29

144

527

Use of hypnotics and sedatives

809

3084

1.51

24.84

1.3

1.4

6.55

6.83

g/l

1.05

577

2125

Iridocyclitis

201

909

2.23

24.82

1.5

1.3

6.49

6.69

g/l

0.29

143

635

Factors influencing health status and contact with health services

201

423

2.40

24.77

1.3

6.64

7.24

g/l

1.13

144

268

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

164

682

2.44

24.64

1.2

1.4

8.17

6.59

g/l

4.44

101

477

Giant cell arteritis with polymyalgia rheumatica

5.95

24.57

1.2

1.4

5.97

7.70

g/l

1.43

Insulin medication

462

2303

1.70

24.55

1.5

1.3

6.70

6.84

g/l

0.25

295

1612

Ulcerative colitis (strict definition, require KELA)

169

714

2.40

24.52

1.2

1.4

8.13

6.59

g/l

4.45

104

498

Diseases of spleen

8.21

24.46

1.7

1.2

7.63

6.91

g/l

0.35

Other overlap syndromes

9.19

24.34

1.6

1.3

8.94

5.75

g/l

1.51

Non-selective monoamine reuptake inhibitors

287

1436

1.94

24.24

1.4

6.11

6.95

g/l

4.37

199

1003

GI-bleeding

229

1100

2.10

24.20

1.4

1.3

7.17

6.92

g/l

0.27

157

762

Sequelae with surgical and medical care as external cause

176

762

2.34

24.13

1.4

6.99

6.76

g/l

0.25

130

515

Disorders of parathyroid gland

160

655

2.44

24.12

1.7

1.3

6.48

6.94

g/l

0.78

112

447

Secondary hypertension

205

3.72

24.10

1.3

1.2

6.30

6.64

g/l

0.22

143

Rotator cuff syndrome

427

1778

1.73

23.80

1.4

1.3

6.26

7.09

g/l

5.09

313

1200

Somatoform disorder

154

634

2.46

23.66

1.4

1.3

6.04

6.67

g/l

2.03

107

431

Drug-induced osteoporosis

9.32

23.54

2.1

1.4

5.09

7.27

g/l

1.07

Other viral diseases

329

1792

1.84

23.52

1.5

1.3

6.80

6.61

g/l

0.34

240

1259

Emphysema

137

4.37

23.42

1.2

1.3

6.90

7.36

g/l

0.27

Cervical disc disorders

262

1338

1.97

23.39

1.4

6.03

7.13

g/l

5.88

178

910

Asthma mixed form (mode)

5.50

23.37

1.7

1.3

6.19

7.36

g/l

1.16

Paroxysmal tachycardia

174

626

2.34

23.35

1.4

1.3

6.64

6.76

g/l

0.17

117

428

Secondary right heart disease

5.41

23.32

1.3

8.51

7.18

g/l

0.50

Migraine without aura and triptan purchases

161

682

2.39

23.24

1.3

1.4

6.22

6.73

g/l

1.25

118

481

Other symptoms and signs involving the circulatory and respiratory systems

155

4.13

23.20

1.4

1.3

6.54

6.58

g/l

0.03

108

Systemic sclerosis (FG)

6.90

23.09

1.3

8.79

6.99

g/l

0.58

Cutaneous abscess, furuncle and carbuncle

225

1097

2.07

22.93

1.3

6.98

6.61

g/l

0.86

164

765

Sequelae of external causes of morbidity and mortality

211

1007

2.11

22.77

1.5

1.4

6.89

6.72

g/l

0.20

154

688

Herpesviral [herpes simplex] infections

221

1074

2.08

22.74

1.4

1.3

6.62

6.68

g/l

0.06

163

737

Diseases of arteries, arterioles and capillaries

450

1986

1.68

22.71

1.3

1.4

6.93

6.86

g/l

0.11

313

1367

Psychiatric diseases

750

2490

1.51

22.60

1.3

1.4

6.58

6.91

g/l

1.27

511

1721

Hypogonadotropic hypogonadism

5.07

22.43

1.2

5.59

6.95

g/l

1.29

130

507

2.60

22.43

1.6

1.3

7.43

6.50

g/l

0.79

340

Other or unspecified ileus, impaction or obstruction

140

566

2.50

22.34

1.3

1.4

6.94

6.85

g/l

0.07

389

Other pulmonary heart/vessel disease

102

4.91

22.30

1.4

1.3

8.41

7.41

g/l

0.38

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

173

770

2.27

22.29

1.2

1.4

8.05

6.62

g/l

4.00

107

535

Other diseases of the digestive system

225

1110

2.04

22.18

1.3

1.4

7.10

6.93

g/l

0.17

157

771

Acute and subacute iridocyclitis

171

759

2.28

22.17

1.4

1.3

6.42

6.69

g/l

0.38

116

533

Idiopathic thrombocytopenic purpura

5.41

22.15

1.4

1.3

7.67

7.30

g/l

0.15

Pain and other conditions associated with female genital organs and menstrual cycle

177

728

2.25

22.11

1.4

6.64

6.83

g/l

0.24

122

506

Arthrosis

486

1612

1.66

22.09

1.3

1.4

6.79

6.87

g/l

0.19

341

1101

Ascites

170

3.88

22.04

1.3

1.2

8.02

6.87

g/l

0.85

125

Extracorporeal dialysis

184

3.78

22.03

1.5

1.3

5.45

6.96

g/l

1.98

131

Disorders of synovium and tendon

385

1964

1.73

22.02

1.5

1.3

6.29

7.00

g/l

4.33

265

1346

Atopic dermatitis

452

2247

1.66

21.95

1.3

6.74

6.73

g/l

0.02

338

1573

Recurrent aphthous stomatitis , including avohilmo

135

543

2.52

21.86

1.4

6.37

6.70

g/l

0.49

107

377

Other specified/unspecified soft tissue disorders

104

4.80

21.78

1.5

1.4

6.26

7.25

g/l

0.85

Other anxiety disorders

375

1885

1.73

21.76

1.3

6.46

6.68

g/l

0.50

291

1288

Gastroduodenal ulcer

172

769

2.25

21.70

1.3

1.4

6.82

7.19

g/l

0.58

111

515

Disorders of the thyroid gland

693

3004

1.51

21.65

1.5

1.3

6.68

6.75

g/l

0.17

455

2129

Triptan medication for migraine, min. 3 purchases

459

2135

1.65

21.65

1.4

1.3

6.13

6.80

g/l

4.93

336

1486

Heart failure and coronary heart disease

270

992

1.94

21.63

1.4

1.3

7.49

7.02

g/l

0.70

190

651

Migraine, single triptan purchase ok & required. ICD-code if available is included

608

2672

1.55

21.57

1.4

6.57

6.73

g/l

0.49

423

1860

Triptan medication for migraine, single purchase ok

608

2672

1.55

21.57

1.4

6.57

6.73

g/l

0.49

423

1860

Other abnormal immunological findings in serum

6.79

21.44

1.7

1.2

6.87

6.13

g/l

0.64

Obesity and other hyperalimentation

486

2935

1.60

21.24

1.4

6.33

6.82

g/l

2.55

341

2069

Lung diseases due to external agents

107

389

2.78

21.20

1.2

1.4

6.96

6.78

g/l

0.18

282

Nonalcoholic fatty liver disease

107

391

2.78

21.08

1.3

1.4

6.85

6.83

g/l

0.02

271

Exposure to unspecified factor

748

3677

1.47

20.95

1.4

6.80

6.72

g/l

0.21

476

2604

Anterior Iridocyclitis

177

816

2.19

20.95

1.4

1.3

6.43

6.74

g/l

0.46

121

564

Otitis media, unspecified

115

399

2.69

20.92

1.3

5.79

6.72

g/l

3.00

298

Volume depletion

244

3.28

20.85

1.4

1.3

6.21

6.67

g/l

0.49

161

Hypothyroidism, other/unspecified

646

2812

1.52

20.81

1.4

1.3

6.76

6.75

g/l

0.01

425

1997

Deforming dorsopathies

212

1051

2.03

20.68

1.5

1.4

6.30

6.92

g/l

1.99

160

718

Other arthrosis

353

1400

1.75

20.59

1.3

1.4

6.62

6.90

g/l

0.67

254

964

Other viral diseases, not elsewhere classified

176

813

2.18

20.58

1.4

6.86

6.59

g/l

0.33

133

582

Obesity

482

2933

1.59

20.55

1.4

6.34

6.82

g/l

2.43

337

2069

Nonorganic sleeping disorders, excluding more controls

164

739

2.24

20.52

1.3

6.11

6.84

g/l

2.46

111

500

Hypothyreosis and Thyroxine purchase for inclusion criteria

669

2935

1.50

20.52

1.4

6.86

6.74

g/l

0.31

443

2086

Total colectomy operation

118

4.43

20.45

1.6

1.4

7.76

7.08

g/l

0.38

Total colectomy

118

4.43

20.45

1.6

1.4

7.76

7.08

g/l

0.38

Glomerular disorders in diseases classified elsewhere

105

386

2.76

20.43

1.4

6.22

6.73

g/l

0.64

273

Other inflammation of eyelid

121

478

2.56

20.39

1.6

1.3

6.39

6.80

g/l

0.53

330

Acute tubulo-interstitial nephritis

441

2345

1.63

20.34

1.4

6.81

6.73

g/l

0.14

314

1654

Chronic gastritis

181

852

2.14

20.28

1.3

1.4

6.76

7.04

g/l

0.43

144

582

Seronegative rheumatoid arthritis

327

2.91

20.25

1.4

1.3

7.12

6.81

g/l

0.19

216

Viral pneumonia (known virus, not influenza)

5.69

20.20

1.5

1.3

6.08

7.26

g/l

0.84

Bronchitis, not specified as acute or chronic

224

3.35

20.19

1.5

1.3

6.49

7.03

g/l

0.73

152

Non-Hodgkin lymphoma, all

4.84

20.16

1.5

1.2

5.40

7.22

g/l

1.86

Dizziness and giddiness

540

2765

1.55

20.12

1.4

6.56

6.82

g/l

0.95

380

1927

Dermatitis due to substances taken internally

150

3.94

20.04

1.5

5.68

7.10

g/l

1.54

105

Acute laryngitis and tracheitis

108

400

2.68

19.96

1.3

5.99

6.97

g/l

2.50

263

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

4.81

19.95

1.4

1.3

7.60

7.21

g/l

0.17

Stomatitis and related lesions

175

820

2.16

19.91

1.3

6.85

6.67

g/l

0.18

135

575

Congenital malformations of the musculoskeletal system, not elsewhere classified

6.09

19.81

1.4

1.2

5.61

6.16

g/l

0.70

Other infectious diseases

273

3.08

19.78

1.4

1.3

6.89

6.98

g/l

0.06

190

Convulsions, not elsewhere classified

166

753

2.19

19.74

1.5

1.3

6.80

6.66

g/l

0.19

118

520

Behavioural syndromes associated with physiological disturbances and physical factors

691

3335

1.47

19.73

1.3

1.4

6.55

6.78

g/l

0.81

483

2322

Myocarditis

117

4.35

19.71

1.4

1.2

7.17

6.35

g/l

0.66

Other and unspecified urticaria

178

845

2.13

19.59

1.4

1.3

6.60

g/l

0.00

127

586

Systemic sclerosis

5.82

19.58

1.3

8.79

6.83

g/l

0.70

Care involving dialysis

270

3.09

19.54

1.4

1.3

5.92

6.59

g/l

0.74

191

Insulin, fast-acting

276

1525

1.82

19.41

1.5

1.3

6.64

6.80

g/l

0.25

179

1072

Endocarditis

5.18

19.37

1.4

1.2

8.64

6.41

g/l

1.04

Other viral diseases, not elsewhere classified

235

1231

1.91

19.28

1.4

6.74

6.53

g/l

0.34

179

867

Ehlers-Danlos syndrome

7.57

19.27

1.4

1.3

5.44

6.49

g/l

1.44

Heart failure and bmi 25plus

218

737

2.01

19.19

1.4

1.3

7.73

6.68

g/l

1.78

136

458

Non-ischemic cardiomyopathy

206

826

2.02

19.09

1.3

7.02

6.84

g/l

0.24

139

559

Other viral diseases

258

1401

1.85

19.07

1.6

1.3

6.97

6.54

g/l

0.78

188

991

Other diseases of hard tissues of teeth

408

1264

1.68

19.04

1.4

1.3

6.69

6.80

g/l

0.20

278

856

6-mercaptopurine

5.32

18.96

2.1

1.2

8.74

6.67

g/l

0.63

Other diseases of intestine

113

452

2.53

18.57

1.4

1.3

6.80

6.72

g/l

0.06

309

Other metabolic disorders

121

500

2.45

18.57

1.7

1.3

6.51

6.65

g/l

0.16

343

Persons with potential health hazards related to communicable diseases

320

1855

1.72

18.53

1.4

1.3

6.30

6.67

g/l

1.13

196

1324

Other arrhythmias

448

2131

1.59

18.46

1.4

6.76

6.64

g/l

0.30

294

1491

Adverse effects, not elsewhere classified

175

845

2.09

18.45

1.6

1.3

6.44

6.62

g/l

0.27

126

599

Senile cataract

413

1549

1.64

18.45

1.3

1.4

6.60

6.91

g/l

0.74

285

1095

Cervicalgia

151

688

2.21

18.44

1.8

1.3

6.30

6.97

g/l

1.75

111

464

Sleep disorders

655

3239

1.47

18.30

1.3

1.4

6.49

6.79

g/l

1.42

455

2246

Chronic iridocyclitis

151

3.79

18.29

1.5

1.3

6.18

6.88

g/l

0.71

108

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

302

2.89

18.29

1.5

1.3

5.70

6.85

g/l

2.25

214

Intestinal stricture

221

1163

1.91

18.21

1.3

1.4

6.61

6.95

g/l

0.51

147

802

Benign neoplasm: Transverse colon

336

2.78

18.19

1.5

1.4

6.34

7.16

g/l

1.36

236

Hernia

676

3116

1.46

18.17

1.4

6.70

6.73

g/l

0.07

473

2146

Other enthesopathies

215

1122

1.93

18.17

1.6

1.3

5.91

7.06

g/l

5.68

154

770

Diabetes mellitus

757

3095

1.43

18.14

1.5

1.4

6.59

6.79

g/l

0.58

501

2193

Selective serotonin reuptake inhibitors

715

2575

1.45

18.02

1.3

1.4

6.36

6.92

g/l

3.41

494

1794

Psoriatic and enteropathic arthropathies

100

383

2.64

18.00

1.3

6.67

6.71

g/l

0.04

259

Type 2 diabetes

710

2876

1.45

17.84

1.5

1.4

6.62

6.81

g/l

0.52

474

2025

Other cataract

297

1286

1.76

17.78

1.4

1.3

6.81

6.85

g/l

0.07

205

909

Misadventures to patients during surgical and medical care

120

505

2.40

17.71

1.3

6.58

6.84

g/l

0.31

356

Diabetes, varying definitions

751

3092

1.43

17.64

1.5

1.4

6.57

6.79

g/l

0.64

494

2192

Diseases of tongue

160

3.62

17.53

1.5

1.3

5.92

7.01

g/l

1.56

109

Insulin, intermediate and long-acting

380

2289

1.62

17.53

1.4

6.64

6.83

g/l

0.41

245

1605

Vascular disorders of the intestines

137

3.84

17.50

1.2

1.3

7.69

7.15

g/l

0.28

Insulin, fast-acting or short human

277

1582

1.76

17.48

1.5

1.3

6.63

6.80

g/l

0.26

180

1100

Radiculopathy

115

479

2.42

17.35

1.4

1.3

6.11

6.99

g/l

2.31

334

Other medical care

317

1687

1.70

17.33

1.3

1.4

6.58

6.84

g/l

0.47

217

1168

Internal derangement of knee

256

1426

1.80

17.31

1.5

1.4

6.37

6.84

g/l

1.18

176

984

Heartburn

311

2.80

17.31

1.3

1.2

6.26

6.84

g/l

0.94

218

L04AC Interleukin inhibitors

206

3.27

17.26

1.4

1.3

6.54

6.77

g/l

0.21

141

Pyothorax

108

4.25

17.25

1.4

1.3

6.81

7.13

g/l

0.20

Viral infections of the central nervous system

274

2.93

17.23

1.3

1.4

6.07

6.72

g/l

0.71

189

Fissure and fistula of anal and rectal regions

174

860

2.04

17.22

1.2

1.3

6.81

6.82

g/l

0.00

115

576

SLE, strict definition

117

4.13

17.21

1.6

1.4

6.90

6.88

g/l

0.01

SLE, ICD10

117

4.13

17.21

1.6

1.4

6.90

6.88

g/l

0.01

Other disorders of ear

656

2967

1.45

17.21

1.5

1.4

6.48

6.84

g/l

1.82

456

2092

Gonarthrosis [arthrosis of knee](FG)

454

1679

1.58

17.17

1.3

6.76

6.83

g/l

0.16

325

1148

Other infectious diseases

222

3.15

17.13

1.4

1.3

7.19

7.00

g/l

0.11

156

Invasive ventilation

217

3.18

17.13

1.3

5.52

6.85

g/l

1.94

154

Haemorrhoids and perianal venous thrombosis

210

1107

1.90

17.11

1.2

1.4

7.46

7.01

g/l

0.66

139

758

Hepatic failure, not elsewhere classified

4.65

17.11

1.4

1.3

7.71

6.58

g/l

0.79

Malignant neoplasm of pancreas, including Hilmo

217

3.17

17.10

1.6

1.4

6.86

7.05

g/l

0.16

158

Dermatographic urticaria

233

3.10

17.07

1.8

1.4

6.12

6.67

g/l

0.82

161

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

684

3053

1.44

17.03

1.4

6.95

6.76

g/l

0.47

460

2138

Panhypopituitarism

6.27

16.98

1.7

1.3

5.03

7.47

g/l

—

Ocular pain

299

2.82

16.89

1.5

6.10

6.64

g/l

0.98

207

Insomnia

635

3201

1.45

16.83

1.3

1.4

6.46

6.79

g/l

1.61

448

2216

Coxibs

198

518

2.02

16.79

1.3

6.27

7.37

g/l

3.48

138

355

Unspecified kidney failure

246

3.00

16.72

1.3

1.4

7.12

6.75

g/l

0.24

172

Ulcerative enterocolitis

4.56

16.67

1.4

1.3

7.73

6.60

g/l

0.79

Other and unspecified effects of external causes

227

1242

1.84

16.63

1.5

1.3

6.54

6.60

g/l

0.11

162

863

Other disorders of eye and adnexa

126

558

2.28

16.58

1.4

6.03

6.85

g/l

2.77

387

Crohn's disease of small intestine

243

3.01

16.50

1.3

1.4

6.44

6.70

g/l

0.19

172

Gastric ulcer

114

484

2.37

16.49

1.3

6.89

6.98

g/l

0.09

331

Chorioretinal inflammation

5.06

16.49

1.4

1.3

6.45

7.09

g/l

0.37

Systemic sclerosis, icd10

4.96

16.49

1.3

8.79

7.14

g/l

0.56

Seropositive rheumatoid arthritis, strict definition

122

535

2.30

16.43

1.4

1.3

6.93

6.75

g/l

0.16

362

Keratitis

265

1524

1.75

16.40

1.4

6.90

6.74

g/l

0.31

178

1044

Psoriasis

217

1178

1.86

16.32

1.3

1.4

6.68

6.79

g/l

0.20

156

811

Symptoms and signs involving the urinary system

527

2701

1.49

16.27

1.5

1.4

6.84

6.79

g/l

0.10

372

1865

Gout, idiopatic and unspecified

163

805

2.04

16.21

1.4

1.3

6.71

7.12

g/l

0.47

108

562

Congenital malformations of the musculoskeletal system, not elsewhere classified

5.81

16.18

1.4

1.2

5.58

6.11

g/l

0.58

Type 2 diabetes, wide definition

497

2103

1.52

16.18

1.4

1.3

6.68

6.88

g/l

0.47

360

1533

Conjunctivitis (acute, non atopic)

220

1198

1.84

16.18

1.4

1.3

6.88

6.67

g/l

0.30

164

838

Other and unspecified types of non-Hodgkin lymphoma, hilmo

105

4.18

16.13

1.7

1.3

6.04

6.98

g/l

0.61

Secondary and unspecified malignant neoplasm of lymph nodes

257

2.92

16.12

1.4

6.87

6.93

g/l

0.03

183

Localized swelling, mass and lump of skin and subcutaneous tissue

229

1269

1.82

16.10

1.6

1.3

7.19

6.75

g/l

0.79

186

862

Benign neoplasm: Colon, unspecified

171

864

1.99

15.97

1.5

1.4

6.65

7.01

g/l

0.54

120

596

Viral infections of the central nervous system

248

2.95

15.93

1.4

5.60

6.73

g/l

2.51

168

Postviral fatigue syndrome

12.65

15.88

2.0

1.4

6.05

6.37

g/l

0.19

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

315

2.70

15.84

1.3

1.4

7.52

6.69

g/l

0.53

227

Chronic apical periodontitis

806

3326

1.38

15.79

1.4

6.63

6.76

g/l

0.45

537

2330

Coronary atherosclerosis

408

1642

1.58

15.78

1.4

7.01

6.84

g/l

0.30

284

1115

Disorders of ocular muscles, binocular movement, accommodation and refraction

354

2199

1.60

15.75

1.5

1.4

6.42

6.73

g/l

1.16

256

1541

Chronic ulcer of skin, not elsewhere classified

167

3.40

15.74

1.9

1.3

6.67

7.31

g/l

0.54

119

Algoneurodystrophy

103

4.18

15.70

1.4

1.3

6.04

6.96

g/l

0.79

Other diseases of stomach and duodenum

158

3.47

15.64

1.3

6.68

7.32

g/l

0.55

109

Soft tissue disorders related to use, overuse and pressure

185

968

1.92

15.60

1.4

1.3

6.43

7.17

g/l

2.07

141

654

Congenital malformations and deformations of the musculoskeletal system

386

2.51

15.55

1.6

1.3

6.16

6.37

g/l

0.32

291

Rare circulating lymphoid malignancy, including Hilmo

4.67

15.47

2.0

1.2

6.22

6.85

g/l

0.21

Pneumothorax

169

3.36

15.46

1.3

1.2

7.68

6.76

g/l

0.84

122

Excessive, frequent and irregular menstruation

284

899

1.74

15.45

1.4

6.19

6.74

g/l

1.81

195

617

Other CVD (FINNGEN)

218

2.83

15.44

1.3

6.71

7.09

g/l

0.25

144

Atopic dermatitis, strict definition

250

1411

1.75

15.36

1.4

6.84

6.61

g/l

0.36

193

990

Cluster headache, strict

4.25

15.36

1.3

6.49

6.55

g/l

0.05

Obesity due to excess calories

351

2211

1.60

15.33

1.3

1.4

6.48

6.82

g/l

1.09

242

1540

Spondylolisthesis/Spondylolysis

129

596

2.18

15.32

1.7

1.3

5.93

6.92

g/l

3.08

408

Abnormal findings on diagnostic imaging of central nervous system

151

3.51

15.28

1.6

1.3

6.51

6.70

g/l

0.15

111

Chronic nephritic syndrome

114

3.95

15.27

1.9

1.3

7.82

6.95

g/l

0.30

Dental operations

406

1322

1.58

15.25

1.4

1.3

6.86

6.75

g/l

0.20

277

928

Pruritus

358

2.54

15.08

1.6

1.4

7.14

7.02

g/l

0.10

255

Genitourinary diseases

434

1404

1.56

15.05

1.3

6.69

6.82

g/l

0.30

304

963

Missing teeth due to accident, extraction or parodontitis

394

2406

1.55

15.04

1.5

1.4

6.87

6.84

g/l

0.05

270

1667

Acute pharyngitis

117

519

2.25

15.03

1.3

6.05

6.92

g/l

2.11

349

Crohn's disease NAS

224

2.99

15.02

1.2

1.3

7.00

6.78

g/l

0.16

157

Congenital malformations and deformations of the musculoskeletal system

112

490

2.30

15.02

1.5

1.4

6.31

6.48

g/l

0.27

371

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

5.92

15.01

1.5

1.3

7.75

7.22

g/l

0.16

Haemolytic anaemias

4.18

14.97

1.6

1.3

8.20

6.78

g/l

0.47

Other/unspecified rheumatoid arthritis

377

2.49

14.97

1.5

1.4

6.25

6.98

g/l

1.37

253

Personality disorders, excluding more controls

190

1018

1.88

14.91

1.3

6.26

6.84

g/l

2.16

130

686

Cluster headache, wide

103

4.06

14.82

1.3

6.38

6.49

g/l

0.10

Cerebral cysts

174

3.27

14.79

1.8

1.3

6.54

6.77

g/l

0.14

126

Exclusions for E4_PCOS_CONSORTIUM

539

2314

1.46

14.72

1.4

6.32

6.73

g/l

1.76

325

1672

Subjective visual disturbances

189

1018

1.87

14.64

1.4

1.3

6.45

6.77

g/l

0.58

137

687

Pyogenic arthritis

170

3.28

14.63

1.3

8.06

7.16

g/l

0.67

117

Other peripheral vascular diseases

249

2.85

14.63

1.3

1.4

5.78

6.62

g/l

1.64

176

Postprocedural disorders of nervous system

255

2.82

14.59

1.5

1.4

6.23

6.58

g/l

0.32

183

Ulcerative ileocolitis

133

3.61

14.39

1.2

1.3

9.33

6.51

g/l

2.10

Diseases of oral cavity, salivary glands and jaws

387

1267

1.58

14.33

1.4

1.3

6.69

6.79

g/l

0.18

274

859

Disorders of mineral metabolism

263

2.77

14.33

1.3

1.4

7.07

6.65

g/l

0.31

181

Acute lymphadenitis

209

3.02

14.30

1.9

1.3

6.63

6.38

g/l

0.20

152

Brachial plexus disorders

356

2.50

14.27

1.5

1.4

5.80

6.52

g/l

1.48

249

Other meningitis

5.85

14.23

1.6

1.3

5.57

6.51

g/l

0.83

Gout, unspecified

133

641

2.09

14.21

1.4

1.3

6.86

7.08

g/l

0.19

449

Other disorders of bone

156

797

1.97

14.19

1.5

1.3

6.00

6.73

g/l

1.97

114

560

Polyarthritis, unspecified

4.24

14.18

1.8

1.4

6.84

7.27

g/l

0.18

Rash and other nonspecific skin eruption

328

2.56

14.14

1.4

6.63

6.91

g/l

0.30

236

Disorders of optic nerve and visual pathways

346

2.52

14.12

1.5

1.4

6.10

6.61

g/l

0.65

244

Lichen simplex chronicus and prurigo

169

3.24

14.11

1.1

1.5

7.36

6.79

g/l

0.41

119

Meniscus derangement

346

1473

1.59

14.00

1.3

1.4

6.55

6.89

g/l

0.95

218

1006

Enthesopathies of lower limb, excluding foot

156

801

1.96

13.98

1.5

1.3

6.53

6.97

g/l

0.88

115

539

Nephrotic syndrome

4.04

13.96

1.9

1.3

4.85

6.82

g/l

2.16

Small fibre neuropathy

4.38

13.91

1.5

1.3

5.79

7.33

g/l

1.82

Exposure to other specified factors

541

3484

1.43

13.90

1.5

1.4

6.77

6.73

g/l

0.08

385

2419

Coeliac disease

101

440

2.32

13.90

1.7

1.4

6.85

6.80

g/l

0.05

307

Cardiac murmurs and other cardiac sounds

264

2.72

13.87

1.2

1.3

6.68

6.60

g/l

0.06

196

Other disorders of skin and subcutaneous tissue, not elsewhere classified

107

478

2.26

13.86

1.7

1.3

6.35

6.87

g/l

0.82

336

Acetic acid derivatives and related substances

187

507

1.92

13.86

1.5

1.3

6.35

7.39

g/l

2.41

131

347

Demyelinating diseases of the central nervous system

332

2.53

13.81

1.4

6.30

6.54

g/l

0.26

232

Other abnormalities of plasma proteins

6.69

13.74

1.8

1.4

7.37

6.08

g/l

0.32

Carpal tunnel syndrome

411

2419

1.50

13.59

1.4

6.48

6.87

g/l

1.66

293

1686

Substance abuse, excluding more controls

374

2087

1.53

13.51

1.3

1.4

6.36

6.95

g/l

2.64

247

1414

Diabetes medication

737

3209

1.37

13.51

1.4

6.60

6.78

g/l

0.50

491

2265

Hypersensitivity pneumonitis due to organic dust

6.26

13.48

1.1

1.4

8.43

7.20

g/l

0.59

Persons encountering health services for specific procedures, not carried out

289

2.63

13.47

1.3

1.4

5.96

6.79

g/l

1.60

201

Abscess of lung

5.76

13.47

1.4

6.68

6.94

g/l

0.11

Postmenopausal osteoporosis with pathological fracture

139

3.43

13.44

1.3

1.4

5.98

6.94

g/l

0.97

Diseases of the myoneural junction and muscle

397

2.37

13.42

1.5

1.4

6.06

6.72

g/l

1.17

286

Type 2 diabetes, definitions combined

648

2740

1.39

13.35

1.4

6.54

6.83

g/l

0.92

433

1936

Cardiomyopathy

116

544

2.15

13.33

1.4

1.3

7.57

6.83

g/l

0.92

379

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

658

2866

1.39

13.32

1.4

6.53

6.79

g/l

0.78

433

2029

Disorders of calcium metabolism

181

3.08

13.24

1.3

1.4

7.32

6.76

g/l

0.32

123

Crohn's disease of large intestine

176

3.12

13.23

1.3

7.31

6.85

g/l

0.24

127

Benign neoplasm: Stomach

310

2.55

13.17

1.8

1.4

5.98

7.00

g/l

2.00

214

Ischaemic heart disease, wide definition

499

2135

1.45

13.13

1.5

1.4

6.85

6.83

g/l

0.03

342

1475

Ankylosing spondylitis

287

2.61

13.12

1.3

6.66

6.89

g/l

0.28

200

Ovarian cyst

253

860

1.71

13.08

1.3

1.4

6.35

6.73

g/l

0.89

177

586

Viral and other specified intestinal infections

213

1186

1.74

13.07

1.5

1.3

6.52

6.50

g/l

0.03

147

829

Tonsillectomy and adenotomy

441

2081

1.48

13.06

1.4

1.3

6.32

6.65

g/l

1.06

331

1433

Inflammatory diseases of female pelvic organs

425

2107

1.49

13.04

1.4

6.43

6.68

g/l

0.76

305

1485

Other diseases of oesophagus

248

2.73

13.01

1.2

1.3

6.76

7.04

g/l

0.26

172

Oxicams

157

452

1.98

13.01

1.3

6.26

7.36

g/l

3.23

117

310

Substance use, excluding alcohol

160

850

1.90

13.01

1.3

6.47

6.71

g/l

0.37

111

588

Postprocedural endocrine and metabolic disorders, not elsewhere classified

101

453

2.25

13.01

1.8

1.3

6.47

6.62

g/l

0.17

312

Pleural plaque

204

2.92

13.00

1.4

1.2

7.35

6.85

g/l

0.45

146

Ulcerative colitis (strict definition, all Crohn cases excluded)

122

590

2.09

12.99

1.2

1.4

8.23

6.60

g/l

3.70

419

Other and unspecified drugs and medicaments

283

2.61

12.98

1.4

5.69

6.77

g/l

1.80

192

Viral and other specified intestinal infections

163

850

1.88

12.96

1.6

1.3

6.56

6.57

g/l

0.01

109

597

Chronic tubulo-interstitial nephritis

4.02

12.93

1.3

1.5

8.27

6.69

g/l

1.07

Benign neoplasm: Pancreas

4.54

12.91

1.5

1.3

6.21

7.60

g/l

0.80

Gonarthrosis

387

1446

1.53

12.91

1.3

1.4

6.79

6.92

g/l

0.27

277

994

Reactive arthropathies, FINNGEN

216

2.86

12.90

1.4

1.3

6.48

6.72

g/l

0.23

147

Obesity, other/unspecified

255

1553

1.65

12.89

1.5

1.4

6.42

6.75

g/l

0.84

195

1081

Marginal zone B-cell lymphoma, including Hilmo

5.52

12.87

1.5

1.3

6.97

6.36

g/l

0.17

Other neurological diseases

468

2540

1.45

12.85

1.4

6.37

6.89

g/l

2.24

324

1757

Disease of hard tissues of teeth, NOS

366

1237

1.55

12.84

1.4

1.3

6.55

6.80

g/l

0.68

247

836

Crohn disease (strict definition, require KELA, min 2 HDR)

234

2.78

12.78

1.2

1.3

6.69

6.77

g/l

0.05

164

Hyperkinetic disorders, excluding more controls

104

454

2.21

12.75

1.3

6.38

6.75

g/l

0.55

313

Panic disorder

125

615

2.05

12.70

1.3

6.86

6.74

g/l

0.15

421

Meningitis

160

3.18

12.65

1.6

1.3

5.91

6.79

g/l

1.15

114

394

2396

1.49

12.63

1.3

1.4

6.54

6.82

g/l

0.76

236

1655

Covid-19 suspected case

175

967

1.82

12.57

1.3

6.58

6.71

g/l

0.22

153

661

Alcohol use disorder, Swedish definition

370

2259

1.51

12.51

1.3

1.4

6.49

6.84

g/l

1.00

221

1561

Crohn disease (strict definition, require KELA)

237

2.74

12.48

1.2

1.3

6.69

6.77

g/l

0.04

167

Retention of urine

209

991

1.74

12.47

1.5

1.4

6.98

7.02

g/l

0.05

146

671

Acquired haemolytic anaemia

4.53

12.45

1.6

1.4

7.31

6.85

g/l

0.10

Type 2 diabetes, strict (exclude DM1)

648

2774

1.38

12.44

1.4

6.55

6.83

g/l

0.90

433

1951

Injuries to the abdomen, lower back, lumbar spine and pelvis

261

1596

1.63

12.41

1.2

1.4

6.41

6.85

g/l

1.40

187

1093

Adenocarcinoma and ductal carcinoma of pancreas

4.16

12.35

1.1

1.4

6.27

7.39

g/l

0.67

Disorders of muscles

320

2.46

12.32

1.3

6.40

6.87

g/l

0.48

223

Colectomy operation

116

562

2.08

12.30

1.4

1.3

7.63

6.83

g/l

0.95

383

Other disorders of conjunctiva

101

464

2.20

12.29

1.5

1.3

6.54

6.89

g/l

0.48

318

Other bursopathies

413

2.27

12.28

1.5

1.3

6.45

6.87

g/l

0.58

282

Psoriasis vulgaris

140

726

1.94

12.27

1.2

1.3

6.64

6.84

g/l

0.30

101

503

Diffuse large B-cell lymphoma, helper endpoint

123

3.47

12.24

1.4

4.98

7.04

g/l

2.77

Diffuse large B-cell lymphoma

123

3.47

12.24

1.4

4.98

7.04

g/l

2.77

Diffuse large B-cell lymphoma, including Hilmo

123

3.47

12.24

1.4

4.98

7.04

g/l

2.77

Other demyelinating diseases of the central nervous system

138

3.33

12.23

1.4

6.42

6.74

g/l

0.22

Chronic lymphocytic leukaemia

4.45

12.21

1.3

1.2

7.02

7.38

g/l

0.09

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

4.45

12.21

1.3

1.2

7.02

7.38

g/l

0.09

Chronic lymphocytic leukaemia, helper endpoint

4.45

12.21

1.3

1.2

7.02

7.38

g/l

0.09

Nonorganic sleeping disorders

164

897

1.84

12.20

1.3

1.4

6.11

6.65

g/l

1.62

111

619

Sacroiliitis, not elsewhere classified

138

3.31

12.20

1.4

1.5

6.63

6.57

g/l

0.03

Other coagulation defects

257

2.64

12.20

1.5

1.4

6.73

6.62

g/l

0.07

176

Hyperlipidaemia, other/unspecified

234

1299

1.67

12.15

1.4

6.84

7.02

g/l

0.22

169

884

Faecal incontinence

218

2.78

12.10

1.4

1.2

6.48

6.93

g/l

0.37

149

Fentanyl

240

2.68

12.10

1.7

1.2

6.56

6.96

g/l

0.30

173

Extreme obesity with alveolar hypoventilation

110

3.61

12.04

1.4

1.3

7.58

7.09

g/l

0.19

Psoriatic arthropathies

342

2.39

12.03

1.3

6.55

6.90

g/l

0.37

231

Other external causes of accidental injury

601

2170

1.39

12.01

1.4

1.3

6.54

6.84

g/l

1.27

420

1523

Hypothyroidism, strict autoimmune, 3 medication purchases required

560

2721

1.39

11.98

1.3

7.07

6.74

g/l

0.92

389

1935

Vitamin deficiency

135

3.31

11.93

1.2

1.3

6.49

6.87

g/l

0.20

Vitamin deficiency, wide

135

3.31

11.93

1.2

1.3

6.49

6.87

g/l

0.20

411

2484

1.46

11.92

1.3

1.4

6.53

6.84

g/l

0.88

248

1718

Erythema nodosum

4.14

11.90

1.6

1.4

7.61

7.14

g/l

0.16

Trochanteric bursitis

438

2.21

11.89

1.5

1.4

5.87

6.99

g/l

2.77

305

Otalgia

284

2.53

11.88

1.7

1.3

5.90

6.94

g/l

1.92

204

Tongue abnormality

177

2.98

11.85

1.6

1.5

5.79

7.01

g/l

1.56

125

Cluster headache, strict, including avohilmo

167

3.04

11.79

1.3

6.14

6.85

g/l

0.95

113

Acute generalized exanthematous pustulosis

142

3.23

11.68

1.4

1.3

5.60

7.10

g/l

1.55

100

Injuries to the knee and lower leg

827

3502

1.31

11.65

1.4

6.58

6.77

g/l

0.77

591

2416

Coxarthrosis [arthrosis of hip](FG)

294

1321

1.57

11.58

1.3

6.56

6.92

g/l

1.03

226

896

Generalized skin eruption due to drugs and medicaments

118

3.45

11.56

1.5

1.3

5.51

7.04

g/l

1.30

Haemorrhage, not elsewhere classified

4.23

11.55

1.4

1.3

6.71

7.65

g/l

0.46

Abnormal findings on examination of urine, without diagnosis

123

3.39

11.53

1.4

1.3

6.07

7.10

g/l

1.09

Secondary uncertain malignant neoplasm

412

2.23

11.50

1.4

6.68

6.93

g/l

0.18

288

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

164

3.03

11.50

1.6

1.4

7.51

7.00

g/l

0.26

123

Synovial cyst of popliteal space [Baker]

180

2.92

11.49

1.3

6.23

7.22

g/l

1.04

126

Type 2 diabetes, definitions combined, including avohilmo

645

2774

1.36

11.46

1.4

6.54

6.82

g/l

0.90

434

1949

Hodgkin lymphoma, hilmo

4.11

11.45

1.6

1.3

6.21

6.72

g/l

0.27

Other diseases of anus and rectum

180

1031

1.75

11.39

1.2

1.4

6.69

6.94

g/l

0.39

134

713

STROKE

353

1600

1.51

11.37

1.3

1.4

7.03

6.79

g/l

0.43

254

1092

Cluster headache, wide,, including avohilmo

176

2.94

11.37

1.3

6.07

6.87

g/l

1.18

120

Diseases of pulp and periapical tissues, including avohilmo

735

2863

1.33

11.33

1.4

6.87

6.72

g/l

0.42

511

1994

Cytomegalovirus infection, IBD co-morbidity

4.42

11.30

1.4

1.2

6.46

7.19

g/l

0.19

Other and unspecified visual disturbances

346

2.34

11.29

1.7

1.3

6.41

6.93

g/l

0.53

237

Oter anti-inflammatory and antirheumatic agents, non-steroids

143

407

1.95

11.28

1.2

1.3

6.68

7.39

g/l

0.91

107

280

Carrier of infectious disease

4.07

11.27

1.6

1.3

6.41

6.75

g/l

0.20

Other or ill-defined heart diseases

145

3.14

11.26

1.4

1.2

7.69

6.76

g/l

0.78

Vitamin D deficiency

4.69

11.26

1.2

1.3

5.86

6.79

g/l

0.44

Rosacea

442

2.17

11.26

1.3

1.4

6.50

6.88

g/l

0.45

302

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

173

873

1.78

11.24

1.3

6.33

6.58

g/l

0.55

127

617

Hyperhidrosis

4.50

11.22

1.4

1.2

6.03

7.41

g/l

0.92

Other diseases of arteries and capillaries

251

2.58

11.16

1.6

1.4

6.72

6.71

g/l

0.01

178

Raynaud syndrome

311

2.41

11.16

1.4

1.5

6.32

6.66

g/l

0.26

220

Cardiomyopathy, other and unspecified

211

2.73

11.14

1.4

1.3

7.93

6.45

g/l

1.28

155

Malignant neoplasm of pancreas

162

3.00

11.11

1.2

1.4

6.47

7.00

g/l

0.42

118

Dental caries, including avohilmo

493

1784

1.42

11.07

1.4

1.3

6.60

6.79

g/l

0.49

335

1248

External causes of morbidity and mortality

475

1672

1.43

11.04

1.4

1.3

6.53

6.96

g/l

1.85

330

1173

Aortic aneurysm

132

682

1.91

11.04

1.4

1.3

7.29

7.02

g/l

0.21

476

Hyperparathyroidism

112

552

2.02

11.01

1.4

1.3

6.51

6.84

g/l

0.40

376

Hernia of abdominal wall

295

1933

1.53

11.00

1.5

1.4

6.77

6.83

g/l

0.08

211

1342

Autonomic disorders

4.73

11.00

1.4

5.48

7.28

g/l

1.14

Ulcerative rectosigmoiditis

295

2.44

10.98

1.3

7.84

6.78

g/l

1.11

206

Falls/tendency to fall

780

2979

1.31

10.85

1.3

1.4

6.67

6.75

g/l

0.23

549

2063

Oesophagitis

128

3.24

10.83

1.3

1.2

5.83

7.14

g/l

1.44

Benign neoplasm: Caecum

334

2.33

10.82

1.6

1.4

6.68

7.18

g/l

0.58

236

Disorders of vestibular function (Vertigo)

297

1923

1.53

10.81

1.3

1.4

6.52

6.81

g/l

0.73

197

1339

Systemic lupus erythematosus, unspecified

3.62

10.81

1.4

7.40

6.58

g/l

0.51

Erythema multiforme

4.51

10.79

1.3

8.49

6.76

g/l

0.76

Phlebitis and thrombophlebitis (not including DVT)

154

860

1.80

10.76

1.4

5.78

6.64

g/l

2.87

105

613

Gout, strict definition

111

557

2.01

10.76

1.4

1.3

6.35

7.15

g/l

1.52

392

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

256

2.53

10.75

1.2

1.4

6.69

6.76

g/l

0.04

181

Iron deficiency anaemia secondary to blood loss (chronic)

103

504

2.06

10.70

1.5

1.3

7.03

6.84

g/l

0.12

344

Cytomegaloviral disease

4.22

10.68

1.4

1.3

6.46

7.00

g/l

0.15

Complications of internal orthopaedic prosthetic devices, implants and grafts

136

733

1.87

10.66

1.3

1.4

6.54

6.97

g/l

0.79

500

Hepatomegaly and splenomegaly, not elsewhere classified

9.61

10.65

1.3

1.2

6.58

5.89

g/l

0.30

Other CVD

114

580

1.98

10.61

1.4

1.3

6.71

6.89

g/l

0.14

408

Bullous disorders

156

2.99

10.59

1.4

7.56

7.11

g/l

0.36

108

Cerebral palsy and other paralytic syndromes

414

2.17

10.57

1.5

1.4

6.10

6.59

g/l

0.54

293

Diabetes, insulin treatment (Kela reimbursement)

679

3096

1.33

10.55

1.4

6.55

6.80

g/l

0.75

449

2179

conjunctival haemorrhage

212

2.67

10.51

1.6

1.3

6.61

7.07

g/l

0.40

149

Accidents

589

2170

1.36

10.49

1.4

1.3

6.59

6.84

g/l

0.94

414

1523

Subacute thyroiditis

101

3.53

10.48

1.5

1.4

6.12

6.94

g/l

0.73

Etanercept

242

2.56

10.44

1.4

1.3

7.29

6.51

g/l

0.98

174

Cellulitis

153

861

1.79

10.44

1.4

1.3

6.73

6.64

g/l

0.10

120

599

Scleritis and episcleritis

213

2.67

10.43

1.4

1.5

6.81

6.61

g/l

0.17

153

Neuromuscular dysfunction of bladder

278

2.43

10.41

1.3

6.23

6.98

g/l

0.82

192

Failure and rejection of transplanted organs and tissues

5.07

10.35

1.3

1.4

6.14

7.10

g/l

0.38

Myelodysplastic syndrome, including Hilmo

4.34

10.34

1.3

1.5

7.12

7.48

g/l

0.17

Viral warts

360

2.25

10.33

1.5

1.4

6.35

6.56

g/l

0.18

247

Hyperkalaemia

132

3.14

10.31

1.6

1.3

6.73

7.14

g/l

0.29

Other obstetric conditions, not elsewhere classified

242

963

1.61

10.30

1.3

1.4

6.32

6.43

g/l

0.23

178

685

Reactive arthropathies

286

2.40

10.26

1.4

1.3

7.01

7.07

g/l

0.03

189

Dystonia

181

2.80

10.25

1.4

1.5

6.88

6.51

g/l

0.12

124

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

236

933

1.61

10.24

1.3

1.4

6.32

6.45

g/l

0.25

173

664

Other noninfective disorders of lymphatic vessels and lymph nodes

3.61

10.23

1.4

6.48

6.49

g/l

0.00

Chronic suppurative otitis media, including avohilmo

275

2.43

10.18

1.7

1.4

6.23

6.71

g/l

0.72

197

Menorrhagia

233

798

1.63

10.17

1.4

6.37

6.73

g/l

0.69

161

547

Benign neoplasm: Small intestine

113

3.33

10.16

1.2

1.5

7.04

7.22

g/l

0.09

Achalasia of cardia

5.39

10.16

1.3

1.4

6.02

6.76

g/l

—

Procreative management

255

1367

1.56

10.14

1.5

1.4

6.67

6.56

g/l

0.20

171

940

Special screening examination for other diseases and disorders

300

2.35

10.09

1.3

6.59

6.87

g/l

0.27

172

Other localized connective tissue disorders

4.90

10.06

1.5

1.2

9.11

7.40

g/l

0.27

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

184

1097

1.68

10.06

1.2

1.3

6.13

6.83

g/l

2.62

125

751

Viral meningitis

114

3.30

10.03

1.4

1.3

5.72

6.20

g/l

0.51

Nonspecific lymphadenitis

212

2.63

10.00

1.4

1.3

6.98

6.38

g/l

0.54

154

Irregular menses

332

1786

1.47

9.96

1.5

1.4

6.15

6.73

g/l

2.85

238

1279

Special screening examination for infectious and parasitic diseases

148

607

1.80

9.92

1.4

1.3

6.30

6.81

g/l

0.83

111

353

Chronic hepatitis NAS

5.31

9.92

1.2

7.91

6.58

g/l

—

Any death

378

1886

1.44

9.92

1.2

1.4

7.37

6.72

g/l

1.43

265

1277

Disorders of continuity of bone

354

2.23

9.89

1.4

1.3

6.55

6.80

g/l

0.21

242

Adhesive capsulitis of shoulder

107

547

1.97

9.88

1.3

6.23

6.95

g/l

1.52

379

Tuberculosis, IBD comorbidity

157

2.89

9.85

2.1

1.4

7.63

6.95

g/l

0.48

111

Coxarthrosis

275

1185

1.54

9.82

1.3

1.4

6.67

6.97

g/l

0.73

212

823

Other and unspecified rosacea

317

2.30

9.82

1.3

1.4

6.41

6.92

g/l

0.55

221

Allergic urticaria

280

2.38

9.79

1.3

1.4

6.57

6.52

g/l

0.04

194

Other retinal disorders

383

2096

1.43

9.74

1.4

6.77

6.91

g/l

0.31

256

1455

Hypotension

461

2.05

9.74

1.3

6.95

6.86

g/l

0.05

323

Disorders of refraction and accommodation

200

1230

1.63

9.72

1.3

6.36

6.61

g/l

0.65

151

865

Fall on same level

798

3393

1.29

9.72

1.3

1.4

6.74

6.73

g/l

0.00

564

2353

Injury, poisoning and certain other consequences of external causes

384

1334

1.45

9.68

1.5

1.3

6.77

6.96

g/l

0.40

272

907

Isolated proteinuria

3.55

9.67

1.4

1.3

6.33

6.53

g/l

0.15

Cutaneous lupus erythematosus

4.37

9.63

1.2

8.68

7.47

g/l

0.31

Benign neoplasm: salivary glands, exclude unknown (D119)

270

2.40

9.62

1.6

1.4

7.26

6.95

g/l

0.22

188

Conductive and sensorineural hearing loss

492

2430

1.37

9.61

1.5

1.3

6.55

6.84

g/l

1.02

329

1704

Neuralgia and neuritis, unspecified

138

3.01

9.59

1.4

1.3

6.40

6.96

g/l

0.36

Other follicular disorders

277

2.38

9.57

1.4

6.44

6.76

g/l

0.35

191

Ulcer of lower limb, not elsewhere classified

431

2.08

9.56

1.3

6.96

6.86

g/l

0.07

300

Thyroiditis

253

2.44

9.54

1.5

6.37

6.85

g/l

0.52

177

Umbilical hernia

178

1073

1.67

9.52

1.6

1.4

7.03

6.76

g/l

0.40

125

741

Disorders of vitreous body and globe

312

2047

1.47

9.52

1.4

6.77

6.81

g/l

0.06

229

1423

Fenamates

321

2.06

9.46

1.5

1.3

6.64

7.62

g/l

1.76

227

Caries of dentine, including avohilmo

523

1964

1.36

9.46

1.4

6.50

6.80

g/l

1.01

353

1386

Combined immunodeficiencies

8.36

9.45

1.4

1.2

4.96

6.74

g/l

1.92

Primary adrenocortical insufficiency

5.33

9.45

1.8

1.2

6.51

6.47

g/l

0.02

Nummular dermatitis

236

2.48

9.44

1.4

6.54

6.94

g/l

0.39

170

Anaemia in chronic diseases classified elsewhere

4.30

9.42

1.5

1.2

5.33

7.74

g/l

1.28

Optic neuritis

156

2.87

9.42

1.6

1.4

5.91

6.92

g/l

1.10

111

Seborrhoeic keratosis

137

771

1.79

9.40

1.5

1.4

6.06

6.92

g/l

2.44

107

535

Other bullous disorders

3.81

9.37

1.2

1.4

7.64

6.68

g/l

0.64

Lesion of ulnar nerve

103

530

1.96

9.37

1.5

1.3

6.30

6.92

g/l

1.34

371

Injuries to the ankle and foot

491

3228

1.36

9.36

1.4

1.3

6.59

6.73

g/l

0.40

358

2230

Other congenital malformations

356

2.19

9.34

1.3

1.4

6.66

6.29

g/l

0.54

260

Diplopia

456

2.03

9.31

1.8

1.3

6.00

6.97

g/l

1.95

319

Acute bronchiolitis

223

2.45

9.30

1.4

1.3

6.57

6.23

g/l

0.20

179

Vasomotor rhinitis (mode)

220

2.53

9.29

1.7

1.4

6.12

6.74

g/l

0.90

151

Calcific aortic valvular stenosis, diagnosis (helper)

151

849

1.73

9.27

1.4

8.13

7.05

g/l

1.52

109

592

Operations 2 for CAVS

151

849

1.73

9.27

1.4

8.13

7.05

g/l

1.52

109

592

Benign neoplasm of major salivary glands

306

2.28

9.27

1.5

1.4

7.23

7.02

g/l

0.14

217

Unspecified/other endometriosis

351

2.19

9.25

1.4

5.67

6.71

g/l

1.80

239

Disorders of vitreous body

303

2000

1.47

9.25

1.4

6.81

6.79

g/l

0.02

220

1393

Adenocarcinoma of pancreas

4.21

9.21

1.1

1.3

6.06

7.78

g/l

0.90

Disorders of lipoprotein metabolism and other lipidaemias

502

2294

1.36

9.20

1.4

6.76

6.84

g/l

0.13

357

1580

Unspecified misadventure during surgical and medical care

158

2.82

9.19

1.3

1.4

6.44

6.96

g/l

0.53

109

Mouth breathing

274

1838

1.50

9.19

1.4

6.48

6.77

g/l

0.65

185

1288

Disorders of choroid and retina

502

2643

1.35

9.18

1.4

6.64

6.83

g/l

0.54

341

1835

Other abnormal findings of blood chemistry

131

3.02

9.18

1.6

1.3

6.63

6.75

g/l

0.07

Calcific aortic valvular stenosis, including rheumatic fever

151

851

1.73

9.17

1.4

8.13

7.05

g/l

1.52

109

592

Childhood allergy (age < 16)

117

516

1.88

9.16

1.3

6.26

6.36

g/l

0.15

366

Stenosis and insufficiency of lacrimal passages

277

2.33

9.10

1.3

7.06

7.23

g/l

0.10

193

Calcific aortic valvular stenosis

151

854

1.72

9.09

1.4

8.13

7.05

g/l

1.53

109

597

Calcific aortic valvular stenosis, operated

151

854

1.72

9.09

1.4

8.13

7.05

g/l

1.53

109

597

Endometriosis

226

839

1.59

9.06

1.2

1.4

6.40

6.72

g/l

0.64

167

571

Viral encephalitis, not elsewhere classified/unspecified

4.17

9.03

1.3

5.13

7.18

g/l

2.68

Other enthesopathy of foot (+metatarsalgia)

316

2.23

9.02

1.6

1.3

5.46

6.75

g/l

2.56

217

Diseases of inner ear

336

2276

1.43

9.01

1.3

1.4

6.60

6.86

g/l

0.70

219

1589

Allergic purpura

3.60

8.98

1.3

5.47

6.29

g/l

0.92

Colonic or urogenital fistula

179

1098

1.64

8.98

1.2

1.4

6.81

6.76

g/l

0.06

119

756

Postprocedural disorders of digestive system, not elsewhere classified

3.59

8.98

2.1

1.3

6.72

7.11

g/l

0.21

Fibroblastic disorders

131

738

1.78

8.97

1.4

1.3

6.89

7.26

g/l

0.39

512

Episcleritis

172

2.71

8.92

1.5

1.4

6.63

6.79

g/l

0.11

125

Unspecified haematuria

248

1356

1.52

8.84

1.6

1.4

7.17

6.89

g/l

0.48

184

922

Benign neoplasm: Duodenum

3.85

8.83

1.3

7.64

7.50

g/l

0.05

Other specified/unspecified bacterial intestinal infections

196

2.58

8.82

1.2

1.4

7.80

6.84

g/l

0.45

136

Sensorineural hearing loss

457

2279

1.36

8.79

1.5

1.3

6.46

6.85

g/l

1.56

300

1599

Other and unspecified nerve root and plexus disorders, also in other diseases

136

781

1.75

8.75

1.5

1.3

6.81

6.82

g/l

0.01

538

Dipeptidyl peptidase 4 (DPP-4) inhibitors

329

1840

1.44

8.74

1.3

1.4

7.06

6.91

g/l

0.21

229

1276

Hypertensive heart and/or renal disease

145

624

1.74

8.73

1.4

6.70

7.35

g/l

0.82

106

406

Paracetamol or NSAID medication

108

277

1.97

8.73

1.4

1.3

6.59

7.50

g/l

1.58

205

Other symptoms and signs involving cognitive functions and awareness

266

1630

1.49

8.73

1.4

6.65

6.92

g/l

0.51

187

1113

Diseases of external ear

221

1437

1.55

8.67

1.4

6.90

6.81

g/l

0.17

162

989

Atherosclerosis, excluding cerebral and coronary sclerosis

210

1060

1.57

8.66

1.4

6.92

6.99

g/l

0.08

153

724

Osteonecrosis

175

2.66

8.63

1.4

1.3

7.34

6.78

g/l

0.14

119

Olecranon bursitis

175

2.66

8.62

1.4

1.2

7.38

7.22

g/l

0.08

119

Supplementary factors related to causes of morbidity and mortality classified elsewhere

212

1369

1.56

8.59

1.7

1.3

6.35

6.70

g/l

0.90

153

937

Gingivitis and periodontal diseases

690

2765

1.29

8.58

1.4

6.65

6.74

g/l

0.23

496

1895

Fracture of lumbar spine and pelvis

127

719

1.77

8.53

1.3

6.40

6.79

g/l

0.63

501

Post-traumatic stress disorder

298

2.23

8.53

1.3

6.05

6.64

g/l

1.15

202

Injuries to the thorax

275

1879

1.47

8.47

1.5

1.4

7.04

6.92

g/l

0.20

204

1283

Tuberculosis, wide

171

2.65

8.45

2.1

1.4

7.63

7.23

g/l

0.25

122

Cervicocranial syndrome

312

2.20

8.44

1.5

1.3

5.82

6.76

g/l

2.36

220

Ankylosing spondylitis, ICD10

332

2.16

8.43

1.3

6.66

6.76

g/l

0.11

231

Other/unspecified reactive arthropathies

231

2.41

8.41

1.4

6.53

6.61

g/l

0.06

163

Amyloidosis

4.53

8.40

1.5

1.4

9.13

7.05

g/l

0.46

Other/unspecified cytomegaloviral diseases

4.07

8.39

1.4

1.2

6.34

6.89

g/l

0.14

Perforation of tympanic membrane

313

2.19

8.39

1.3

1.4

6.68

6.87

g/l

0.17

220

Acute nasopharyngitis (common cold)

396

2.05

8.38

1.3

7.09

g/l

0.00

252

Vascular diseases of the intestine

3.50

8.38

1.1

1.3

9.04

7.15

g/l

0.74

Benign neoplasm: Ascending colon

440

1.99

8.37

1.4

1.3

6.86

7.01

g/l

0.13

305

Superficial injury of lower leg

166

1019

1.64

8.34

1.3

6.38

6.66

g/l

0.46

128

701

Fracture of rib(s), sternum and thoracic spine

180

1127

1.60

8.34

1.5

1.3

7.14

6.87

g/l

0.39

133

765

Smoking dependency

315

2.18

8.27

1.3

1.4

6.83

6.67

g/l

0.13

216

Other hearing loss

152

894

1.67

8.25

1.5

1.3

5.88

7.17

g/l

5.21

100

616

Symptoms and signs involving emotional state

3.25

8.25

1.1

1.3

6.83

6.26

g/l

0.35

Arthropathic psoriasis

422

2.01

8.25

1.3

1.4

6.58

6.80

g/l

0.21

296

Other diseases of gallbladder

3.37

8.22

1.4

1.3

5.91

6.83

g/l

1.09

Metatarsalgia

290

2.23

8.21

1.6

1.3

5.39

6.71

g/l

2.39

200

Mental and behavioural disorders due to tobacco

317

2.17

8.15

1.3

1.4

6.83

6.69

g/l

0.11

218

Other and unspecified disorders of vitreous body

252

1684

1.48

8.13

1.4

6.73

6.84

g/l

0.14

188

1171

Cramp and spasm

152

2.74

8.11

1.4

5.87

7.17

g/l

1.74

107

Later onset COPD

129

588

1.75

8.11

1.1

1.4

7.43

7.26

g/l

0.15

412

Non-allergic asthma

285

2.23

8.11

1.9

1.5

6.28

6.83

g/l

0.65

200

Other noninflammatory disorders of vulva and perineum

331

2.13

8.09

1.4

1.3

7.88

6.78

g/l

1.00

223

Benign neoplasm: Descending colon

205

2.47

8.07

1.3

1.4

7.15

6.96

g/l

0.13

140

Kidney transplant status

188

2.54

8.01

1.7

1.3

5.60

6.63

g/l

0.87

134

Peripheral artery disease

224

1176

1.52

7.99

1.3

1.4

7.07

6.99

g/l

0.10

167

803

Juvenile arthritis (FINNGEN)

159

2.68

7.98

1.3

1.4

7.57

6.41

g/l

1.29

116

Chronic suppurative otitis media

200

2.47

7.98

1.8

1.3

6.14

6.94

g/l

1.19

139

Ulcer of oesophagus

165

2.63

7.94

1.3

1.2

7.02

7.13

g/l

0.06

114

Artrosis, including avohilmo

545

2273

1.32

7.94

1.3

1.4

6.70

6.84

g/l

0.40

385

1549

Disturbance of activity and attention

101

536

1.86

7.93

1.3

1.4

6.27

6.50

g/l

0.31

375

Polycystic ovarian syndrome, consortium definition

466

2062

1.34

7.92

1.4

6.36

6.70

g/l

1.37

328

1460

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

110

3.03

7.90

1.4

1.2

7.77

7.24

g/l

0.18

Idiopathic gout

263

2.26

7.89

1.3

6.44

6.91

g/l

0.42

179

Anogenital herpesviral [herpes simplex] infection

423

1.98

7.85

1.4

1.5

6.36

6.53

g/l

0.16

296

Type of accident

195

1263

1.55

7.84

1.7

1.3

6.30

6.71

g/l

1.07

141

870

Glaucoma

318

1943

1.41

7.84

1.3

1.4

6.56

6.90

g/l

0.96

209

1358

Peritonsillar abscess

120

687

1.75

7.84

1.3

1.4

6.16

7.13

g/l

2.91

447

Prurigo nodularis

4.11

7.83

1.1

1.4

6.98

6.95

g/l

0.01

Substance abuse

374

2571

1.37

7.82

1.3

1.4

6.36

6.84

g/l

1.99

247

1768

Hallux valgus (acquired)

190

870

1.58

7.81

1.4

6.92

6.84

g/l

0.10

142

609

Endometriosis of pelvic peritoneum

115

620

1.78

7.79

1.4

6.26

6.82

g/l

0.78

429

Duodenal ulcer

258

2.26

7.78

1.2

1.3

7.22

6.93

g/l

0.19

180

Dental pulpitis, including avohilmo

627

3181

1.28

7.78

1.4

6.70

6.73

g/l

0.08

417

2218

Other disorders of kidney and ureter

445

1.95

7.78

1.4

6.90

6.82

g/l

0.07

315

Restless leg syndrome

487

1.90

7.78

1.7

1.3

5.68

6.92

g/l

4.29

335

Other and unspecified coagulation defects

173

2.58

7.77

1.5

1.4

7.29

6.88

g/l

0.24

117

Other/unspecified synovitis and tenosynovitis

363

2.05

7.77

1.6

1.3

5.64

6.77

g/l

2.98

253

Other and unspecified follicular disorders

122

2.91

7.77

1.6

1.3

6.89

6.65

g/l

0.14

Benign paroxysmal vertigo

177

1124

1.58

7.77

1.3

1.4

6.39

6.71

g/l

0.62

114

781

Appendectomy

431

3085

1.34

7.77

1.3

1.4

6.29

6.79

g/l

2.44

290

2147

Oesophageal varices

106

3.06

7.76

1.6

1.3

11.02

6.53

g/l

2.30

Hordeolum and other deep inflammation of eyelid

191

2.49

7.75

1.6

1.3

6.23

6.89

g/l

0.68

131

Open wound of lower leg

102

559

1.84

7.74

1.5

1.3

6.20

6.62

g/l

0.67

387

CR(E)ST syndrome

4.43

7.73

1.4

1.3

8.24

7.83

g/l

0.06

Oral lichen planus

3.59

7.73

1.8

1.3

6.09

7.36

g/l

0.92

Disorders of plasma-protein metabolism, not elsewhere classified

8.44

7.72

1.3

1.4

6.51

6.03

g/l

—

Other endocrine disorders

212

2.38

7.70

1.3

7.13

6.39

g/l

0.75

169

Other aneurysm

134

2.79

7.65

1.5

1.2

7.08

7.10

g/l

0.00

Disorders resulting from impaired renal tubular function

107

3.04

7.65

1.3

6.58

7.07

g/l

0.21

Other obstructive and reflux uropathy

118

2.92

7.60

1.2

1.3

8.36

6.53

g/l

1.75

Other juvenile arthritis

146

2.71

7.60

1.3

1.4

7.72

6.52

g/l

1.21

103

Presence of cardiac and vascular implants and grafts

230

1144

1.50

7.59

1.4

7.42

7.01

g/l

0.64

170

802

Mental and behavioural disorders due to psychoactive substance use

384

2628

1.36

7.56

1.3

1.4

6.39

6.84

g/l

1.76

250

1806

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

249

2.27

7.56

1.5

1.4

6.59

6.71

g/l

0.06

174

Arthropathies in other diseases classified elsewhere

3.20

7.56

1.3

6.15

7.29

g/l

0.77

Cardiomyopathies, Primary/intrinsic

368

2.02

7.50

1.4

1.3

7.26

6.75

g/l

0.53

261

Other bacterial agents as the cause of diseases classified to other chapters

6.65

7.48

1.2

1.3

6.74

6.92

g/l

0.08

Adult respiratory distress syndrome

6.63

7.48

1.1

1.2

4.13

6.99

g/l

2.18

Ulcerative proctitis

213

2.37

7.46

1.4

1.3

7.22

6.67

g/l

0.46

152

Pure hypercholesterolaemia

429

2093

1.34

7.41

1.4

6.87

6.85

g/l

0.03

305

1440

Other diseases of blood and blood-forming organs

202

2.40

7.35

1.3

1.4

8.62

6.89

g/l

0.61

139

Inflammation of lacrimal passages (acute and unspecified)

4.22

7.31

1.7

1.2

6.04

6.29

g/l

0.16

Other autoimmune haemolytic anaemias

6.42

7.31

1.8

1.2

8.30

7.02

g/l

0.18

Other congenital malformations

541

1.82

7.28

1.3

1.4

6.78

6.38

g/l

0.69

388

Other disorders of eyelid

243

1592

1.46

7.26

1.5

1.3

6.57

6.93

g/l

0.82

178

1115

Hypertensive Heart Disease

125

574

1.71

7.25

1.5

1.4

6.63

7.32

g/l

0.78

381

Other keratitis

429

1.93

7.22

1.4

6.57

6.75

g/l

0.18

301

Malignant neoplasm, wide definition for exclusion

580

2654

1.28

7.22

1.3

1.4

6.97

6.71

g/l

0.62

384

1871

Urethritis and urethral syndrome

3.99

7.19

1.4

1.3

7.32

7.47

g/l

0.05

Abnormal involuntary movements

479

1.87

7.19

1.3

5.90

6.76

g/l

2.23

336

Other contact dermatitis

261

2.20

7.18

1.5

6.40

6.84

g/l

0.47

188

Myeloid leukaemia

3.60

7.17

1.5

1.3

5.69

7.64

g/l

1.19

Superficial injury of abdomen, lower back and pelvis

102

573

1.79

7.17

1.2

1.4

6.38

6.67

g/l

0.53

406

Other embolism and thrombosis

437

1.91

7.17

1.7

1.3

6.55

6.67

g/l

0.10

308

Polyuria

135

820

1.65

7.15

1.3

6.81

6.96

g/l

0.17

564

Conduction disorders

160

815

1.60

7.14

1.3

7.06

6.72

g/l

0.46

107

566

Cardiodefibrillation

190

1248

1.52

7.13

1.3

1.4

7.52

7.01

g/l

0.65

115

856

Nonischemic cardiomyopathy

275

2.16

7.10

1.3

7.38

6.63

g/l

0.70

195

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

304

2.09

7.06

1.3

1.4

6.41

6.18

g/l

0.25

232

Injuries to the wrist and hand

664

3672

1.25

7.04

1.3

1.4

6.61

6.76

g/l

0.45

471

2544

Cardiomyopathy (excluding other)

377

1.98

7.04

1.4

1.3

7.26

6.82

g/l

0.44

265

Lichen planus

433

1.91

7.03

1.9

1.3

6.46

6.88

g/l

0.59

303

Atypical facial pain

158

2.56

7.03

1.7

1.4

5.84

6.71

g/l

1.05

115

Decubitus ulcer and pressure area

129

2.74

7.02

1.5

1.2

7.94

7.40

g/l

0.22

Abnormal blood-pressure reading, without diagnosis

107

2.93

7.02

1.7

1.4

5.77

6.83

g/l

0.91

Other sleep disorders

357

2.00

7.01

1.4

6.36

6.81

g/l

0.75

255

Intestinal adhesions without obstruction

219

2.30

7.01

1.7

1.3

6.24

7.04

g/l

0.89

151

Other and unspecified glaucoma

170

2.49

7.00

1.5

1.3

6.74

7.25

g/l

0.32

119

Psoriatic arthropathies, ICD10

420

1.92

6.99

1.3

1.4

6.55

6.77

g/l

0.22

295

Hyperkinetic disorders

106

594

1.76

6.99

1.3

1.4

6.35

6.42

g/l

0.08

421

Lesion of lateral popliteal nerve

141

2.65

6.98

1.5

1.3

6.76

6.92

g/l

0.09

Excessive vomiting in pregnancy

324

2.06

6.98

1.4

1.5

6.12

6.68

g/l

0.78

224

Diseases of pulp and periapical tissues and dental caries

419

1605

1.34

6.95

1.4

1.3

6.67

6.78

g/l

0.24

282

1121

Phobic anxiety disorders

542

1.80

6.92

1.5

1.3

6.44

6.67

g/l

0.35

375

MS-disease / Multiple Sclerosis

279

2.14

6.89

1.4

6.02

6.53

g/l

0.71

198

Lichen simplex chronicus

3.21

6.86

1.2

1.3

7.86

7.27

g/l

0.23

Corneal ulcer

124

746

1.67

6.84

1.5

1.3

6.86

6.70

g/l

0.19

525

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

202

1344

1.49

6.83

1.4

6.14

6.67

g/l

2.40

157

948

Other disorders of optic [2nd] nerve and visual pathways

203

2.34

6.83

1.6

1.3

6.42

6.68

g/l

0.16

146

Other and unspecified psoriasis

203

2.34

6.82

1.2

1.5

7.62

6.87

g/l

0.56

142

Neovascular glaucoma

2.99

6.82

1.4

1.2

6.66

6.86

g/l

0.09

Nail disorders

287

2.11

6.80

1.2

1.4

6.23

6.76

g/l

0.62

200

Other extrapyramidal and movement disorders in other diseases

144

901

1.61

6.80

1.5

1.4

6.11

6.70

g/l

1.68

107

621

Ganglion

127

771

1.65

6.76

1.5

1.3

6.16

6.83

g/l

2.01

533

Personality disorders

190

1268

1.51

6.73

1.3

6.26

6.70

g/l

1.44

130

871

Other epidermal thickening

121

2.76

6.72

1.4

1.2

6.00

7.24

g/l

1.37

Glaucoma secondary to other eye disorders

2.96

6.71

1.4

1.3

6.66

6.91

g/l

0.11

Acute peritonitis

180

2.41

6.70

1.5

1.3

7.53

7.08

g/l

0.14

127

Myocardial infarction

253

1244

1.43

6.68

1.3

1.4

6.80

6.84

g/l

0.05

178

822

Disorders of adult personality and behaviour

201

1360

1.48

6.66

1.3

1.4

6.35

6.69

g/l

0.92

141

940

Drug-induced neutropenia

231

2.23

6.64

1.4

1.5

6.59

6.75

g/l

0.09

158

Trigeminal neuralgia

181

2.40

6.62

1.8

1.4

5.77

6.71

g/l

1.56

127

Superficial injury of hip and thigh

456

1.85

6.62

1.3

6.89

6.77

g/l

0.10

316

Other (not insulin) diabetes medications

615

2902

1.26

6.61

1.3

1.4

6.72

6.83

g/l

0.23

414

2033

Lateral epicondylitis

457

1.85

6.59

1.5

1.3

6.06

7.02

g/l

2.11

316

Exophthalmic conditions

5.87

6.52

1.6

1.2

6.10

5.97

g/l

0.05

Other specified and unspecified retinal disorders

3.04

6.52

1.6

1.3

7.20

7.02

g/l

0.07

Vulvovaginal ulceration/inflammation in other diseases

221

2.24

6.46

1.5

1.4

6.41

6.60

g/l

0.15

157

Dialysis

130

2.65

6.41

1.4

1.3

5.97

6.85

g/l

0.55

Viral warts

145

923

1.58

6.40

1.5

1.3

6.65

6.66

g/l

0.01

102

644

Myocardial infarction, strict

234

1159

1.44

6.39

1.3

1.4

6.76

6.90

g/l

0.23

166

763

Elevated blood glucose level

261

2.12

6.39

2.1

1.3

7.03

6.58

g/l

0.34

175

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

280

2.08

6.37

1.1

1.4

6.57

7.11

g/l

0.49

199

Barrett oesophagus

119

2.72

6.35

1.5

1.3

7.48

7.26

g/l

0.11

Glaucoma suspect

201

1375

1.47

6.32

1.4

6.74

6.93

g/l

0.30

131

961

Other and unspecified diseases of blood and blood-forming organs

3.39

6.30

1.4

1.3

10.28

7.49

g/l

0.54

Thoracic aortic aneurysm

457

1.83

6.29

1.5

1.3

6.67

6.87

g/l

0.22

320

Desensitization to allergens

224

2.21

6.27

1.3

1.4

6.65

6.21

g/l

0.42

156

Hypercalcemia

120

2.70

6.26

1.2

1.4

7.05

7.10

g/l

0.02

Unspecified fall

308

2239

1.36

6.26

1.5

1.4

6.26

6.85

g/l

2.75

205

1572

Viral hepatitis, IBD co-morbidity

103

2.83

6.26

1.0

1.2

6.73

6.61

g/l

0.06

Pleural plaque with presence of asbestos

180

2.35

6.23

1.3

1.2

7.29

7.10

g/l

0.12

130

Pneumonitis due to solids and liquids

199

2.28

6.21

1.3

1.2

6.58

6.94

g/l

0.27

142

Unspecific neurodegenerative disorder

954

0.56

6.20

1.2

1.4

6.67

7.29

g/l

0.74

655

Otitis externa

147

946

1.56

6.20

1.3

6.85

6.69

g/l

0.28

117

665

Familial hypercholesterolemia

468

1.80

6.13

1.5

1.4

6.57

7.09

g/l

0.54

321

Infective dermatitis

404

1.87

6.11

1.4

1.3

6.82

6.85

g/l

0.03

289

Alcoholic liver disease

320

1.98

6.11

1.3

8.18

6.55

g/l

1.59

226

Acne

404

1.87

6.08

1.3

6.45

6.58

g/l

0.13

282

Dislocation, sprain and strain of joints and ligaments of knee

393

2777

1.31

6.08

1.4

1.3

6.48

6.74

g/l

0.88

273

1910

Excessive attrition of teeth

364

2767

1.32

6.07

1.5

1.4

6.68

6.78

g/l

0.21

249

1942

Diabetes insipidus

5.73

6.07

1.9

1.3

6.72

6.43

g/l

—

Eustachian salpingitis and obstruction

335

1.96

6.06

1.6

1.3

6.13

6.86

g/l

1.24

236

Hidradenitis suppurativa

134

2.57

6.06

1.3

1.4

6.34

g/l

0.00

Autoimmune hyperthyroidism

170

2.37

6.05

1.4

6.31

6.52

g/l

0.22

120

Anogenital herpesviral [herpes simplex] infection

234

2.16

6.04

1.5

1.4

6.30

6.49

g/l

0.12

163

Appendicitis, broad definition

475

3378

1.27

6.04

1.4

6.64

6.78

g/l

0.38

315

2348

Speech and linguistic disorders, excluding more controls

282

2.02

6.03

1.2

1.3

6.72

6.53

g/l

0.19

199

Other psoriatic arthropathies

406

1.86

6.03

1.3

1.4

6.56

6.80

g/l

0.24

284

Tuberculosis

134

2.56

6.03

1.9

1.3

7.35

7.19

g/l

0.08

Crohn disease (strict definition, all UC cases excluded)

183

2.32

6.03

1.1

1.3

5.59

6.78

g/l

1.44

128

Diseases of appendix

478

3391

1.27

6.02

1.4

6.60

6.78

g/l

0.48

318

2360

Pacemaker

156

980

1.53

6.02

1.2

1.4

7.25

7.07

g/l

0.18

103

692

Diabetic maculopathy, excluding more controls

350

1.93

5.99

1.5

1.3

6.63

6.66

g/l

0.02

242

Infections with a predominantly sexual mode of transmission

263

1774

1.39

5.99

1.3

6.68

6.65

g/l

0.05

185

1210

Injuries to the head

725

3656

1.22

5.95

1.5

1.3

6.68

6.75

g/l

0.17

505

2546

Other and unspecified acquired haemolytic anaemias

6.58

5.92

1.9

1.2

6.14

6.57

g/l

—

Oral lichen planus, including avohilmo , including avohilmo

224

2.16

5.86

1.5

6.57

6.97

g/l

0.33

155

Heterophoria

306

1.98

5.78

1.6

1.5

6.59

6.51

g/l

0.06

210

Type 1 diabetes

163

1089

1.50

5.78

1.4

1.3

6.72

6.77

g/l

0.04

110

767

Acute appendicitis, no complications

361

2749

1.31

5.77

1.4

6.61

6.74

g/l

0.28

239

1913

Adjustment and management of implanted device

559

1.71

5.76

1.1

1.4

7.64

7.00

g/l

0.62

394

Morphin

4.94

5.76

1.6

1.3

6.57

7.42

g/l

0.35

Abnormality of white blood cells, not elsewhere classified

5.78

5.76

1.3

1.2

5.46

6.14

g/l

—

Angina pectoris

295

1449

1.36

5.74

1.5

1.4

6.60

6.76

g/l

0.27

195

971

Sleep disorders, other/unspecified

120

2.62

5.74

1.2

1.4

6.02

6.41

g/l

0.30

Spondylopathies in diseases classified elsewhere

5.71

5.73

1.2

1.3

10.81

9.53

g/l

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

144

2.46

5.72

1.3

1.4

6.42

6.12

g/l

0.18

107

Spasmodic torticollis

103

2.76

5.72

1.6

1.4

7.98

6.70

g/l

0.27

Impingement syndrome of shoulder

132

846

1.57

5.70

1.4

1.3

6.11

7.15

g/l

2.08

587

Dermatophytosis

450

1.79

5.70

1.6

1.4

6.56

6.78

g/l

0.26

316

Right bundle-branch block

2.99

5.70

1.1

7.48

6.61

g/l

0.42

Paralytic ileus

2.99

5.70

1.3

1.2

6.01

7.63

g/l

1.30

Impetigo

163

2.36

5.67

1.4

1.2

7.23

6.58

g/l

0.47

121

Noninflammatory disorders of female genital tract

254

911

1.40

5.66

1.4

6.63

6.75

g/l

0.17

177

627

Hypersplenism

8.99

5.66

1.4

1.3

7.17

5.53

g/l

—

Benign neoplasm: Rectum

103

624

1.66

5.62

1.5

1.3

6.72

6.86

g/l

0.14

429

Use of pramipexole

128

818

1.57

5.61

1.4

5.79

6.85

g/l

3.72

567

Papilloedema, unspecified

3.33

5.61

1.4

5.57

6.73

g/l

1.21

Other specified and unspecified disorders of eyelid

5.12

5.60

1.9

1.3

5.47

7.08

g/l

—

Other/unspecified enthesopathies, not elsewhere classified

248

2.07

5.60

1.8

1.3

6.07

7.11

g/l

1.12

178

Injuries to the shoulder and upper arm

523

3377

1.25

5.60

1.4

6.62

6.80

g/l

0.46

367

2335

Other and unspecified myopathies

242

2.08

5.56

1.4

1.3

6.29

6.88

g/l

0.71

167

Sudden idiopathic hearing loss

318

1.93

5.53

1.8

1.3

6.07

6.89

g/l

1.23

226

Spontaneous rupture of synovium and tendon

223

2.12

5.51

1.8

1.3

7.05

7.03

g/l

0.01

160

Testicular hypofunction

117

2.60

5.49

1.3

1.2

6.80

7.26

g/l

0.13

Contact with and exposure to communicable diseases

217

1542

1.41

5.48

1.4

6.26

6.62

g/l

0.76

110

1099

Diseases of peritoneum

333

1.91

5.48

1.5

1.4

7.29

6.82

g/l

0.23

231

Bell's palsy

419

1.80

5.48

1.3

5.57

6.82

g/l

2.28

292

Benign neoplasm of mouth and pharynx

383

1.84

5.48

1.4

5.74

6.81

g/l

1.82

264

Major coronary heart disease event excluding revascularizations

312

1558

1.34

5.47

1.3

1.4

6.90

6.84

g/l

0.09

221

1044

Chronic Coagulation defects

3.00

5.44

1.7

1.3

5.94

6.89

g/l

0.71

Other and unspecified epidermal thickening

2.99

5.44

1.3

5.73

7.56

g/l

1.41

Fracture of foot, except ankle

158

1068

1.49

5.36

1.4

1.3

6.67

g/l

0.00

115

740

Excessive earwax

316

2341

1.32

5.36

1.5

1.4

6.74

6.85

g/l

0.21

207

1645

Hypertrophic disorders of skin

193

2.20

5.35

1.3

1.4

6.45

6.72

g/l

0.20

137

Visual impairment including blindness (binocular or monocular)

180

2.24

5.35

1.3

5.97

7.02

g/l

1.25

127

Benign neoplasm: Rectum, anus and anal canal

113

710

1.60

5.35

1.4

1.3

6.88

6.79

g/l

0.08

494

Other disorders of central nervous system

4.83

5.35

1.4

5.37

6.80

g/l

0.62

Acne vulgaris

301

1.94

5.34

1.2

1.3

6.27

6.44

g/l

0.15

207

Localized scleroderma [morphea]

4.82

5.34

1.4

1.2

6.76

7.32

g/l

0.15

Complications following infusion, transfusion and therapeutic injection

4.81

5.33

1.5

1.3

8.25

6.81

g/l

—

Autoimmune thyroiditis

3.34

5.33

1.3

6.71

6.70

g/l

0.00

Acute epiglottitis

4.81

5.33

1.6

1.3

6.49

7.83

g/l

—

Extrapyramidal and movement disorders

209

1491

1.41

5.31

1.5

1.3

6.40

6.89

g/l

0.96

144

1031

Other disorders of bladder

358

1.85

5.31

1.2

1.3

7.23

6.85

g/l

0.21

251

Haemorrhage in early pregnancy

181

1225

1.44

5.30

1.2

1.4

6.05

6.72

g/l

2.15

135

870

Plantar fascial fibromatosis

302

1.93

5.29

1.4

1.3

6.71

6.84

g/l

0.07

212

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

536

1.69

5.27

1.4

6.96

6.77

g/l

0.14

379

Benign neoplasm: Parotid gland

241

2.05

5.25

1.5

1.4

7.45

6.92

g/l

0.31

167

Pleural plaque without asbestos

3.08

5.23

1.5

1.2

7.04

7.53

g/l

0.26

Injuries to the neck

146

978

1.50

5.20

1.4

1.3

6.44

6.61

g/l

0.21

108

671

Disorder of the sleep-wake schedule

3.39

5.19

1.3

1.4

7.21

6.69

g/l

0.29

Other disorders of nervous system

196

2.16

5.16

1.3

1.5

5.52

6.71

g/l

1.47

140

Bacterial, viral and other infectious agents

355

1.84

5.14

1.3

1.4

6.79

6.63

g/l

0.15

244

Infections with a predominantly sexual mode of transmission

202

1440

1.41

5.13

1.3

1.4

6.77

6.68

g/l

0.13

146

985

Problems related to lifestyle

377

1.81

5.12

1.3

7.14

6.44

g/l

0.72

253

Alcohol abuse, main dg, excluding more controls

548

1.67

5.12

1.3

6.27

6.71

g/l

0.60

369

Other abnormal uterine and vaginal bleeding

136

638

1.53

5.12

1.2

1.4

6.54

6.74

g/l

0.21

436

Lichen ruber planus, wide definition including periferal and oral lichen planus

130

853

1.53

5.11

1.7

1.4

6.80

6.84

g/l

0.04

589

Atrophic disorders of skin

541

1.67

5.11

1.5

1.4

7.33

6.72

g/l

0.59

376

Allergic contact dermatitis

511

1.69

5.10

1.3

1.4

5.99

6.87

g/l

2.05

356

Fracture at wrist and hand level

220

1593

1.38

5.08

1.3

1.4

6.83

6.69

g/l

0.17

145

1094

Other hammer toe(s) (acquired)

477

1.69

5.08

1.5

6.57

6.88

g/l

0.40

330

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

272

1.96

5.07

1.3

5.93

6.68

g/l

0.65

185

Otitis externa, unspecified

430

1.76

5.06

1.4

6.89

6.59

g/l

0.37

306

Caries of enamel

579

3420

1.22

5.06

1.4

6.89

6.65

g/l

0.77

442

2344

Alopecia areata

2.94

5.05

1.5

1.3

6.75

6.13

g/l

0.46

Nonpyogenic thrombosis of intracranial venous system

4.85

5.05

1.3

6.44

6.80

g/l

—

Other and unspecified aplastic anaemias

4.82

5.04

1.3

7.35

6.24

g/l

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

178

1250

1.43

4.98

1.2

1.3

6.69

6.82

g/l

0.15

124

850

AV-block

415

1.72

4.98

1.2

1.3

7.56

6.84

g/l

0.64

300

Other disorders starting during childhood or adolecense, excluding more controls

190

2.14

4.98

1.3

5.90

6.23

g/l

0.38

143

Injuries to the hip and thigh

257

1734

1.35

4.96

1.3

1.4

6.72

6.90

g/l

0.33

192

1192

Osteomyelitis

180

2.18

4.94

1.5

1.2

7.34

6.76

g/l

0.35

128

Hypocalcemia

3.16

4.94

1.4

1.3

7.72

7.76

g/l

0.01

Injury of muscle and tendon at forearm level

3.27

4.92

1.3

8.20

7.15

g/l

0.34

Specific personality disorders

159

1097

1.46

4.91

1.3

1.4

6.19

6.61

g/l

1.23

114

756

Tinnitus

136

910

1.50

4.90

1.4

6.56

6.85

g/l

0.50

628

Abscess of anal and rectal regions

297

1.90

4.87

1.3

6.21

6.74

g/l

0.60

203

Valvular operations

413

1.75

4.85

1.5

1.3

8.26

6.82

g/l

1.04

295

Maternal care for other conditions predominantly related to pregnancy

142

942

1.48

4.84

1.2

1.4

6.55

6.76

g/l

0.32

673

Occupational exposure to risk-factors

2.66

4.84

1.7

1.3

6.36

6.90

g/l

0.38

Squamous cell neoplasms and carcinomas of the skin

175

2.18

4.83

1.1

1.3

6.28

7.19

g/l

0.67

128

Other/unspecified enthesopathies of lower limb, excluding foot

222

2.04

4.81

1.2

1.4

6.70

6.90

g/l

0.14

157

Follicular lymphoma, hilmo

119

2.46

4.81

1.7

1.4

4.61

7.14

g/l

3.06

Malignant neoplasm

532

2562

1.23

4.79

1.3

1.4

6.94

6.71

g/l

0.49

357

1800

Other maternal disorders predominantly related to pregnancy

361

1764

1.29

4.79

1.2

1.4

6.35

6.73

g/l

1.46

261

1255

Acute appendicitis

436

3270

1.25

4.79

1.4

6.54

6.78

g/l

0.74

292

2278

D07AA Corticosteroids, weak (group I)

106

675

1.58

4.77

1.4

6.44

6.61

g/l

0.26

489

Disorders of psychological development

475

1.67

4.75

1.3

1.4

6.39

6.41

g/l

0.03

336

Amenorrhoea

265

1.94

4.73

1.8

1.5

6.62

6.71

g/l

0.07

184

Gluteal tendinitis

102

2.57

4.73

1.4

1.5

6.58

7.11

g/l

0.27

Ventral hernia

132

885

1.50

4.72

1.4

1.3

6.38

6.77

g/l

0.59

100

611

Sequelae of injuries, of poisoning and of other consequences of external causes

146

1000

1.47

4.70

1.4

1.3

7.05

6.68

g/l

0.30

692

Chronic mastoiditis

3.06

4.69

1.9

1.3

6.99

7.66

g/l

0.29

Striking against or struck by other objects

212

1550

1.37

4.69

1.4

1.3

6.41

6.71

g/l

0.58

140

1071

Testicular dysfunction

133

2.36

4.68

1.3

1.2

6.71

7.14

g/l

0.13

Ptosis of eyelid

330

1.83

4.67

1.7

1.3

6.78

6.98

g/l

0.14

226

Superficial injury of wrist and hand

136

920

1.48

4.67

1.4

6.26

6.60

g/l

0.71

650

Scar conditions and fibrosis of skin

127

2.39

4.66

1.2

1.4

8.49

6.91

g/l

0.59

Other superficial mycoses

3.15

4.66

1.6

1.2

6.57

6.86

g/l

0.15

Acute gastritis

198

2.08

4.65

1.5

1.3

6.11

6.96

g/l

1.16

139

Female infertility

177

754

1.43

4.64

1.4

6.20

6.81

g/l

1.51

130

520

Intracranial injury

350

2601

1.28

4.63

1.5

1.4

6.76

g/l

0.01

244

1813

Vitamin B12 deficiency anaemia

267

1.92

4.62

1.1

1.3

7.16

6.94

g/l

0.16

185

Acute posthaemorrhagic anaemia

2.93

4.61

1.3

6.82

7.47

g/l

0.27

Other disorders of patella

100

635

1.58

4.59

1.2

1.4

6.92

6.74

g/l

0.23

425

Congenital malformations of the urinary system

213

2.04

4.57

1.2

1.3

7.00

6.71

g/l

0.20

155

Disorder of lipoprotein metabolism, unspecified

406

1.73

4.57

1.3

1.4

6.44

6.85

g/l

0.43

276

Convalescence

173

2.16

4.57

1.5

1.4

6.49

6.64

g/l

0.09

121

Respiratory tuberculosis

122

2.39

4.56

2.1

1.3

7.61

7.08

g/l

0.29

Respiratory tuberculosis, confirmed and not-confirmed

122

2.39

4.56

2.1

1.3

7.61

7.08

g/l

0.29

Other specified/unspecified dorsopathies

2.83

4.56

1.6

1.5

6.82

7.12

g/l

0.10

Abrasion of teeth

208

1526

1.37

4.55

1.3

1.4

6.99

6.76

g/l

0.37

146

1065

Tubulo-interstitial nephritis, not specified as acute or chronic

180

2.12

4.53

1.3

1.4

10.16

6.57

g/l

1.99

127

Anti-inflammatory and antirheumatic products, non-steroids

167

581

1.45

4.53

1.4

1.3

6.43

7.30

g/l

1.72

120

409

DVT of lower extremities

103

661

1.56

4.53

1.4

1.3

6.66

6.59

g/l

0.06

465

Trigger finger

475

1.67

4.52

1.3

6.63

6.95

g/l

0.43

331

Other shoulder lesions

298

1.86

4.51

1.4

1.3

5.90

6.90

g/l

1.37

209

Panniculitis affecting regions of neck and back

2.67

4.50

1.6

1.5

6.33

7.29

g/l

0.70

Artificial joint operation, meniscal resection

537

2866

1.22

4.49

1.4

6.57

6.85

g/l

1.04

360

1988

Female infertility, cervical, vaginal, other or unspecified origin

163

739

1.44

4.49

1.4

6.13

6.84

g/l

1.85

122

507

Viral conjunctivitis

117

2.42

4.49

1.3

7.91

6.59

g/l

0.65

Other erythematous conditions

2.55

4.48

1.3

1.4

6.65

6.83

g/l

0.09

Endometriosis ASRM stages 1,2

117

775

1.52

4.47

1.4

6.26

6.69

g/l

0.59

539

Unspecified nephritic syndrome

2.97

4.46

1.5

1.3

8.92

6.66

g/l

0.77

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

2.72

4.43

1.3

1.4

5.68

6.83

g/l

1.02

Mixed and other personality disorders

329

1.81

4.43

1.5

1.3

6.22

6.59

g/l

0.46

234

Generalized anxiety disorder

101

649

1.56

4.43

1.3

6.38

6.69

g/l

0.48

441

Benign neoplasm: Pituitary gland, craniopharyngeal duct

169

2.15

4.41

1.4

1.3

6.00

6.95

g/l

0.93

119

Arterial embolism and thrombosis

124

2.35

4.40

1.3

1.2

5.37

7.15

g/l

2.04

Recurrent dislocation of patella

163

2.16

4.37

1.1

1.4

7.59

6.51

g/l

0.87

109

Paralytic strabismus

210

2.01

4.37

1.7

1.4

6.12

6.89

g/l

0.74

145

Campylobacter enteritis

2.76

4.37

1.2

1.4

7.26

6.83

g/l

0.21

Hyperfunction of pituitary gland

170

2.14

4.35

1.3

6.18

6.74

g/l

0.44

117

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

302

1.83

4.34

1.3

1.4

7.78

6.96

g/l

0.47

210

Schizophrenia

691

0.49

4.34

1.1

1.4

6.28

6.73

g/l

0.49

469

Hyperaldosteronism

2.81

4.30

1.6

1.2

6.19

6.93

g/l

0.48

Pure hyperglyceridaemia

2.99

4.30

1.4

6.74

6.66

g/l

—

Abdominal aortic aneurysm (AAA)

223

1.97

4.29

1.3

1.2

8.03

7.22

g/l

0.29

158

Speech therapy

150

1053

1.43

4.28

1.5

1.4

6.51

6.69

g/l

0.23

139

722

Contusion of toe(s) without damage to nail

2.73

4.27

1.2

5.52

6.37

g/l

0.49

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

280

1879

1.30

4.26

1.5

1.4

6.52

6.68

g/l

0.30

204

1339

Spirochaetal infections, other/unspecified

297

1.83

4.25

1.1

1.4

6.52

6.94

g/l

0.28

199

Artificial opening status

152

2.19

4.25

1.4

7.13

6.85

g/l

0.11

113

Bruxism

2.79

4.21

1.3

1.4

6.79

6.29

g/l

0.26

Endometriosis of rectovaginal septum and vagina

255

1.90

4.21

1.5

5.82

6.75

g/l

1.38

172

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

107

706

1.52

4.19

1.4

1.3

6.40

6.57

g/l

0.18

486

Other disorders of the musculoskeletal system and connective tissue

548

1.60

4.18

1.6

1.3

6.22

6.84

g/l

0.92

385

Benign neoplasm: Sigmoid colon

103

675

1.53

4.16

1.5

1.4

6.53

6.85

g/l

0.40

471

Visual field defects

249

1.90

4.15

1.5

1.3

6.40

7.00

g/l

0.60

170

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

109

2.41

4.15

2.0

1.3

6.95

7.04

g/l

0.05

Iron deficiency

2.51

4.15

1.2

1.3

5.67

6.50

g/l

0.87

Type 1 diabetes, wide definition, subgroup 1

123

837

1.47

4.12

1.4

1.3

6.68

6.80

g/l

0.11

620

Myocardial infarction, without ST-elevation

186

1240

1.37

4.12

1.4

6.84

7.06

g/l

0.36

144

836

Alzheimer disease, including avohilmo

761

0.60

4.08

1.4

6.66

7.20

g/l

0.60

528

Poisoning by drugs, medicaments and biological substances

152

1080

1.41

4.08

1.3

6.16

6.62

g/l

1.14

108

747

Congenital malformations of the urinary system

230

1.93

4.06

1.2

1.3

7.09

6.70

g/l

0.28

166

Other condition

576

1.57

4.05

1.7

1.3

6.15

6.71

g/l

1.09

402

KRA_PSY_EATING, excluding more controls

286

1.82

4.03

1.2

1.3

6.12

6.84

g/l

1.08

196

Cholesteatoma of middle ear

136

2.22

4.03

1.9

1.3

6.56

7.13

g/l

0.54

Mature T/NK-cell lymphomas, hilmo

3.97

4.02

1.3

1.2

6.61

6.98

g/l

—

Convergence insufficiency and excess

3.96

4.02

1.2

1.3

6.10

6.11

g/l

—

Radial styloid tenosynovitis [de Quervain]

169

2.09

4.02

1.7

1.4

5.56

6.60

g/l

1.68

124

Normotensive glaucoma

217

1.95

4.01

1.4

1.3

6.56

7.12

g/l

0.47

155

Persistent mood disorders

113

762

1.49

4.00

1.3

6.40

6.73

g/l

0.60

513

Idiopathic urticaria

2.85

3.97

1.4

1.3

5.70

6.41

g/l

0.71

Other acquired deformities of musculoskeletal system and connective tissue

150

2.15

3.97

1.9

1.3

6.81

6.85

g/l

0.02

Hydronephrosis

348

1.73

3.97

1.4

1.3

7.81

6.51

g/l

1.85

251

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

619

1.54

3.96

1.2

1.4

6.65

6.92

g/l

0.28

439

Tuberculosis of other organs, strict

3.16

3.94

2.1

1.3

8.61

7.89

g/l

—

Epilepsy

168

1218

1.38

3.93

1.3

1.4

7.19

6.93

g/l

0.28

129

871

Other disorders of glucose regulation and pancreatic internal secretion

283

1.81

3.92

1.8

1.3

7.03

6.53

g/l

0.37

196

Strabismus

164

1186

1.38

3.92

1.6

1.3

6.43

6.55

g/l

0.18

109

839

Tuberculosis of other organs

3.30

3.92

2.1

1.3

8.49

7.22

g/l

—

Bacterial, viral and other infectious agents

335

1.74

3.91

1.3

6.68

6.72

g/l

0.04

229

Left ventricular outflow tract obstruction (LVOTO), broad definition

418

1.66

3.91

1.6

1.3

7.50

6.58

g/l

0.54

298

Suppurative otitis media, unspecified

2.91

3.91

1.7

1.4

6.49

6.92

g/l

0.14

Other dialysis

2.48

3.90

1.3

6.17

6.64

g/l

0.29

Benign neoplasm of other and unspecified endocrine glands

511

1.59

3.90

1.4

1.3

6.71

6.86

g/l

0.13

358

Other symptoms and signs involving general sensations and perceptions

100

2.42

3.90

1.2

1.3

6.06

7.19

g/l

0.85

Calculus of kidney and ureter

160

1157

1.39

3.89

1.3

6.61

6.98

g/l

0.71

111

802

Poisoning by medicine

138

974

1.42

3.87

1.3

1.4

5.94

6.55

g/l

1.96

666

Other specified disorders of muscle

2.80

3.86

1.6

1.2

6.00

7.45

g/l

0.80

192

1310

1.35

3.85

1.5

1.4

6.48

7.00

g/l

1.01

136

895

Presbycusis

304

1.77

3.83

1.6

1.2

5.46

7.23

g/l

2.33

218

Superficial injury of ankle and foot

506

1.59

3.82

1.5

1.4

6.97

6.54

g/l

0.37

353

Gonarthrosis,primary

498

2547

1.21

3.81

1.3

1.4

6.71

6.86

g/l

0.37

351

1766

Respiratory tuberculosis, not confirmed

2.55

3.80

2.3

1.3

7.88

7.15

g/l

0.35

Injury of nerves at forearm level

3.24

3.80

1.4

5.30

6.80

g/l

—

Myopia

538

1.57

3.80

1.3

1.4

6.05

6.51

g/l

1.07

375

Tobacco use

173

2.04

3.80

1.3

7.52

6.88

g/l

0.44

118

Other peripheral vertigo

301

1.77

3.79

1.5

1.4

6.30

6.90

g/l

0.65

212

Thyrotoxicosis

144

1028

1.41

3.79

1.5

1.4

6.39

6.77

g/l

0.75

707

Respiratory conditions due to other external agents

3.22

3.79

1.4

1.2

4.86

6.85

g/l

—

Herpesviral keratitis and keratoconjunctivitis

114

2.30

3.79

1.6

1.3

7.59

6.95

g/l

0.23

Alzheimer disease

636

0.57

3.78

1.2

1.3

6.32

7.16

g/l

0.90

443

Scoliosis

272

1.81

3.78

1.3

1.4

7.11

6.69

g/l

0.35

191

Infliximab

2.77

3.78

1.1

1.3

6.83

6.68

g/l

—

Delirium, not induced by alcohol and other psychoactive substances

301

1.76

3.76

1.4

1.3

7.08

6.82

g/l

0.15

213

Thyrotoxicosis, other and/or unspecified

114

781

1.47

3.76

1.4

6.33

6.78

g/l

0.82

542

Other diseases of spinal cord

2.67

3.74

1.3

5.12

6.89

g/l

1.02

Oesophageal obstruction

2.66

3.74

1.2

7.50

7.74

g/l

0.09

Open wound of ankle and foot

393

1.66

3.72

1.3

6.23

6.59

g/l

0.36

272

Speech and linguistic disorders

377

1.66

3.71

1.4

1.3

6.53

6.30

g/l

0.25

278

Benign lipomatous neoplasm of other sites/unspecified

252

1.84

3.71

1.2

1.4

6.55

6.91

g/l

0.23

177

Other and unspecified local infections of skin and subcutaneous tissue

326

1.73

3.69

1.4

1.3

6.92

6.65

g/l

0.21

232

Psychotic depression

182

1.99

3.68

1.1

1.5

7.52

7.02

g/l

0.18

122

Propionic acid derivatives

161

581

1.40

3.67

1.3

6.20

7.30

g/l

2.61

116

409

Erosion of teeth , including avohilmo

157

1145

1.38

3.66

1.3

1.4

7.53

6.51

g/l

1.35

106

792

Degenerative diseases of the nervous system

779

0.62

3.66

1.2

1.4

6.48

7.20

g/l

0.96

544

Degeneration of macula and posterior pole

223

1357

1.31

3.66

1.4

6.98

6.93

g/l

0.07

154

947

Sequelae of injuries of neck and trunk

2.50

3.64

1.6

1.3

7.08

7.28

g/l

0.06

Cardiac arrest

120

2.15

3.64

1.2

1.3

7.04

7.15

g/l

0.04

Left hemicolectomy

2.89

3.64

1.4

1.2

6.85

8.05

g/l

—

Benign neoplasm of middle ear and respiratory system

232

1.86

3.64

1.7

1.3

6.84

g/l

0.00

156

Other and unspecified disorders of skin and subcutaneous tissue

176

2.00

3.64

1.5

1.4

5.78

7.09

g/l

1.80

124

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

184

1377

1.34

3.63

1.2

1.4

6.13

6.76

g/l

2.24

125

956

Golimumab

123

2.22

3.62

1.1

1.3

7.91

6.64

g/l

0.99

Hemiplegia

136

2.15

3.61

1.3

6.90

6.98

g/l

0.03

Mental and behavioural disorders due to alcohol

290

2215

1.26

3.61

1.3

1.4

6.48

6.82

g/l

0.93

182

1513

Other disorders of binocular movement

2.68

3.58

1.5

1.3

6.26

5.81

g/l

0.29

Disorders of tooth development and eruption

484

1.53

3.58

1.5

1.3

5.80

6.52

g/l

1.94

332

Follicular cysts of skin and subcutaneous tissue

107

732

1.47

3.58

1.4

1.3

5.69

6.85

g/l

3.32

510

Lichen planus, including avohilmo

106

724

1.47

3.57

1.7

1.4

6.64

6.73

g/l

0.09

497

Other specified and unspecified personality disorders

352

1.69

3.57

1.3

1.4

6.09

6.54

g/l

0.65

245

Other local infections of skin and subcutaneous tissue

352

1.69

3.57

1.4

1.3

7.45

6.61

g/l

0.57

249

Actinic keratosis

170

1165

1.35

3.57

1.5

1.4

6.26

7.09

g/l

2.58

119

787

Malignant neoplasm of breast, HER2-negative

137

1244

0.72

3.56

1.1

1.4

6.54

6.72

g/l

0.25

893

Malignant neoplasm of breast

139

1255

0.72

3.55

1.2

1.4

6.73

6.72

g/l

0.01

901

Melanocytic naevi

176

1314

1.34

3.54

1.3

6.15

6.71

g/l

1.77

137

906

Routine general health check-up of defined subpopulation

3.07

3.54

1.4

1.2

6.36

7.45

g/l

0.34

Artificial joint re-operation

185

1.96

3.53

1.3

1.5

7.03

7.26

g/l

0.17

133

Flat foot [pes planus] (acquired)

293

1.75

3.53

1.2

1.5

7.13

6.93

g/l

0.11

207

Persons encountering health services in circumstances related to reproduction

374

2055

1.23

3.51

1.3

1.4

6.55

6.66

g/l

0.21

261

1430

Achilles tendinitis

331

1.70

3.51

1.8

1.3

6.21

6.94

g/l

1.03

229

Benign neoplasm: Rectosigmoid junction

2.34

3.51

1.2

1.3

8.26

7.47

g/l

0.21

Other misadventures during surgical and medical care

2.73

3.50

1.1

1.3

6.13

7.00

g/l

0.72

Other facial nerve disorders

2.50

3.47

1.5

1.3

7.22

7.11

g/l

0.04

Other and unspecified injuries of lower leg

280

1.76

3.47

1.5

1.3

7.34

6.77

g/l

0.45

190

Leisure time condition

107

737

1.46

3.47

1.8

1.3

6.39

6.73

g/l

0.51

516

Ankylosing spondylitis, strict definition

159

2.03

3.46

1.2

1.3

7.12

6.63

g/l

0.44

114

Skin changes due to chronic exposure to nonionizing radiation

176

1215

1.34

3.44

1.5

1.4

6.30

7.04

g/l

2.25

123

822

Mixed conductive and sensorineural hearing loss

379

1.64

3.43

1.3

7.03

6.94

g/l

0.07

264

Heart failure and hypertrophic cardiomyopathy

3.02

3.43

1.4

1.3

5.86

7.39

g/l

—

Dementia, including avohilmo

117

1137

0.71

3.42

1.2

1.4

7.09

7.10

g/l

0.00

775

Mantle cell lymphoma, including Hilmo

3.81

3.41

2.2

1.3

5.39

6.58

g/l

—

Status epilepticus

2.41

3.40

1.3

5.55

6.53

g/l

0.84

Other degenerative diseases of the nervous system

129

684

1.41

3.40

1.4

1.3

6.35

7.26

g/l

2.12

468

2.53

3.39

1.2

6.11

5.69

g/l

0.19

Chromosomal abnormalities, not elsewhere classified

107

2.27

3.39

1.4

1.3

7.00

6.14

g/l

0.73

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

108

725

1.45

3.39

1.3

1.4

7.11

6.69

g/l

0.47

533

Abnormalities of gait and mobility

373

1.64

3.38

1.5

1.3

6.29

6.90

g/l

0.64

268

Female genital prolapse

160

662

1.37

3.36

1.5

1.4

6.38

6.70

g/l

0.55

111

458

Hypertrophy of breast in women and men

120

850

1.42

3.36

1.4

1.3

6.11

6.72

g/l

1.30

590

Speech disturbances, not elsewhere classified

246

1.80

3.35

1.3

1.4

6.78

6.96

g/l

0.10

172

Primary open-angle glaucoma

144

1016

1.37

3.35

1.3

1.4

6.44

7.01

g/l

1.26

693

Monoamine oxidase A inhibitors

413

1.61

3.34

1.2

1.3

6.25

6.91

g/l

1.10

281

Glaucoma-related operations

134

2.10

3.34

1.4

5.75

7.16

g/l

1.50

Chondrocostal junction syndrome [Tietze]

108

2.24

3.33

1.5

1.4

5.82

6.92

g/l

1.05

Benign neoplasm of eye and adnexa

329

1.68

3.32

1.7

1.4

5.68

7.03

g/l

2.37

237

Deep endometriosis

352

1.66

3.32

1.5

1.4

6.10

6.59

g/l

0.52

244

Dementia

107

1050

0.70

3.31

1.2

1.4

7.07

7.17

g/l

0.08

714

Chondropathies

638

1.48

3.30

1.5

1.4

5.91

6.69

g/l

2.19

434

Dissociative [conversion] disorders

128

2.13

3.30

1.2

1.3

5.54

6.44

g/l

1.18

Biguanides

567

2947

1.17

3.27

1.4

6.72

6.82

g/l

0.21

389

2057

Event of undetermined intent

241

1.80

3.27

1.2

1.3

6.90

6.72

g/l

0.10

170

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

251

1.77

3.27

1.3

5.82

6.00

g/l

0.20

191

Hypertrophic cardiomyopathy

122

2.15

3.27

1.4

1.3

5.45

7.10

g/l

2.12

Early lumbar disc prolapse, operated

369

1.63

3.26

1.3

6.55

6.51

g/l

0.04

245

Amiodarone users

293

1.72

3.26

1.2

1.4

8.22

6.94

g/l

0.95

206

Hypertrophy of tongue papillae

3.40

3.24

1.6

1.3

6.62

6.70

g/l

—

Pilonidal cyst

339

1.66

3.24

1.4

1.3

6.41

6.42

g/l

0.01

233

Use of memantine

582

0.57

3.23

1.3

6.67

7.15

g/l

0.41

408

Use of other anti-dementia drugs

582

0.57

3.23

1.3

6.67

7.15

g/l

0.41

408

Melanoma in situ

116

2.17

3.23

1.5

1.4

6.83

7.23

g/l

0.17

L01XX Other antineoplastic agents

143

2.04

3.21

1.2

1.4

6.18

7.16

g/l

0.55

103

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

112

767

1.42

3.20

1.3

1.4

7.12

6.69

g/l

0.50

560

Primary open-angle glaucoma, strict

118

839

1.41

3.20

1.3

1.4

6.38

7.01

g/l

1.20

572

Ingrowing nail

185

1.91

3.20

1.2

1.3

6.12

6.99

g/l

0.83

130

Other problems related to primary support group, including family circumstances

515

1.52

3.18

1.4

6.06

6.56

g/l

1.00

376

Dislocation, sprain and strain of joint and ligaments of hip

2.33

3.18

1.1

1.3

6.13

7.32

g/l

0.65

Cauda equina syndrome

3.31

3.16

1.2

1.4

4.91

7.18

g/l

—

Impotence

165

1.95

3.14

1.4

1.3

6.35

6.90

g/l

0.54

105

Social phobias

319

1.67

3.14

1.5

1.3

6.64

6.67

g/l

0.03

216

Cerebrovascular diseases

398

2326

1.20

3.14

1.3

1.4

7.15

6.75

g/l

0.94

288

1586

Urolithiasis

167

1262

1.33

3.14

1.4

1.3

6.58

6.94

g/l

0.71

113

870

Use of antiglaucoma preparations and miotics

179

1.91

3.14

1.3

6.60

7.01

g/l

0.28

127

Dronedarone medication

2.56

3.13

1.3

1.1

5.98

6.84

g/l

—

Muscle strain

2.49

3.13

1.2

6.42

7.22

g/l

—

Dilated cardiomyopathy

390

1.60

3.10

1.4

1.3

7.30

6.89

g/l

0.37

270

Acidosis

2.83

3.10

1.1

1.3

10.62

7.55

g/l

—

Melanocytic naevi, other sites/unspecified

276

1.71

3.06

1.7

1.4

5.84

6.73

g/l

1.36

194

IgA nephropathy (IgA glomerulonephritis)

2.53

3.05

1.4

6.22

7.03

g/l

0.51

Other disorders of bone density and structure

2.61

3.05

1.4

1.3

6.66

6.61

g/l

0.03

Use of anticholinesterases

798

0.65

3.05

1.3

1.4

6.61

7.15

g/l

0.52

547

N06DA Anticholinesterases

798

0.65

3.05

1.3

1.4

6.61

7.15

g/l

0.52

547

Seborrhoeic dermatitis

315

1.66

3.02

1.3

6.81

6.90

g/l

0.06

229

Hypertrophic scar

175

1.90

3.00

1.4

1.3

6.39

6.68

g/l

0.18

125

Other secondary gonarthrosis

154

1.96

3.00

1.2

1.5

5.71

7.02

g/l

1.27

108

Exposure to other and unspecified inanimate mechanical forces

278

1.70

2.99

1.4

1.3

7.02

6.75

g/l

0.19

198

Malignant neoplasm of eye, brain and central nervous system

120

2.10

2.99

1.5

1.2

6.29

6.83

g/l

0.32

Other female pelvic inflammatory diseases

628

1.45

2.98

1.2

1.4

6.30

6.69

g/l

0.39

433

Other specified/unspecified hearing loss

241

1.75

2.97

1.6

1.4

6.08

6.97

g/l

1.57

173

Complications of other internal prosthetic devices, implants and grafts

2.25

2.97

1.1

1.3

6.72

7.26

g/l

0.23

Transport accidents

274

1907

1.24

2.95

1.5

1.3

6.67

6.84

g/l

0.34

190

1328

Gestational [pregnancy-induced] hypertension

152

1143

1.33

2.94

1.6

1.4

6.54

6.63

g/l

0.15

109

805

Benign neoplasm: Skin, unspecified

121

2.08

2.93

1.2

1.4

6.11

6.89

g/l

0.45

Salpingitis and oophoritis

103

730

1.42

2.93

1.4

6.48

6.76

g/l

0.40

506

Postmenopausal bleeding

138

539

1.37

2.93

1.4

1.3

6.66

6.76

g/l

0.09

369

2.34

2.92

1.8

1.3

6.65

6.62

g/l

0.01

Aortic valve malfunction, age under 60 years

373

1.59

2.91

1.6

1.3

8.05

6.61

g/l

0.80

264

Kyphosis

3.49

2.91

1.2

1.3

10.00

8.62

g/l

—

Medial epicondylitis

108

2.15

2.91

1.4

5.96

6.81

g/l

0.76

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

171

1313

1.31

2.90

1.2

1.3

6.58

6.73

g/l

0.21

125

913

Oligomenorrhoea

115

2.10

2.89

1.6

1.4

6.28

6.89

g/l

0.48

Diabetic retinopathy, excluding more controls

145

602

1.35

2.89

1.4

6.46

6.61

g/l

0.17

384

Allergic contact dermatitis due to drugs in contact with skin

2.53

2.88

1.3

5.81

7.18

g/l

—

Diseases of male genital organs

297

1216

1.23

2.88

1.3

1.4

6.61

6.89

g/l

0.66

202

825

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

2.27

2.88

1.2

1.3

5.74

6.40

g/l

0.74

Unstable angina pectoris

161

964

1.32

2.87

1.4

6.81

7.00

g/l

0.26

123

621

Dermatophytosis

343

2851

1.20

2.86

1.4

6.54

6.78

g/l

0.77

233

1991

Familial hypercholesterolemia, with ischemic heart disease

229

1.75

2.86

1.5

1.2

6.67

7.15

g/l

0.26

162

Embedded teeth, including avohilmo

359

1.60

2.86

1.4

6.31

6.40

g/l

0.10

250

Malignant neoplasm of breast, including Hilmo

149

1274

0.76

2.86

1.1

1.4

6.75

6.72

g/l

0.03

915

Discitis, unspecified

3.20

2.86

1.5

1.3

10.33

7.47

g/l

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

149

1274

0.76

2.86

1.1

1.4

6.75

6.72

g/l

0.03

915

Medicines for HER+ breast cancer

116

1497

0.73

2.85

1.2

1.4

6.77

6.68

g/l

0.10

1067

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

340

2234

1.21

2.84

1.4

6.75

6.70

g/l

0.09

227

1602

Other benign neoplasms of skin

197

1546

1.28

2.84

1.6

1.3

6.51

6.88

g/l

0.87

141

1063

Use of donepezil

473

0.52

2.83

1.3

1.2

6.10

7.15

g/l

0.90

336

Unspecified privation

384

1.57

2.82

1.7

1.4

6.87

6.66

g/l

0.14

269

Inflammatory disease of uterus

586

1.46

2.82

1.4

1.3

5.44

6.53

g/l

2.91

405

Injuries to unspecified part of trunk, limb or body region

361

1.59

2.80

1.6

1.3

6.00

6.82

g/l

1.24

256

535

1.46

2.80

1.3

6.76

7.22

g/l

0.57

376

Hypoglycaemia, other or unspecified

216

1.77

2.80

2.0

1.3

6.33

6.56

g/l

0.22

149

Other chondrocalcinosis

3.63

2.80

1.9

1.2

5.63

6.66

g/l

—

Sub-endpoint used in defining T1D endpoints

163

1230

1.31

2.79

1.4

1.3

6.65

6.70

g/l

0.04

112

861

Malignant neoplasm of endocrine gland

246

1.72

2.79

1.7

1.4

7.28

6.81

g/l

0.33

171

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

163

1252

1.31

2.78

1.2

1.4

6.34

6.87

g/l

1.29

116

867

Glucagon-like peptide-1 (GLP-1) analogues

163

1252

1.31

2.78

1.2

1.4

6.34

6.87

g/l

1.29

116

867

Tooth eruption problems

638

1.43

2.76

1.4

1.3

6.17

6.51

g/l

0.61

462

Other predominantly sexually transmitted diseases, not elsewhere classified

128

951

1.35

2.76

1.2

1.4

6.90

6.64

g/l

0.34

662

Dysplasia of cervi uteri

131

702

1.35

2.76

1.3

1.4

7.04

6.83

g/l

0.19

485

Unspecified event, undetermined intent

2.33

2.75

1.4

1.3

5.78

6.70

g/l

0.56

Statin medication

433

2062

1.18

2.75

1.4

6.70

6.84

g/l

0.27

295

1411

Contraceptive management

259

1470

1.24

2.74

1.3

1.4

6.75

6.70

g/l

0.07

183

1030

Malignant neoplasm of breast, HER-positive

1062

0.72

2.72

1.2

1.4

6.66

6.76

g/l

0.11

763

Drug-induced systemic lupus erythematosus

3.85

2.70

1.4

1.3

7.84

6.57

g/l

—

Retinal vascular occlusion

318

1.61

2.68

1.2

1.3

6.28

6.97

g/l

0.68

223

Pain associated with micturition

405

1.54

2.68

1.3

1.4

6.07

6.83

g/l

0.78

285

Suicide or other Intentional self-harm

144

1094

1.32

2.68

1.3

6.06

6.66

g/l

2.00

756

Other disorders starting during childhood or adolescence

247

1.70

2.67

1.3

1.4

5.90

5.99

g/l

0.09

190

Impacted teeth

122

803

1.36

2.67

1.3

6.64

6.62

g/l

0.03

555

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

126

2.00

2.66

1.4

1.3

7.26

6.85

g/l

0.20

Other congenital malformations of skin

140

1.94

2.66

1.3

6.44

6.80

g/l

0.32

105

Alcohol abuse, main dg

644

1.42

2.64

1.3

6.27

6.62

g/l

0.45

439

Corns and callosities

198

1.78

2.64

1.2

1.4

7.09

6.92

g/l

0.07

140

Status post-ami

107

590

1.39

2.63

1.2

1.3

7.32

7.05

g/l

0.32

388

Malignant neoplasm of digestive organs

181

1118

1.28

2.62

1.3

1.4

6.70

6.94

g/l

0.33

113

777

119

766

1.36

2.61

1.2

1.4

6.81

7.25

g/l

0.72

532

Hyperprolactinaemia

120

2.02

2.61

1.3

1.2

6.18

6.73

g/l

0.39

L01XE Protein kinase inhibitors

148

1.90

2.61

1.4

7.87

6.81

g/l

0.49

102

Crossbite

296

1.60

2.60

1.3

1.4

6.24

6.57

g/l

0.40

230

Disorders of breast

279

2087

1.22

2.59

1.5

1.4

6.10

6.72

g/l

3.15

205

1469

Malignant neoplasm of breast, ER-positive, including Hilmo

102

1077

0.73

2.59

1.2

1.4

7.00

6.75

g/l

0.27

773

Obsessive-compulsive disorder

229

1.71

2.59

1.4

1.3

5.62

6.56

g/l

1.89

155

Embedded and impacted teeth

167

1070

1.29

2.59

1.3

6.51

6.65

g/l

0.26

132

743

Dislocation, sprain and strain of joints and ligaments at neck level

647

1.41

2.59

1.5

1.4

6.27

6.52

g/l

0.38

439

Retinal vascular disorders

322

1.59

2.56

1.2

1.3

6.28

6.94

g/l

0.64

226

Pregnancy hypertension

241

1755

1.23

2.56

1.5

1.4

6.49

6.61

g/l

0.27

174

1247

Malignant neoplasm of thyroid gland

230

1.71

2.56

1.8

1.4

7.28

6.81

g/l

0.32

159

Mental and behavioural disorders due to opioids

135

1.94

2.56

1.3

5.97

6.44

g/l

0.20

Other and unspecified trigeminal disorders

2.89

2.56

1.2

1.5

5.93

5.99

g/l

—

Type 1 diabetes, wide definition

127

954

1.33

2.55

1.4

1.3

6.66

6.74

g/l

0.08

681

Prolonged pregnancy

637

0.63

2.55

1.2

1.4

6.63

6.41

g/l

0.15

452

Secondary polycythaemia

2.44

2.55

1.5

1.3

5.72

6.74

g/l

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

226

1820

1.24

2.54

1.4

1.3

6.34

6.68

g/l

1.01

173

1258

Palmar fascial fibromatosis [Dupuytren]

427

1.50

2.53

1.4

1.3

6.75

7.53

g/l

0.69

292

Other appendicitis

308

1.60

2.52

1.2

1.4

7.25

6.62

g/l

0.49

210

Certain conditions originating in the perinatal period

350

1.53

2.50

1.3

6.08

6.39

g/l

0.40

259

Other noninflammatory disorders of vagina

262

1.65

2.50

1.3

7.45

6.85

g/l

0.37

176

Other predominantly sexually transmitted diseases, not elsewhere classified

107

787

1.36

2.50

1.2

1.4

6.97

6.64

g/l

0.44

544

Major anomalies of jaw size

2.13

2.50

1.4

1.3

7.38

6.59

g/l

0.44

Specific development disorders of scholastic skills

199

1.75

2.49

1.4

1.3

6.18

6.30

g/l

0.09

145

Any dementia

868

0.72

2.48

1.2

1.4

7.05

7.15

g/l

0.08

595

Congenital malformations of eye, ear, face and neck

255

1.66

2.48

1.3

6.69

6.54

g/l

0.09

180

Other otitis externa (chronic)

217

1.71

2.48

1.4

1.3

6.37

6.72

g/l

0.27

159

Chalazion

413

1.51

2.48

1.7

1.4

6.91

6.83

g/l

0.07

282

Dislocation, sprain and strain of joints and ligaments of head

151

1.87

2.47

1.5

1.3

5.50

6.64

g/l

1.08

105

Alzheimer’s disease, strict definition

525

0.61

2.47

1.1

1.3

6.31

7.15

g/l

0.93

367

Alcohol use disorder, ICD-based

225

1827

1.23

2.47

1.2

1.4

6.48

6.89

g/l

1.03

140

1252

Benign neoplasm: Skin of trunk

130

1.94

2.46

2.1

1.3

7.14

7.01

g/l

0.07

Benign neoplasm of meninges

334

1.56

2.45

1.6

1.4

5.74

7.02

g/l

2.52

229

Acute nephritic syndrome

2.57

2.45

1.2

5.83

7.18

g/l

—

Superficial injury of forearm

382

1.53

2.45

1.4

6.85

6.55

g/l

0.18

270

Malignant neoplasm of small intestine, including Hilmo

2.26

2.45

1.1

1.4

6.30

7.01

g/l

—

Cystic kidney disease

2.10

2.43

1.3

6.38

7.28

g/l

0.53

Other symptoms and signs involving the urinary system

335

1.56

2.42

1.5

1.3

6.58

6.77

g/l

0.15

229

L02BG Aromatase inhibitors

1235

0.73

2.42

1.2

1.4

6.69

6.73

g/l

0.03

865

Gonarthrosis, primary, with knee surgery

285

1886

1.20

2.41

1.4

6.76

6.94

g/l

0.32

196

1314

Injury of unspecified body region

242

1.66

2.40

1.5

1.3

6.08

6.78

g/l

0.67

171

Malignant neoplasm of thyroid gland, including Hilmo

273

1.62

2.40

1.8

1.4

6.87

6.76

g/l

0.07

193

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

138

1.90

2.40

1.3

1.4

5.85

6.29

g/l

0.43

105

Effects of foreign body entering through natural orifice

138

1061

1.30

2.40

1.3

1.4

6.72

6.77

g/l

0.06

724

Benign neoplasm: Skin of eyelid, including canthus

548

1.43

2.39

1.7

1.4

6.85

6.71

g/l

0.16

380

Residual foreign body in soft tissue

160

1.82

2.39

1.4

1.3

5.98

6.98

g/l

0.93

108

Psoriasis (vulgaris), strict definition

2.13

2.39

1.1

1.3

6.14

6.70

g/l

0.38

Thyrotoxicosis with diffuse goitre

540

1.43

2.39

1.5

1.3

6.23

6.68

g/l

0.80

377

Emotional disorders and disorders of social functioning with onset specific to childhood

201

1.72

2.39

1.3

1.4

6.56

6.27

g/l

0.33

148

Amputation

250

1.65

2.39

1.3

1.2

8.06

6.97

g/l

0.38

173

Contusion of other and unspecified parts of foot

175

1.78

2.38

1.2

1.3

7.46

6.36

g/l

0.64

119

Stroke, excluding SAH

295

1797

1.20

2.37

1.3

1.4

7.27

6.89

g/l

0.66

213

1224

Superficial injury of head

123

932

1.32

2.37

1.5

1.3

6.73

6.55

g/l

0.21

642

Foreign body in respiratory tract

168

1.80

2.37

1.5

1.4

7.37

6.82

g/l

0.31

120

Malignant neoplasm of bronchus and lung, including Hilmo

549

1.39

2.36

1.2

1.5

6.67

7.01

g/l

0.39

388

Other disorders of veins

215

1737

1.23

2.36

1.3

1.4

7.46

6.74

g/l

1.01

142

1233

Congenital malformations of the circulatory system

631

1.39

2.35

1.6

1.4

7.51

6.57

g/l

1.14

462

Sequelae of other external causes

176

1.77

2.34

1.5

1.3

6.89

6.73

g/l

0.06

126

Other eating disorders

191

1.74

2.33

1.2

1.4

6.42

6.02

g/l

0.50

128

Coxarthrosis, primary

290

2053

1.20

2.33

1.3

1.4

6.65

6.96

g/l

0.85

229

1413

Papillary adenocarcinoma of thyroid gland

169

1.79

2.33

2.0

1.5

7.33

6.56

g/l

0.48

120

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

101

746

1.36

2.32

1.3

1.4

5.87

6.67

g/l

2.37

506

Urethral stricture

140

1.87

2.32

1.2

7.80

7.01

g/l

0.38

101

Hallux rigidus

436

1.47

2.32

1.4

1.5

7.32

6.96

g/l

0.32

303

Presence of other devices

104

769

1.35

2.31

1.3

1.4

7.16

6.89

g/l

0.35

562

Disturbances of smell and taste

119

1.95

2.31

1.3

1.6

6.67

6.92

g/l

0.15

Personal history of other diseases and conditions

484

1.45

2.30

1.5

1.4

5.78

6.41

g/l

1.60

359

Congenital malformations of ovaries, fallopian tubes and broad ligaments

215

1.68

2.29

1.2

1.4

7.32

6.60

g/l

0.61

152

112

1.97

2.28

1.3

1.2

7.86

6.79

g/l

0.65

Other specified disorders of kidney and ureter

2.08

2.27

1.5

1.3

6.58

7.21

g/l

0.37

Injury of muscle and tendon at shoulder and upper arm level

178

1424

1.25

2.27

1.4

6.40

6.92

g/l

1.32

121

978

All dysplastic lesions of the vagina

2.17

2.25

1.5

1.4

9.17

6.62

g/l

0.88

Necrosis of pulp, including avohilmo

340

2891

1.17

2.24

1.4

6.95

6.72

g/l

0.45

222

2020

Primary hyperparathyroidism

358

1.51

2.24

1.6

1.4

6.58

6.99

g/l

0.44

244

Degenerative macular diseases

318

1.55

2.23

1.4

1.3

7.68

6.99

g/l

0.70

222

Hypertrophy of breast

102

760

1.35

2.23

1.5

1.3

6.02

6.68

g/l

1.21

528

Use of glatiramer acetate

2.36

2.23

1.4

6.07

6.06

g/l

—

Biomechanical lesions, not elsewhere classified

135

1.86

2.22

1.2

1.4

6.03

6.95

g/l

0.76

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

240

1.63

2.22

1.4

1.3

5.62

6.72

g/l

1.54

168

Periodontal disease, other/unspecified

2.21

1.3

6.72

6.81

g/l

—

Other abnormal findings in urine

2.89

2.21

1.5

1.2

4.41

7.00

g/l

—

Benign neoplasm: Cerebral meninges

303

1.56

2.21

1.7

1.4

5.73

6.91

g/l

2.13

212

Meralgia paraesthetica

100

2.02

2.21

1.6

1.4

5.82

7.08

g/l

1.37

Cystic kidney disease

100

2.02

2.21

1.3

6.38

7.22

g/l

0.50

Benign neoplasm: Long bones of lower limb

107

1.98

2.21

1.9

1.4

5.61

6.99

g/l

0.96

Other menopausal disorders

147

643

1.29

2.21

1.8

1.4

6.28

6.66

g/l

0.81

105

443

Other/unspecified disorders of vestibular function

114

1.94

2.21

1.1

1.4

5.95

7.06

g/l

0.79

Emotionally unstable personality disorder

533

1.41

2.19

1.3

1.4

6.31

6.44

g/l

0.15

368

Other strabismus

128

986

1.30

2.17

1.6

1.3

6.72

6.54

g/l

0.23

693

Cyst of kidney

196

1.69

2.15

1.5

1.4

7.81

7.00

g/l

0.57

133

Peripheral arterial reconstruction

477

1.43

2.14

1.2

1.4

6.67

7.14

g/l

0.45

337

Varicose veins

316

2026

1.18

2.14

1.5

1.4

6.79

6.78

g/l

0.01

210

1437

Benign neoplasm: Choroid

174

1.73

2.13

1.2

1.5

5.95

7.00

g/l

0.96

120

Autism spe, excluding more controls

2.12

2.13

1.4

4.68

6.16

g/l

—

Peripheral artery operations in Hilmo

330

1.52

2.12

1.3

8.31

6.72

g/l

0.76

231

Open wound of wrist and hand

256

2094

1.20

2.11

1.3

1.4

6.62

6.80

g/l

0.30

187

1443

Short stature starting before birth

2.82

2.11

1.4

1.2

6.57

6.24

g/l

—

Family history of other conditions

2.48

2.11

1.1

1.3

6.02

6.52

g/l

—

Infective bursitis

2.22

2.11

1.3

6.57

7.21

g/l

—

Endometriosis of ovary

631

1.36

2.11

1.3

1.4

6.72

6.75

g/l

0.03

432

Sixth [abducent] nerve palsy

2.02

2.11

1.6

1.3

5.87

7.29

g/l

0.95

Disorders of synovium and tendon in diseases classified elsewhere

2.47

2.11

1.4

1.3

7.68

7.43

g/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

331

1.52

2.11

1.4

1.3

6.44

6.73

g/l

0.32

232

Myeloproliferative diseases

236

1.62

2.10

1.2

1.4

6.50

7.18

g/l

0.44

163

Any event in cancer register

554

2883

1.13

2.09

1.3

1.4

7.07

6.71

g/l

0.91

374

2026

Other and unspecified mood [affective] disorders

260

1.58

2.09

1.2

1.4

6.29

6.58

g/l

0.25

179

Other conjunctival vascular disorders and cysts

2.28

2.08

1.6

1.2

6.52

7.53

g/l

—

UC patients in KELA-register (code 208), prior to 1994

131

1.84

2.08

1.6

1.3

6.61

6.92

g/l

0.19

Mental and behavioural disorders due to alcohol, excluding acute intoxication

237

1964

1.20

2.08

1.2

1.4

6.41

6.88

g/l

1.28

147

1347

Malignant neoplasm of respiratory system and intrathoracic organs

538

1.36

2.07

1.2

1.5

6.57

6.95

g/l

0.45

377

Other noninflammatory disorders of uterus, except cervix

105

532

1.33

2.06

1.5

1.4

7.19

6.62

g/l

0.45

365

Benign neoplasm: Tongue

2.19

2.05

1.5

1.3

4.88

7.47

g/l

—

Pustular psoriasis

154

1.76

2.04

1.2

1.5

6.71

6.81

g/l

0.06

107

Blepharochalasis

134

1052

1.28

2.04

1.5

1.4

6.70

6.80

g/l

0.11

731

Mental and behavioural disorders due to sedatives or hypnotics

254

1.58

2.03

1.3

1.4

5.79

6.69

g/l

1.34

180

Other puerperal infections

334

1.50

2.03

1.5

1.4

6.36

6.40

g/l

0.03

236

Background retinopathy and retinal vascular changes

2.42

2.03

1.3

1.2

5.92

6.54

g/l

—

Other congenital malformations of circulatory system

2.12

2.03

2.6

1.3

6.59

6.78

g/l

—

Ischaemic Stroke, excluding all haemorrhages

269

1685

1.19

2.03

1.3

1.4

7.28

6.94

g/l

0.51

191

1148

Inflammatory diseases of prostate (prostatitis)

416

1.45

2.03

1.1

1.4

6.61

7.24

g/l

0.90

279

All dysplastic lesions of the vulva

147

1.78

2.03

1.3

1.5

8.86

6.65

g/l

1.01

106

Bicipital tendinitis

125

1.85

2.02

1.3

6.64

7.23

g/l

0.34

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

177

1.70

2.02

2.2

1.5

5.91

7.38

g/l

1.79

123

Transient ischemic attack

249

1687

1.20

2.02

1.4

6.41

6.90

g/l

1.34

175

1159

Somnolence, stupor and coma

118

1.87

2.02

1.3

1.4

5.76

7.02

g/l

0.88

Specific development disorders of speech and language

245

1.58

2.01

1.4

1.3

6.72

6.35

g/l

0.34

186

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

2.24

2.01

1.5

1.4

4.79

7.36

g/l

—

Emotional disorders starting during childhood or adolecense, excluding more controls

158

1.74

2.01

1.4

1.3

6.42

6.26

g/l

0.13

112

Other benign neoplasms of connective and other soft tissue

343

1.49

2.01

1.5

1.4

6.59

6.81

g/l

0.08

238

Other other unspecified disorders of the circulatory system

104

1.94

2.01

1.8

1.3

5.92

6.78

g/l

0.38

Wet age-related macular degeneration

412

1.44

2.00

1.2

1.4

6.98

7.05

g/l

0.05

299

Lesion of sciatic nerve

2.01

2.00

1.3

7.19

7.51

g/l

0.16

Fracture of femur

108

748

1.31

2.00

1.4

6.38

7.04

g/l

1.20

520

Pustulosis palmaris et plantaris

133

1.82

2.00

1.1

1.5

6.79

6.91

g/l

0.07

Other and unspecified injuries of ankle and foot

133

1.82

1.99

1.8

1.2

7.72

6.25

g/l

1.18

Scabies

163

1.73

1.98

1.7

1.3

6.39

6.46

g/l

0.05

113

Glucosamine medication

224

1485

1.21

1.98

1.3

1.4

6.92

6.96

g/l

0.05

154

1035

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

163

1.72

1.97

1.5

1.4

6.68

7.13

g/l

0.29

115

Maltreatment syndromes

194

1.66

1.96

1.2

1.3

6.72

6.35

g/l

0.41

139

Fracture of neck

156

1.74

1.96

1.1

1.3

6.90

7.13

g/l

0.07

110

Contact with other hot fluids

105

1.92

1.96

1.5

1.3

6.15

6.51

g/l

0.23

Acute alcohol intoxication, ICD10

108

830

1.30

1.95

1.4

6.45

6.61

g/l

0.17

573

Viral haemorrhagic fevers, not elsewhere classified/unspecified

257

1.56

1.95

1.5

1.3

6.50

6.87

g/l

0.37

178

Atlantoaxial subluxation

3.81

1.94

1.2

1.6

6.42

6.39

g/l

—

Astigmatism

249

1.57

1.94

1.2

1.4

6.95

6.33

g/l

0.60

180

Disorders of porphyrin and bilirubin metabolism

2.76

1.94

2.0

1.3

7.09

6.75

g/l

—

Behavioural disorders, excluding more controls

2.20

1.94

1.3

6.47

6.29

g/l

—

Cardiomyopathy, Hypertrophic obstructive

2.47

1.93

1.5

1.3

5.71

7.42

g/l

—

Benign neoplasm of bone and articular cartilage

322

1.50

1.93

2.0

1.4

5.64

6.59

g/l

1.64

225

Haemangioma, any site

306

1.51

1.92

1.6

1.3

7.15

6.61

g/l

0.69

211

Congenital malformations of genital organs

427

1.43

1.92

1.2

1.4

6.81

6.39

g/l

0.52

316

Haemangioma and lymphangioma, any site

339

1.48

1.91

1.5

1.4

7.06

6.55

g/l

0.73

239

Stroke, including SAH

313

1947

1.17

1.91

1.2

1.4

7.25

6.87

g/l

0.70

227

1323

Malignant neoplasm, without specification of site, including Hilmo

1.93

1.90

1.4

5.63

7.35

g/l

1.45

Unspecified urinary incontinence

267

1.54

1.89

1.4

7.12

7.06

g/l

0.03

181

Other disorders of pigmentation

121

1.83

1.88

1.4

8.09

7.24

g/l

0.22

Impacted maxillary molar

220

1.60

1.88

1.5

1.4

6.65

6.33

g/l

0.22

150

Medical abortion

361

1695

1.16

1.87

1.3

1.4

6.47

6.68

g/l

0.54

255

1194

Melanocytic naevi of lower limb, including hip

144

1.75

1.85

1.5

1.3

5.91

6.89

g/l

1.25

100

Arthropod-borne viral fevers and viral haemorrhagic fevers

750

1.31

1.84

1.4

1.3

6.40

6.81

g/l

0.76

528

Implicit parasitic Sepsis

4.25

1.83

1.6

1.3

6.95

6.68

g/l

—

Carbimazole or st.post thyroidectomy, condition for graves disease

112

874

1.28

1.82

1.8

1.4

5.93

6.70

g/l

1.95

602

Exposure to other and unspecified animate mechanical forces

101

1.89

1.81

1.2

1.3

6.46

6.60

g/l

0.07

Lesion of femoral nerve

3.09

1.81

1.1

1.4

6.43

g/l

—

Eating disorders

443

1.40

1.80

1.2

1.4

6.26

6.52

g/l

0.26

312

Amputation of toe

184

1.64

1.78

1.1

1.3

7.13

7.15

g/l

0.01

126

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

233

1332

1.19

1.76

1.6

1.4

6.17

6.87

g/l

2.70

162

936

Fracture of lower leg, including ankle

297

2537

1.16

1.76

1.5

1.3

6.80

6.79

g/l

0.02

218

1753

Brain meningioma, including Hilmo

154

1.70

1.76

1.5

5.58

6.94

g/l

2.17

107

Other salmonella infections

124

1.78

1.76

1.6

1.3

7.13

6.65

g/l

0.20

Disorder of external ear, unspecified

1.94

1.75

1.6

1.3

6.61

6.83

g/l

—

Carcinoma in situ of skin of other and unspecified parts of face

185

1.63

1.75

1.2

1.3

6.94

7.07

g/l

0.04

137

Arterial embolism and thrombosis of lower extremity artery

2.04

1.75

1.1

1.2

5.21

6.55

g/l

—

Cysts of oral region, not elsewhere classified

193

1.61

1.75

1.8

1.4

6.39

6.80

g/l

0.40

136

Malignant neoplasm of small intestine

2.24

1.74

1.1

1.2

6.27

7.40

g/l

—

Early complications of trauma

132

1.75

1.74

1.4

1.3

6.79

7.04

g/l

0.16

!Aliquae complicationes praecoces traumatis

132

1.75

1.74

1.4

1.3

6.79

7.04

g/l

0.16

Fall on same level involving ice and snow

313

2716

1.15

1.73

1.6

1.4

6.78

6.85

g/l

0.11

219

1896

Cerebral aneurysm, nonruptured

314

1.47

1.73

1.3

1.4

6.03

6.87

g/l

0.83

212

Vitreous haemorrhage

314

1.47

1.73

1.5

1.4

6.86

6.81

g/l

0.03

220

Endometriosis ASRM stages 3,4

122

970

1.26

1.73

1.3

1.4

6.33

6.72

g/l

0.64

668

Glaucoma, exfoliation

225

1.56

1.72

1.3

6.38

6.98

g/l

0.60

165

Essential (haemorrhagic) thrombocythaemia

103

1.86

1.72

1.1

1.4

6.95

7.20

g/l

—

Parkinson's disease

446

0.63

1.71

1.3

7.42

7.07

g/l

0.16

310

Diabetic nephropathy, excluding more controls

444

1.36

1.71

1.4

1.5

7.43

6.69

g/l

0.83

278

Female infertility, associated with anovulation

315

1.47

1.70

1.5

6.32

6.66

g/l

0.41

218

Myeloproliferative diseases (CML excluded)

210

1.58

1.70

1.1

1.4

6.81

7.18

g/l

0.19

143

Single spontaneous delivery

152

988

0.81

1.70

1.4

6.43

6.54

g/l

0.17

730

Varicella [chickenpox]

187

1.61

1.69

1.2

1.3

6.71

6.59

g/l

0.08

133

Any dementia, excluding more controls

773

0.76

1.69

1.2

1.4

7.17

7.24

g/l

0.05

529

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

275

1.50

1.68

1.3

1.4

6.63

6.75

g/l

0.08

190

Ménière disease

308

1.47

1.68

1.5

1.4

6.77

7.10

g/l

0.29

214

Bursitis of shoulder

2.20

1.68

1.4

1.5

5.76

7.57

g/l

—

Other congenital malformations of skin

300

1.47

1.67

1.3

6.86

6.48

g/l

0.45

211

Congenital lens malformations

3.23

1.67

1.2

1.4

5.10

6.61

g/l

—

Congenital ovarian cysts

172

1.64

1.67

1.3

1.4

7.22

6.34

g/l

0.72

122

Whooping cough

2.53

1.67

1.2

5.68

6.16

g/l

—

Additional codes for the location of defect, injury or illness

180

1.62

1.66

1.2

1.3

7.61

6.76

g/l

0.35

126

Open wound of abdomen, lower back and pelvis

1.87

1.66

1.1

1.2

7.11

6.72

g/l

0.12

Other salmonella infections

1.90

1.65

1.4

1.3

7.42

6.88

g/l

0.18

Postprocedural musculoskeletal disorders, not elsewhere classified

212

1.56

1.65

1.5

5.82

6.96

g/l

1.37

147

Benign neoplasm of urinary organs

127

1.74

1.64

1.2

1.4

6.47

7.00

g/l

0.29

Laparoscopic right hemicolectomy

150

1.67

1.63

1.2

1.3

7.91

7.31

g/l

0.27

105

Other superficial mycoses

402

1.40

1.63

1.2

1.4

6.30

6.58

g/l

0.40

279

Injuries to the elbow and forearm

402

3132

1.13

1.62

1.4

6.70

6.75

g/l

0.11

285

2195

Benign lipomatous neoplasm

146

1195

1.22

1.61

1.3

1.4

6.21

6.85

g/l

1.59

831

Insulin, fast-acting (human)

548

1.34

1.61

1.3

6.48

6.77

g/l

0.34

375

Sequelae of injuries of upper limb

378

1.41

1.60

1.2

1.4

6.47

6.72

g/l

0.17

267

Coxarthrosis, primary, with hip surgery

215

1707

1.18

1.60

1.3

1.4

6.66

6.90

g/l

0.47

168

1168

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

151

1.67

1.60

1.6

1.3

6.78

6.60

g/l

0.08

115

Preterm labour and delivery

140

1142

1.23

1.60

1.4

6.72

6.66

g/l

0.06

808

Other and unspecified mononeuropathies of lower limb

2.01

1.59

1.2

1.3

6.64

7.31

g/l

—

Retinal detachments and breaks

163

1352

1.21

1.58

1.6

1.4

6.71

6.97

g/l

0.40

118

942

Hypermetropia

279

1.47

1.58

1.5

1.4

7.28

6.49

g/l

1.03

205

Viral haemorrhagic fevers, not elsewhere classified/unspecified

654

1.30

1.58

1.4

6.51

6.80

g/l

0.43

471

Female infertility, tubal origin

183

1.59

1.57

1.1

1.4

5.60

6.89

g/l

1.64

133

Alzheimer’s disease (Late onset)

468

0.68

1.57

1.1

1.3

6.23

7.14

g/l

0.95

326

Mental disorders, not otherwise specified

322

1.43

1.55

1.3

1.4

6.50

6.58

g/l

0.06

229

Anomalies of dental arch relationship, including avohilmo

117

847

1.25

1.54

1.3

6.19

6.60

g/l

0.91

596

Parkinson's disease, strict definition

396

0.63

1.53

1.3

7.56

6.98

g/l

0.27

274

Fracture of shoulder and upper arm

180

1512

1.19

1.52

1.5

1.3

6.48

6.77

g/l

0.57

131

1046

Nontoxic multinodular goitre

685

1.29

1.52

1.5

1.3

6.69

6.80

g/l

0.07

474

Hydatidiform mole

0.00

1.52

0.0

1.5

—

6.11

—

Primary gonarthrosis, bilateral

243

1792

1.16

1.51

1.3

1.4

6.76

6.95

g/l

0.36

179

1246

Bitten or struck by other mammals

468

1.35

1.51

1.4

6.03

6.61

g/l

0.96

327

Sequelae of cerebrovascular disease

153

1092

1.21

1.51

1.2

1.4

7.49

6.91

g/l

0.65

113

737

Diffuse brain injury

1.91

1.49

1.1

1.4

8.98

7.13

g/l

—

Superficial injury of thorax

547

1.32

1.49

1.5

1.3

6.40

6.70

g/l

0.29

386

Endometriosis diagnosis and infertility diagnosis occurring together

478

1.34

1.49

1.4

6.32

6.51

g/l

0.18

327

Benign neoplasm of ovary

635

1.29

1.48

1.2

1.4

6.67

6.59

g/l

0.08

438

Conductive hearing loss, unspecified

277

1.45

1.44

1.3

7.48

6.67

g/l

0.62

197

Retinal haemorrhage

1.98

1.44

1.5

1.3

5.66

7.30

g/l

—

Open wound of forearm

336

1.40

1.43

1.3

7.03

6.75

g/l

0.18

231

Outcome of delivery

482

0.74

1.43

1.2

1.4

6.53

6.42

g/l

0.11

349

Malignant neoplasm of prostate, including Hilmo

612

0.78

1.43

1.1

1.4

7.29

6.93

g/l

0.34

422

Contusion of ankle

133

1.66

1.42

1.5

1.3

8.66

6.57

g/l

0.76

Alzheimer disease, excluding more controls

337

0.68

1.42

1.3

1.5

6.50

7.44

g/l

0.73

224

Entropion and trichiasis of eyelid

180

1.56

1.42

1.5

1.3

6.06

7.32

g/l

1.15

127

Fitting and adjustment of other devices

156

1176

1.20

1.42

1.4

7.15

6.85

g/l

0.49

128

814

Impacted cerumen

303

1.42

1.4

7.36

6.93

g/l

0.27

215

Brain meningioma

149

1.62

1.41

1.5

5.38

6.91

g/l

2.87

104

Eating disorder

379

1.37

1.41

1.2

1.4

6.12

6.43

g/l

0.40

269

Other malignant neoplasms of skin (=non-melanoma skin cancer)

208

1219

1.17

1.40

1.6

1.4

6.21

6.86

g/l

2.08

146

851

Wide developmental disorders, excluding more controls

124

1.68

1.40

1.3

5.06

6.14

g/l

1.27

Acute alcohol intoxication

126

1035

1.22

1.39

1.3

1.4

6.50

6.81

g/l

0.43

718

malignant neoplasm of male genital organs

630

0.78

1.37

1.3

1.4

7.22

6.90

g/l

0.29

433

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

135

1.64

1.36

1.2

1.4

8.78

6.99

g/l

0.33

Peripheral retinal degeneration

1.84

1.36

1.4

1.3

3.18

6.93

g/l

—

Sequelae of infectious and parasitic diseases

256

1.45

1.35

1.4

1.3

7.08

6.72

g/l

0.22

176

Benign neoplasm: Adrenal gland

248

1.46

1.35

1.2

1.4

7.04

6.80

g/l

0.13

172

Primary coxarthrosis, bilateral

123

1012

1.22

1.34

1.4

6.33

7.01

g/l

1.84

684

Adenomyosis (Endometriosis of uterus)

478

1.32

1.34

1.2

1.4

6.44

6.54

g/l

0.10

326

Complications predominantly related to the puerperium

144

1204

1.20

1.34

1.5

1.4

6.42

6.69

g/l

0.43

107

846

Use of interferon beta-1a

1.79

1.33

1.4

6.37

6.29

g/l

—

Carcinoma in situ of breast, intraductal

309

0.61

1.33

1.2

1.4

7.05

6.82

g/l

—

213

Intussusception

1.98

1.33

1.0

1.4

4.88

7.44

g/l

—

Benign neoplasm: Kidney

1.79

1.33

1.3

1.4

6.48

7.41

g/l

0.42

Other lesions of median nerve

1.98

1.33

1.1

1.3

6.74

7.21

g/l

—

Anorexia (incl.atypical)

216

1.49

1.32

1.1

1.4

6.39

6.36

g/l

0.02

142

Other vitreous opacities

113

1.69

1.32

1.4

1.3

7.99

7.05

g/l

0.48

LSIL lesion of the cervix uteri, vagina or vulva

629

1.28

1.32

1.3

1.4

7.84

6.43

g/l

1.84

431

Calcific tendinitis of shoulder

176

1.54

1.31

1.1

1.4

6.20

7.03

g/l

0.64

119

Pediculosis, acariasis and other infestations

727

1.25

1.31

1.5

1.4

6.49

6.60

g/l

0.12

510

Delivery

158

989

0.84

1.31

1.4

6.40

6.54

g/l

0.24

730

Cicatricial alopecia [scarring hair loss]

2.53

1.31

1.7

1.4

7.28

6.20

g/l

—

Diabetic retinopathy

172

908

1.18

1.31

1.4

6.52

6.68

g/l

0.20

103

604

Malignant neoplasm of oral cavity, including Hilmo

121

1.66

1.30

1.2

1.3

4.98

6.87

g/l

2.06

Benign mammary dysplasia

516

1.30

1.29

1.5

1.4

5.75

6.73

g/l

2.33

348

Amblyopia ex anopsia

145

1.59

1.29

1.2

1.3

7.00

6.59

g/l

0.29

111

Granulomatous disorders of skin and subcutaneous tissue

1.90

1.29

1.6

1.2

5.87

7.15

g/l

—

Delivery, wide proxy

123

791

0.82

1.28

1.4

6.21

6.53

g/l

0.52

569

L02BB Anti-androgens

231

0.56

1.28

2.2

1.2

8.35

6.91

g/l

—

166

Long labour

985

0.81

1.27

1.3

1.4

6.93

6.50

g/l

0.36

702

Conduct disorder

1.83

1.26

1.3

6.47

6.23

g/l

—

Pedestrian injured in transport accident

219

1.47

1.25

1.2

1.3

6.63

6.86

g/l

0.10

150

Pregnancy with abortive outcome

365

1704

1.12

1.25

1.3

1.4

6.28

6.68

g/l

1.56

254

1200

Infectious mononucleosis

346

1.36

1.24

2.1

1.4

6.70

6.44

g/l

0.21

238

Other spirochaetal diseases

156

1325

1.18

1.24

1.4

6.55

6.80

g/l

0.39

124

922

Congenital cataract

2.68

1.22

1.0

1.4

4.90

6.61

g/l

—

Lichen sclerosus et atrophicus

347

1.36

1.22

1.6

1.4

7.04

6.89

g/l

0.10

239

Other and unspecified disorders of adult personality and behaviour

2.67

1.22

1.2

1.5

5.82

6.14

g/l

—

Exposure to other and unspecified forces of nature

2.67

1.22

2.0

1.1

5.43

8.04

g/l

—

Other spirochaetal diseases

154

1309

1.18

1.21

1.4

6.57

6.79

g/l

0.35

123

909

Oral leukoplakia, including avohilmo

1.81

1.21

1.4

1.3

5.40

7.77

g/l

—

False labour

174

927

1.17

1.21

1.3

1.4

6.60

6.48

g/l

0.22

121

665

Sequelae of injuries of head

180

1.51

1.21

1.5

1.3

7.70

6.90

g/l

0.19

123

Left bundle-branch block

180

1.50

1.20

1.4

1.3

6.69

6.45

g/l

0.12

125

Myocardial infarction, with ST-elevation

531

1.28

1.20

1.2

1.4

6.70

7.10

g/l

0.38

369

Other disorders of cornea

314

1.37

1.20

1.1

1.4

7.36

6.73

g/l

0.40

220

Non-small cell lung cancer, adenocarcinoma

148

1.56

1.20

1.1

1.4

6.73

7.07

g/l

0.23

110

Parkinson's disease, including avohilmo

466

0.71

1.20

1.7

1.3

7.15

7.02

g/l

0.07

326

Hepatocellular carcinoma, including Hilmo

1.84

1.19

1.5

1.2

6.39

7.69

g/l

—

Malignant neoplasm of bronchus and lung

462

1.28

1.19

1.2

1.4

6.50

6.98

g/l

0.58

327

Pediculosis, acariasis and other infestations

222

1.45

1.19

1.6

1.3

7.00

6.66

g/l

0.18

153

Primary ovarian failure

1.89

1.18

1.3

5.91

6.60

g/l

—

Dementia in Alzheimer disease

344

0.69

1.18

1.1

1.3

6.20

7.14

g/l

0.55

244

Other disorders of breast

515

1.28

1.18

1.4

6.30

6.64

g/l

0.53

355

Vestibular neuronitis

298

1.38

1.18

1.3

1.4

7.41

6.89

g/l

0.37

214

Sequelae of injuries of lower limb

358

1.34

1.18

1.6

1.3

7.17

6.68

g/l

0.19

250

Persistent delusional disorders

249

0.60

1.17

1.1

1.4

9.93

6.70

g/l

—

170

Other and unspecified vascular occlusions

231

1.43

1.17

1.2

1.4

6.22

7.02

g/l

0.67

168

L02BA Anti-estrogens

646

0.76

1.16

1.1

1.4

6.72

6.67

g/l

0.05

448

Diabetic nephropathy

581

1.26

1.14

1.4

1.5

7.40

6.68

g/l

0.84

380

Right hemicolectomy

142

1.55

1.14

1.2

1.3

7.74

7.29

g/l

0.20

Macular pucker

474

1.29

1.14

1.7

1.4

6.94

7.08

g/l

0.11

335

Other renal tubulo-interstitial diseases

1.86

1.13

1.1

1.3

9.11

5.80

g/l

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

309

1.36

1.13

1.0

1.4

6.88

6.86

g/l

0.01

223

Foreign body on external eye

581

1.26

1.13

1.2

1.3

6.96

6.64

g/l

0.34

391

Retinoschisis and retinal cysts

1.91

1.12

2.8

1.3

5.85

7.41

g/l

—

Recurrent dislocation and subluxation of joint

250

1.40

1.12

1.2

1.4

6.40

6.69

g/l

0.20

164

Coronary artery bypass grafting

552

1.23

1.11

1.6

1.3

7.29

7.04

g/l

0.22

357

Vertical strabismus

104

1.64

1.09

1.4

7.55

7.16

g/l

0.13

Presbyopia

260

1.39

1.09

1.4

6.15

6.76

g/l

0.57

182

Impacted maxillary canine

1.97

1.09

1.3

1.2

7.20

6.41

g/l

—

Thyrotoxicosis with toxic single thyroid nodule

2.40

1.09

1.8

1.5

5.82

6.21

g/l

—

Colitis due to radiation

2.40

1.09

1.4

4.72

8.16

g/l

—

Postmenopausal atrophic vaginitis

122

563

1.20

1.09

1.4

6.70

6.72

g/l

0.01

385

Injury of muscle and tendon at hip and thigh level

372

1.32

1.09

1.1

1.4

7.23

6.56

g/l

0.50

256

Overexertion and strenuous or repetitive movements

372

1.32

1.09

1.2

1.4

6.43

6.72

g/l

0.23

258

256

0.62

1.09

1.1

1.3

9.13

7.00

g/l

—

181

Dementia in other diseases classified elsewhere

112

1.61

1.09

1.2

7.28

7.49

g/l

—

In situ neoplasms

178

1548

1.15

1.08

1.4

7.07

6.88

g/l

0.21

116

1078

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

347

1.33

1.07

1.1

1.4

6.94

6.75

g/l

0.08

235

Congenital musculoskeletal deformities of head, face, spine and chest

1.94

1.07

1.6

1.3

6.02

g/l

—

Obstructed labour due to maternal pelvic abnormality

623

1.24

1.05

1.3

1.4

6.34

6.63

g/l

0.36

435

Other congenital malformations of the digestive system

210

1.42

1.04

1.6

1.3

7.65

6.41

g/l

0.71

162

Fracture of skull and facial bones

107

896

1.20

1.04

1.4

1.3

6.90

6.74

g/l

0.13

612

Hereditary corneal dystrophies

1.67

1.04

1.1

1.5

6.73

7.18

g/l

—

Gilbert syndrome

2.29

1.04

2.2

1.3

5.98

6.92

g/l

—

Malignant neoplasm of prostate

588

0.81

1.03

1.3

1.4

7.11

6.91

g/l

0.17

404

Non-small cell lung cancer, adenocarcinoma, helper endpoint

154

1.50

1.03

1.1

1.4

6.73

7.09

g/l

0.25

112

Early lumbar disc prolapse operation

482

1.27

1.02

1.2

1.3

6.98

6.54

g/l

0.33

323

Benign neoplasm: Brain, supratentorial

1.93

1.02

1.4

1.3

7.48

6.35

g/l

—

Fall on and from stairs and steps

126

1073

1.18

1.02

1.5

1.3

6.73

6.64

g/l

0.08

746

Car occupant injured in other and unspecified transport accidents

798

1.21

1.02

1.6

1.4

6.79

6.67

g/l

0.12

553

Polyp of the female genital tract

147

724

1.17

1.01

1.3

1.4

6.06

6.73

g/l

1.96

107

498

Varicella [chickenpox]

230

1.40

1.01

1.2

1.3

6.82

6.39

g/l

0.32

169

Sequelae of other and unspecified infectious and parasitic diseases

205

1.42

1.01

1.6

1.4

6.68

6.72

g/l

0.02

142

Migraine with aura, drug-induced

2.02

1.00

2.4

1.4

6.06

6.42

g/l

—

Contact with heat and hot substances

197

1.43

1.00

1.4

1.3

5.79

6.97

g/l

1.40

140

Malignant neoplasm of rectum, including Hilmo

402

0.72

0.99

1.3

1.4

5.91

6.89

g/l

0.78

284

Motorcycle rider injured in other and unspecified transport accidents

223

1.39

0.98

1.5

1.2

5.86

6.74

g/l

1.33

155

Diabetic maculopathy

465

1.26

0.98

1.5

1.4

6.64

6.56

g/l

0.06

305

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

0.00

0.98

0.0

1.2

—

6.45

—

Other congenital malformations of heart

1.97

0.97

1.4

1.2

7.45

6.80

g/l

—

Other congenital malformations of the digestive system

180

1.44

0.97

1.7

1.3

7.61

6.36

g/l

0.65

138

Other disorders of breast and lactation associated with childbirth

1.86

0.97

1.3

6.54

6.16

g/l

—

Torticollis

1.81

0.97

1.1

1.3

6.08

6.55

g/l

—

Scabies

612

1.23

0.97

1.5

1.3

6.41

6.64

g/l

0.37

429

Pathological resorption of teeth

108

1.58

0.96

1.2

7.67

7.01

g/l

0.31

Perineal laceration during delivery

664

0.80

0.96

1.7

1.4

6.47

6.39

g/l

0.07

461

Contact with machinery

389

1.29

0.96

1.2

1.3

6.02

6.75

g/l

0.94

269

Melanocytic naevi of trunk

460

1.26

0.96

1.2

1.4

6.23

6.66

g/l

0.56

327

Maternal care for other known or suspected fetal problems

136

739

1.17

0.96

1.3

1.4

6.40

6.42

g/l

0.04

536

Assault

559

1.24

0.95

1.2

1.3

6.58

6.55

g/l

0.02

377

Male infertility

174

1.44

0.95

1.2

1.3

7.81

6.75

g/l

0.50

112

Infections of genitourinary tract in pregnancy

381

1.29

0.95

1.3

1.5

6.26

6.85

g/l

0.93

261

Behavioural disorders

1.66

0.94

1.3

1.2

6.47

6.37

g/l

—

Schizophrenia or delusion

125

1453

0.86

0.94

1.2

1.3

6.89

6.61

g/l

0.30

986

All dysplastic lesions of the cervix uteri, vagina or vulva

153

1313

1.15

0.94

1.3

1.4

7.12

6.52

g/l

0.98

110

928

Acute myeloid leukaemia, helper endpoint

2.24

0.94

1.7

1.1

5.47

6.62

g/l

—

Acute myeloid leukaemia

2.24

0.94

1.7

1.1

5.47

6.62

g/l

—

Acute myeloid leukaemia, including Hilmo

2.24

0.94

1.7

1.1

5.47

6.62

g/l

—

Autism spe

109

1.57

0.94

1.4

1.3

4.68

6.27

g/l

—

Autism

109

1.57

0.94

1.4

4.68

6.32

g/l

—

Juvenile osteochondrosis

109

1.57

0.93

1.8

1.4

5.81

6.51

g/l

0.61

Primary angle-closure glaucoma

101

1.59

0.93

1.8

1.3

5.31

7.26

g/l

2.18

Other ill-defined and unspecified causes of mortality

175

1.43

0.92

1.2

7.04

7.19

g/l

0.08

123

Complications of the puerperium, not elsewhere classified

167

1.44

0.92

1.3

1.4

6.40

6.34

g/l

0.04

118

LSIL lesion of the cervix uteri

508

1.24

0.92

1.3

1.4

7.96

6.39

g/l

1.58

353

Premature rupture of membranes

722

0.83

0.91

1.3

1.4

6.74

6.51

g/l

0.15

515

Erectile dysfunction

235

1.37

0.91

1.5

1.2

9.05

6.81

g/l

1.13

167

Malignant neoplasm of skin

230

1409

1.12

0.91

1.5

1.4

6.48

6.84

g/l

0.65

162

996

Ovarian dysfunction

287

1.33

0.91

1.4

5.64

6.56

g/l

1.41

200

Schizophrenia, schizotypal and delusional disorders

126

1458

0.86

0.90

1.2

1.3

6.87

6.61

g/l

0.28

989

Carcinoma in situ of skin

227

1.37

0.90

1.3

6.60

7.15

g/l

0.24

162

Bipolar affective disorders

819

1.19

0.90

1.3

6.46

6.67

g/l

0.28

551

Non-small cell lung cancer, including Hilmo

429

1.25

0.89

1.1

1.4

6.92

7.06

g/l

0.12

300

Malignant neoplasm of kidney, except renal pelvis

245

1.35

0.89

1.0

1.4

6.99

6.87

g/l

0.06

182

Thiazolidinediones

359

1.28

0.88

1.3

1.4

7.29

6.84

g/l

0.23

250

Lyme disease

148

1295

1.14

0.88

1.4

6.59

6.81

g/l

0.33

120

896

Sexual dysfunction

1.87

0.87

1.5

1.3

6.75

6.89

g/l

—

Intermittent heterotropia

237

1.35

0.87

1.4

6.14

6.46

g/l

0.29

171

Non-small cell lung cancer

270

1.33

0.86

1.2

1.4

6.76

7.21

g/l

0.37

195

Pregnancy, childbirth and the puerperium

107

655

0.85

0.86

1.4

6.29

6.67

g/l

0.67

467

Mental and behavioural disorders due to cannabinoids

104

1.55

0.84

1.1

1.3

6.32

6.34

g/l

—

1.95

0.84

1.7

1.2

5.58

7.13

g/l

—

Benign neoplasm of thyroid gland

1.57

0.84

2.6

1.3

8.12

7.00

g/l

—

Spirochaetal infections, other/unspecified

149

1309

1.14

0.84

1.4

6.57

6.80

g/l

0.35

121

910

Diabetic neuropathy

404

1.26

0.84

1.5

1.4

6.39

6.81

g/l

0.35

263

Malignant neoplasm of stomach, including Hilmo

137

1.46

0.84

1.5

1.4

5.50

6.88

g/l

1.12

102

Congenital malformations of great arteries

127

1.48

0.82

1.7

1.4

5.51

6.36

g/l

0.49

106

Basal cell carcinoma, including avohilmo

202

1245

1.12

0.82

1.6

1.4

6.28

6.88

g/l

1.87

146

872

Other and unspecified injuries of abdomen, lower back and pelvis

1.88

0.82

1.0

1.1

5.59

5.77

g/l

—

Congenital malformations of heart and great arteries

562

1.21

0.81

1.3

1.4

7.30

6.47

g/l

0.76

411

Other and unspecified mononeuropathies, also in other diseases

1.61

0.81

1.4

1.3

5.09

7.27

g/l

2.12

Pre-eclampsia or poor fetal growth

159

1402

1.13

0.81

1.4

6.73

6.58

g/l

0.22

109

990

Other fall from one level to another

112

967

1.16

0.81

1.3

1.4

6.40

6.71

g/l

0.59

683

Abnormal findings in secretions and smears from cervix uteri vagina vulva

263

1806

1.10

0.81

1.4

6.83

6.64

g/l

0.33

187

1296

Congenital musculoskeletal deformities of head, face, spine and chest

1.74

0.80

1.6

1.3

6.02

6.31

g/l

—

Organic, including symptomatic, mental disorders

176

1405

0.89

0.80

1.3

1.4

7.10

6.99

g/l

0.12

121

956

Other chromosome abnormalities, not elsewhere classified

1.85

0.80

1.5

1.3

6.40

5.33

g/l

—

Alcohol dependence

124

1081

1.15

0.80

1.2

1.4

6.41

6.92

g/l

0.97

756

Other specified/unspecified nutritional deficiencies

0.00

0.79

0.0

1.5

—

6.66

—

Benign neoplasm: Bone and articular cartilage, unspecified

0.00

0.79

0.0

1.2

—

6.59

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, including Hilmo

0.00

0.79

0.0

1.3

—

5.83

—

Graves disease, strict definition

392

1.25

0.79

1.4

5.83

6.82

g/l

1.76

278

Other disorders of the genitourinary system

437

1.24

0.79

1.4

7.42

6.85

g/l

0.37

294

Open wound of head

273

2402

1.10

0.79

1.5

1.3

6.63

6.80

g/l

0.30

179

1638

Femoral hernia

106

1.51

0.79

1.4

1.2

6.33

7.05

g/l

—

Malignant melanoma

492

1.22

0.78

1.3

1.4

7.67

6.77

g/l

0.50

344

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

295

1.29

0.78

1.2

1.4

6.41

6.85

g/l

0.36

191

Kela-code for behavioural disturbances in mental retardation

0.00

0.78

0.0

1.3

—

6.79

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

340

1.27

0.77

1.2

1.5

6.33

6.44

g/l

0.09

239

Spontaneous abortion

244

1493

1.10

0.77

1.3

1.4

6.57

6.70

g/l

0.21

175

1060

Emotional disorders starting during childhood or adolescence

207

1.34

0.76

1.4

6.42

6.27

g/l

0.13

159

Other and unspecified corneal deformities and disorders

1.52

0.75

1.2

1.4

7.79

7.00

g/l

—

Superficial injury of shoulder and upper arm

413

1.24

0.75

1.6

1.4

7.24

6.70

g/l

0.45

291

Injury of muscle and tendon at lower leg level

586

1.20

0.75

2.0

1.3

7.07

6.77

g/l

0.24

402

Basal cell carcinoma

189

1175

1.11

0.74

1.6

1.4

6.33

6.85

g/l

1.40

136

821

Benign neoplasm: Skin of other and unspecified parts of face

334

1.26

0.73

1.5

1.4

5.81

6.99

g/l

1.52

238

Solid cancers, helper endpoint

455

2509

1.07

0.72

1.3

1.4

6.94

6.73

g/l

0.48

301

1769

Foreign body entering into or through eye or natural orifice

299

1.27

0.72

1.3

6.83

6.70

g/l

0.10

215

Inguinal hernia

291

1788

1.09

0.72

1.3

1.4

7.36

6.72

g/l

1.45

201

1203

Hydrocele

371

1.24

0.71

1.4

6.71

7.28

g/l

0.44

262

Unspecified abortion

194

1.34

0.71

1.5

1.4

6.20

6.97

g/l

0.71

133

Parkinson's disease, strict definition, excluding more controls

317

0.75

0.71

1.3

1.4

7.56

7.44

g/l

0.04

211

Malignant neoplasm of brain

101

1.49

0.70

1.4

1.2

6.81

6.97

g/l

—

Unspecified maternal hypertension

1.72

0.70

1.1

1.4

7.14

5.95

g/l

—

Varicose veins of other sites

212

1.32

0.70

1.2

1.3

8.05

6.67

g/l

0.57

148

Intracerebral haemorrhage

345

1.25

0.70

1.2

1.3

7.39

6.69

g/l

0.72

240

Aneurysms, operations, SAH

583

1.19

0.68

1.3

1.4

6.49

6.75

g/l

0.25

397

Traumatic subdural haemorrhage

341

1.24

0.68

1.5

1.4

6.82

7.18

g/l

0.30

240

Supervision of normal pregnancy

613

0.87

0.67

1.2

1.4

6.56

6.47

g/l

0.12

445

Alzheimer’s disease (Late onset), excluding more controls

261

0.78

0.67

1.1

1.5

6.65

7.48

g/l

0.68

167

Malignant neoplasm of breast, HER-negative

711

0.84

0.66

1.2

1.5

6.35

6.75

g/l

0.36

503

Tibial collateral bursitis [Pellegrini-Stieda]

1.79

0.66

1.0

1.5

5.89

6.20

g/l

—

Diabetic retinopathy, strict definition

606

1.17

0.66

1.5

1.4

6.90

6.74

g/l

0.14

394

Nontoxic goitre/thyroid nodule

131

1166

1.12

0.65

1.9

1.4

6.48

6.74

g/l

0.30

809

Short Achilles tendon (acquired)

1.62

0.65

1.4

8.85

7.50

g/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

349

1.23

0.65

1.2

1.4

6.33

6.57

g/l

0.20

239

Crushed, pushed or stepped on by crowd or human stampede

304

1.25

0.65

1.2

1.3

6.73

6.61

g/l

0.09

215

Toxic effects of substances chiefly nonmedicinal as to source

449

1.20

0.65

1.3

6.14

6.58

g/l

0.54

315

Inguinal or femoral hernia, bilateral

340

1.24

0.65

1.2

1.3

7.41

6.67

g/l

0.63

238

Inflammatory disorders of breast

233

1.29

0.64

1.7

1.4

5.92

6.39

g/l

0.49

162

Inguinal hernia, bilateral

332

1.24

0.63

1.2

1.3

7.34

6.67

g/l

0.52

233

Pervasive developmental disorders excl. Autism + Asperger

1.61

0.63

1.0

1.3

5.40

6.11

g/l

—

Foreign body or object entering through skin

225

1.29

0.63

1.4

1.3

5.99

6.57

g/l

0.71

159

Follow-up examination after treatment for malignant neoplasms

225

1.29

0.63

1.1

1.3

5.54

7.00

g/l

1.97

131

Malignant melanoma, including Hilmo

589

1.17

0.62

1.3

1.4

7.25

6.82

g/l

0.23

417

Parkinson's disease, excluding more controls

338

0.78

0.62

1.3

1.4

7.42

7.46

g/l

0.02

228

Maternal care for known or suspected malpresentation of fetus

639

0.86

0.62

1.4

6.11

6.44

g/l

0.47

460

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

291

0.75

0.62

1.4

6.04

6.93

g/l

0.62

213

Chronic periodontitis, including avohilmo

527

3339

1.06

0.62

1.4

6.72

6.81

g/l

0.16

374

2299

Malignant neoplasm of breast, ER-negative, including Hilmo

797

0.86

0.62

1.2

1.5

6.36

6.70

g/l

0.35

566

Redundant prepuce, phimosis and paraphimosis

852

1.14

0.61

1.2

1.3

6.67

6.94

g/l

0.40

573

Malignant neoplasm of ovary

152

0.66

0.61

1.4

1.6

4.64

6.88

g/l

—

105

Mandibular retrognathia

270

1.26

0.61

1.4

6.22

6.30

g/l

0.06

191

Malignant neoplasm of bladder, including Hilmo

314

1.24

0.60

1.6

1.4

6.98

7.06

g/l

0.05

230

Injury of muscle and tendon at wrist and hand level

536

1.18

0.60

1.3

1.4

6.46

6.87

g/l

0.31

374

Focal brain injury

165

1.34

0.60

1.6

1.3

6.15

6.75

g/l

0.43

115

Epidural haemorrhage

0.00

0.60

0.0

1.4

—

7.62

—

Injury of eye and orbit

601

1.17

0.60

1.2

1.3

6.18

6.64

g/l

0.84

406

0.00

0.60

0.0

1.1

—

5.64

—

Nontoxic single thyroid nodule

236

1.27

0.59

2.1

1.3

5.72

7.08

g/l

1.54

167

Malignant neoplasm of urinary organs

272

1.25

0.59

1.0

1.4

7.02

6.96

g/l

0.03

198

Traction detachment of retina

0.00

0.58

0.0

1.2

—

6.37

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

327

1.23

0.58

1.4

6.51

6.26

g/l

0.22

228

Vascular dementia

160

1.33

0.58

1.4

1.2

7.06

7.25

g/l

0.07

117

Other mental disorders due to brain damage and dysfunction and to physical disease

327

1.23

0.58

1.4

6.77

6.70

g/l

0.03

230

Intrahepatic Cholestasis of Pregnancy (ICP)

291

1.24

0.58

1.1

1.4

6.32

6.34

g/l

0.01

208

Hyperplasia of prostate

150

768

1.11

0.58

1.3

1.4

6.52

7.13

g/l

1.36

104

527

HSIL lesion of the cervix uteri

852

0.87

0.58

1.4

6.77

6.59

g/l

0.12

601

Alzheimer’s disease (Atypical or mixed)

183

0.70

0.57

1.1

1.3

7.85

6.98

g/l

—

131

Other osteochondropathies

265

1.25

0.56

1.5

1.3

6.18

6.64

g/l

0.39

181

Puerperal sepsis

503

1.17

0.56

1.7

1.4

6.01

6.60

g/l

0.91

347

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

293

1.23

0.55

1.1

1.4

6.32

6.34

g/l

0.01

205

Postpartum haemorrhage due to retained placenta

548

0.84

0.55

1.2

1.3

6.73

6.55

g/l

0.17

385

Maternal care for known or suspected fetal abnormality and damage

647

0.86

0.55

1.3

1.4

6.72

6.53

g/l

0.20

461

Viral hepatitis

276

1.23

0.54

1.1

1.3

6.77

6.71

g/l

0.03

190

Leiomyoma of uterus

323

1714

1.07

0.54

1.4

6.33

6.73

g/l

1.21

220

1231

Bulimia nervosa (incl. atypical)

125

1.36

0.53

1.2

1.4

6.01

6.23

g/l

—

Malignant neoplasm of bladder

151

1.33

0.53

1.5

1.2

6.01

7.27

g/l

0.75

113

Calculus of lower urinary tract

134

1.35

0.53

1.7

1.3

4.90

7.08

g/l

—

All dysplastic lesions of the cervix uteri

132

1185

1.11

0.53

1.3

1.4

7.09

6.55

g/l

0.71

842

Periodontitis

526

3346

1.05

0.52

1.4

6.73

6.81

g/l

0.15

375

2301

Left ventricular outflow tract obstruction, narrow definition

187

1.29

0.52

1.4

1.3

7.11

6.52

g/l

0.21

132

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

0.61

0.52

1.3

1.4

5.05

5.97

g/l

—

Toxic effect of contact with venomous animals

143

1.33

0.52

1.1

1.3

6.70

6.87

g/l

0.10

100

Transitory endocrine and metabolic disorders specific to fetus and newborn

0.60

0.52

1.3

1.4

5.05

6.04

g/l

—

Assault by bodily force

323

1.21

0.52

1.2

1.3

6.64

6.49

g/l

0.09

222

Transient global amnesia

293

0.78

0.52

2.4

1.4

5.55

7.13

g/l

2.09

202

Pedestrian injured in collision with pedal cycle

1.45

0.52

1.2

1.3

6.67

6.68

g/l

—

Wide developmental disorders

161

1.31

0.51

1.3

1.4

5.06

6.16

g/l

1.35

124

Malignant neoplasm of rectum

280

0.78

0.50

1.4

5.87

6.88

g/l

0.61

203

Other blood glucose lowering drugs, excl. Insulins

547

1.15

0.50

1.2

1.4

6.36

6.94

g/l

0.69

377

Slow fetal growth and fetal malnutrition

1.56

0.49

2.1

1.3

5.72

6.25

g/l

—

Obstructed labour due to malposition and malpresentation of fetus

999

0.90

0.49

1.3

1.4

7.08

6.51

g/l

0.68

711

Other abnormal products of conception

172

1047

1.09

0.48

1.4

1.3

5.98

6.67

g/l

2.97

119

750

Malignant neoplasm of corpus uteri, including Hilmo

271

1.22

0.48

1.1

1.5

7.07

6.82

g/l

0.14

184

Poisoning by narcotics and psychodysleptics [hallucinogens]

1.53

0.48

1.1

1.3

7.34

6.00

g/l

—

Other and unspecified nonorganic psychotic disorders

880

0.89

0.48

1.2

1.4

6.80

6.61

g/l

0.14

591

Foreign body in alimentary tract

172

1.28

0.48

1.2

1.3

6.41

6.90

g/l

0.23

125

Ill-defined and unknown causes of mortality

199

1.26

0.47

1.2

7.04

7.19

g/l

0.08

137

Pregnancy examination and test

474

1.13

0.47

1.6

1.4

6.09

6.39

g/l

0.56

345

Pedal cyclist injured in noncollision transport accidents

474

0.84

0.47

1.5

1.3

6.14

6.61

g/l

0.51

331

Generalized epilepsy, mode (most common among epilepsy diagnosis)

111

1.36

0.46

1.4

1.3

6.96

6.24

g/l

—

Malignant neoplasm of head and neck

236

1.23

0.46

1.2

1.3

4.77

6.91

g/l

3.57

169

Other disorders of iris and ciliary body

1.43

0.45

1.2

1.3

7.76

7.50

g/l

—

Scissor bite

140

0.70

0.45

1.4

1.5

6.11

6.28

g/l

—

113

Carcinoma in situ of cervix uteri

385

0.83

0.45

1.5

1.4

7.58

6.32

g/l

0.57

268

Generalized epilepsy

156

1.29

0.45

1.4

1.3

9.15

6.31

g/l

1.10

113

HSIL lesion of the cervix uteri, vagina or vulva

927

0.89

0.44

1.4

6.83

6.60

g/l

0.17

658

Type 1 diabetes, strict (exclude DM2)

449

1.16

0.44

1.2

1.4

6.27

6.59

g/l

0.27

330

Pre-eclampsia

886

1.11

0.43

1.5

1.4

6.53

6.67

g/l

0.17

613

Type 1 diabetes, definitions combined

450

1.15

0.43

1.2

1.3

6.27

6.58

g/l

0.26

332

Polyhydramnios

184

1.25

0.43

1.4

6.72

6.03

g/l

0.64

126

Benign leiomyoma with endometriosis

583

1.13

0.43

1.2

1.4

6.12

6.59

g/l

0.79

394

Macular hole

151

0.73

0.42

1.1

1.5

6.07

7.30

g/l

—

112

Complications following abortion and ectopic and molar pregnancy

113

1.33

0.42

1.1

1.6

5.71

7.25

g/l

—

Clear cell adenocarcinoma of kidney

122

1.31

0.42

1.0

1.4

7.29

7.06

g/l

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

745

1.11

0.42

1.3

6.88

6.69

g/l

0.13

525

Medical treatment for female infertility

108

978

1.10

0.42

1.3

1.4

6.70

6.43

g/l

0.40

687

Malignant neoplasm of hypopharynx

0.00

0.41

0.0

1.1

—

7.58

—

Alcoholic cardiomyopathy

0.00

0.41

0.0

1.4

—

7.47

—

Open bite

240

1.21

0.41

1.2

1.4

6.94

6.23

g/l

0.94

172

Other viral hepatitis

240

1.21

0.41

1.1

1.3

6.94

6.66

g/l

0.16

166

Polycystic ovarian syndrome, broad definition

463

1.15

0.41

1.5

1.4

6.28

6.52

g/l

0.30

334

Manic episode

1.40

0.40

1.4

1.3

5.17

6.82

g/l

—

Antenatal screening

102

630

0.91

0.40

1.2

1.4

6.51

6.50

g/l

0.02

456

Prominent ears

1.48

0.40

1.4

1.2

7.11

6.73

g/l

—

Frostbite

1.48

0.40

1.4

5.92

6.83

g/l

—

Focal epilepsy

871

1.10

0.40

1.3

6.96

6.67

g/l

0.24

614

Malignant neoplasm of brain, including Hilmo

150

1.27

0.40

1.3

1.4

6.35

6.88

g/l

0.25

111

Intentional self-harm by hanging, strangulation and suffocation

0.00

0.40

0.0

1.4

—

6.82

—

Malignant neoplasm of other and ill-defined digestive organs

0.00

0.40

0.0

1.2

—

6.57

—

Non-small cell lung cancer, squamous

1.37

0.40

1.4

1.2

6.82

7.34

g/l

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

270

0.81

0.39

1.4

6.04

6.91

g/l

0.60

195

Malignant neoplasm of hypopharynx, including Hilmo

0.00

0.39

0.0

1.1

—

7.40

—

Deep bite

457

1.13

0.39

1.3

1.4

6.35

6.59

g/l

0.28

336

Colorectal adenocarcinoma

600

0.88

0.38

1.3

1.4

6.47

6.90

g/l

0.40

424

Malignant melanoma of skin

367

0.84

0.38

1.4

7.96

6.83

g/l

0.38

261

Other disorders of amniotic fluid and membranes

617

0.88

0.38

1.8

1.4

7.27

6.41

g/l

0.77

438

Pedal cyclist injured in transport accident

977

0.91

0.37

1.5

1.3

6.78

6.71

g/l

0.07

676

Lesion of plantar nerve

189

1.22

0.36

2.1

1.4

6.75

7.06

g/l

0.18

132

Congenital malformations of aortic and mitral valves

153

1.24

0.35

1.4

1.3

7.21

6.66

g/l

0.16

109

Postpartum care and examination

419

0.89

0.35

1.3

1.4

6.40

6.36

g/l

0.03

299

Noise effects on inner ear

126

1.27

0.35

1.2

1.3

5.41

7.06

g/l

—

Benign neoplasm: Peripheral nerves and autonomic nervous system

1.37

0.34

1.0

1.4

5.88

6.55

g/l

—

Unspecified lump in breast

604

1.11

0.34

1.6

1.4

5.95

6.60

g/l

1.08

415

Otosclerosis

246

1.18

0.34

1.0

1.5

8.35

7.05

g/l

1.00

172

Postpartum haemorrhage due to anatomy

446

0.87

0.33

1.1

1.3

7.03

6.50

g/l

0.51

311

Other and unspecified injuries of head

228

1.19

0.33

1.2

1.3

6.00

6.61

g/l

0.57

156

Single delivery by forceps and vacuum extractor

459

0.90

0.32

1.2

1.4

6.98

6.42

g/l

0.74

345

Non-small cell lung cancer, squamous, helper endpoint

1.31

0.31

1.4

1.2

6.82

7.64

g/l

—

Malignant melanoma of skin, including Hilmo

496

0.89

0.31

1.4

7.23

6.78

g/l

0.17

352

Malignant neoplasm of corpus uteri

221

1.18

0.30

1.1

1.5

7.42

6.75

g/l

0.35

153

Contact with other sharp object(s)

272

0.84

0.30

1.3

5.79

6.40

g/l

0.52

192

Kela-code for severe mental illness

160

1697

0.94

0.30

1.2

1.4

6.55

6.76

g/l

0.26

106

1157

Other specified disorders of external ear

102

1.28

0.30

1.8

1.3

4.91

7.66

g/l

—

Polycystic ovarian syndrome

203

1.18

0.30

1.4

5.54

6.38

g/l

1.03

135

Retinal breaks without detachment

621

1.10

0.29

1.8

1.4

6.36

6.88

g/l

0.77

442

Pre-eclampsia or eclampsia

103

960

1.07

0.28

1.5

1.4

6.55

6.69

g/l

0.19

667

Use of disulfiram, acamprosate or naltrexone

356

1.12

0.27

1.4

1.3

5.99

6.64

g/l

0.85

240

Acute and transient psychotic disorders

490

0.90

0.27

1.1

1.4

6.77

6.81

g/l

0.03

333

Focal epilepsy, strict definition

797

1.08

0.27

1.3

6.50

6.67

g/l

0.14

562

Malignant neoplasm of ovary, including Hilmo

204

0.83

0.27

1.2

1.5

5.14

6.84

g/l

—

141

Convergent concomitant strabismus

243

1.15

0.27

1.5

1.4

6.84

6.65

g/l

0.09

175

Burn and corrosion of head and neck

1.21

0.26

1.3

6.94

6.93

g/l

—

Nontraumatic intracranial haemmorrhage

653

1.09

0.26

1.3

1.4

7.39

6.74

g/l

0.87

450

Abnormal spermatozoa

395

1.11

0.26

1.2

1.3

6.64

7.07

g/l

0.29

279

Ectopic pregnancy

760

1.08

0.26

1.4

6.20

6.95

g/l

1.50

532

Multiple gestation

405

1.11

0.26

1.4

6.49

6.36

g/l

0.17

283

Benign neoplasm of breast

457

0.90

0.26

1.3

1.4

6.41

6.69

g/l

0.22

318

Alzheimer’s disease (Atypical or mixed), excluding more controls

127

0.81

0.25

1.1

1.2

7.85

6.92

g/l

—

Poor fetal growth

579

1.09

0.25

1.3

1.4

7.22

6.44

g/l

0.88

415

Other and/or unspecified nontoxic goitre

266

0.86

0.24

3.3

1.3

5.82

6.90

g/l

1.18

182

Labour and delivery complicated by fetal stress [distress]

124

765

1.06

0.24

1.3

1.4

6.86

6.32

g/l

1.04

546

Postpartum haemorrhage

114

1018

0.94

0.24

1.2

1.4

6.82

6.52

g/l

0.56

724

Gestational diabetes (for exclusion)

176

1283

0.95

0.23

1.2

1.4

6.28

6.63

g/l

0.86

131

919

Maternal care related to the fetus and amniotic cavity and possible delivery problems

233

1312

1.04

0.23

1.4

6.59

g/l

0.00

176

944

Fracture of forearm

276

2437

1.04

0.23

1.3

1.4

6.67

g/l

0.01

195

1700

Twin gestation

389

1.11

0.23

1.4

6.43

6.35

g/l

0.10

269

Sulfonylureas

110

929

0.94

0.23

1.1

1.4

7.23

7.13

g/l

0.07

628

Hydrocephalus

190

1.16

0.23

2.0

1.3

5.98

6.95

g/l

0.55

142

Type 1 diabetes, strict definition, subgroup 1

341

1.11

0.23

1.3

5.99

6.49

g/l

0.41

259

Postpartum hemorraghe, all women as controls

114

1187

0.94

0.22

1.2

1.4

6.82

6.60

g/l

0.37

843

Undescended testis, unilateral

1.25

0.22

1.0

1.4

7.86

6.03

g/l

—

Ependymoma

0.00

0.21

0.0

1.2

—

6.92

—

Chronic viral hepatitis

199

0.85

0.21

1.1

1.3

7.36

6.66

g/l

0.23

135

Malignant neoplasm of larynx, including Hilmo

1.19

0.21

1.0

1.2

7.50

6.93

g/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

536

1.08

0.21

1.2

1.3

5.98

6.89

g/l

1.85

379

Syndactyly

0.00

0.21

0.0

1.2

—

5.89

—

Benign neoplasm of other and unspecified female genital organs

126

1.19

0.21

1.5

1.6

6.76

6.57

g/l

—

Helminthiases

1.25

0.20

1.5

1.2

7.06

6.51

g/l

—

Malignant neoplasm of testis, including Hilmo

1.23

0.20

1.2

1.3

7.80

6.81

g/l

—

Complications of labour and delivery

320

1726

1.03

0.19

1.3

1.4

6.64

6.61

g/l

0.05

225

1212

Colorectal cancer

731

0.94

0.19

1.2

1.4

6.85

6.91

g/l

0.05

504

Burn and corrosion of trunk

1.22

0.19

1.3

5.84

6.80

g/l

—

Supervision of high-risk pregnancy

106

605

1.05

0.18

1.4

6.49

6.50

g/l

0.02

438

424

1.09

0.18

1.2

1.4

6.39

6.41

g/l

0.04

290

malignant neoplasm of female genital organs

495

0.92

0.18

1.2

1.5

6.57

6.79

g/l

0.14

344

Other sexually transmitted chlamydial diseases

415

0.92

0.18

1.3

1.4

6.34

6.51

g/l

0.12

277

Bicuspidal aortic valve syndrome

119

1.18

0.17

1.4

1.3

7.77

6.56

g/l

—

Alcohol withdrawal state with delirium

233

1.12

0.17

1.1

1.3

5.86

7.02

g/l

1.30

165

Placenta praevia

195

1.13

0.17

1.3

1.4

6.58

6.28

g/l

0.12

132

Periapical abscess

223

2160

1.03

0.17

1.4

6.80

6.83

g/l

0.02

156

1518

Use of levodopa decarboxylase inhibitor

372

0.91

0.17

1.3

7.08

6.95

g/l

0.06

257

Renal cell carcinoma of kidney

0.73

0.17

1.0

1.2

7.29

7.39

g/l

—

Struck by thrown, projected or falling objec

178

1.12

0.15

1.3

7.42

6.37

g/l

0.74

122

Burns and corrosions

594

0.94

0.14

1.5

1.3

6.25

6.55

g/l

0.35

413

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

0.82

0.14

1.4

1.3

6.41

5.89

g/l

—

Memory loss

247

1.09

0.13

1.2

1.4

6.93

6.96

g/l

0.01

172

Antepartum haemorrhage, not elsewhere classified

397

0.93

0.13

1.3

1.4

7.10

6.43

g/l

0.30

284

Other disorders of penis

355

1.07

0.12

1.6

1.3

6.59

6.91

g/l

0.27

256

Colon adenocarcinoma

334

0.93

0.12

1.2

1.4

6.81

7.00

g/l

0.10

235

Contact with sharp glass

133

1.13

0.12

1.2

1.3

5.89

6.58

g/l

—

Malignant neoplasm of colon, including Hilmo

590

1.05

0.12

1.5

1.4

7.25

6.93

g/l

0.31

414

Diabetes mellitus in pregnancy

163

1014

1.03

0.11

1.2

1.4

6.16

6.63

g/l

1.28

119

729

Abnormalities of forces of labour

466

0.94

0.11

1.3

1.4

6.03

6.54

g/l

0.62

328

Unspecified mental disorder

198

1933

1.02

0.11

1.2

1.4

6.52

6.79

g/l

0.47

136

1328

Abnormal findings on antenatal screening of mother

363

0.94

0.11

1.5

5.36

6.60

g/l

1.90

261

Uterine polyps

348

1.06

0.10

1.4

5.51

6.56

g/l

2.08

247

Thyrotoxicosis with toxic multinodular goitre

177

0.90

0.10

1.9

1.6

5.39

7.03

g/l

—

125

Type1 diabetes, definitions combined, early onset

308

1.07

0.10

1.3

6.31

6.46

g/l

0.08

225

Schizophrenia or delusion, excluding more controls

125

1202

1.03

0.10

1.2

1.4

6.89

6.90

g/l

0.00

812

Acute appendicitis, with complications

779

0.96

0.10

1.4

1.3

6.19

6.75

g/l

0.74

550

Donors of organs and tissues

1.11

0.10

1.0

1.3

14.02

6.54

g/l

—

Malignant neoplasm of testis

1.11

0.10

1.2

1.4

7.76

6.55

g/l

—

Combinations of oral blood glucose lowering drugs

107

1099

0.97

0.08

1.3

1.4

7.38

7.00

g/l

0.42

757

Other obstetric trauma

224

1.07

0.08

1.2

1.4

6.38

6.08

g/l

0.25

158

severe traumatic brain injury, does not include concussion

765

1.03

0.08

1.5

1.3

7.22

6.90

g/l

0.22

530

Injury of nerves at wrist and hand level

117

1.11

0.08

1.3

6.98

6.90

g/l

—

Malignant neoplasm of rectosigmoid junction, including Hilmo

1.03

0.08

1.1

1.2

6.73

7.27

g/l

—

Other disorders of prostate

1.03

0.08

1.6

1.3

5.96

7.60

g/l

—

Gonococcal infection

108

1.11

0.07

1.4

1.5

6.97

7.03

g/l

—

Myocardial infarction, unclassifiable

563

0.97

0.07

1.3

8.12

6.98

g/l

1.32

395

Other obstructed labour

304

1.05

0.07

1.2

1.4

6.00

6.56

g/l

0.62

209

Pedal cyclist injured in collision with motor vehicle

1.12

0.07

2.0

1.3

5.82

6.87

g/l

—

Divergent concomitant strabismus

285

1.05

0.06

1.7

1.4

6.53

6.76

g/l

0.11

197

Chronic periodontitis, complicated

251

2455

1.01

0.06

1.4

6.61

6.85

g/l

0.45

172

1702

Maternal care for known or suspected abnormality of pelvic organs

122

814

1.02

0.06

1.2

1.4

6.24

6.54

g/l

0.44

583

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

830

0.98

0.06

1.2

1.4

7.84

6.89

g/l

0.61

580

Subarachnoid haemorrhage

304

0.95

0.05

1.4

7.40

6.83

g/l

0.35

209

Family history of certain disabilities and chronic diseases leading to disablement

182

0.93

0.05

1.1

1.3

6.36

6.31

g/l

—

131

Use of rivastigmine

325

1.04

0.05

1.4

1.3

6.91

6.92

g/l

0.00

229

Dislocation, sprain and strain of joints and ligaments of elbow

248

1.05

0.05

1.9

1.4

6.89

6.53

g/l

0.26

176

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

201

0.94

0.04

1.5

1.4

6.02

6.81

g/l

—

139

Multiple delivery

368

1.03

0.04

1.4

1.3

6.21

6.59

g/l

0.50

283

Orchitis and epididymitis

309

1.04

0.03

1.3

1.4

7.02

7.06

g/l

0.02

215

Retinal detachment with retinal break

431

1.02

0.02

1.6

1.3

6.93

6.84

g/l

0.05

307

Fall on and from ladder

242

1.03

0.02

1.4

1.2

8.04

6.89

g/l

0.56

173

Burn and corrosion of wrist and hand

117

0.94

0.01

2.1

1.3

5.28

6.51

g/l

0.85

Postpartum hemorraghe, parous women as controls

114

979

0.99

0.01

1.2

1.3

6.82

6.57

g/l

0.44

687

Failed induction of labour

243

1.03

0.01

1.3

1.4

6.01

6.27

g/l

0.16

171

Retained placenta and membranes, without haemorrhage

503

1.01

0.01

1.3

5.90

6.45

g/l

0.68

344

Other complications of labour and delivery, not elsewhere classified

489

1.01

0.01

1.1

1.4

6.65

6.39

g/l

0.28

347

Spermatocele

234

1.03

0.00

1.5

1.3

5.88

7.10

g/l

1.14

158

Family history of malignant neoplasm

444

1.01

0.00

1.2

1.4

6.79

6.58

g/l

0.08

324

Type 1 diabetes, strict definition

388

1.00

0.00

1.3

6.13

6.52

g/l

0.30

288

Rubella [German measles]

122

0.98

0.00

2.5

1.4

4.98

6.40

g/l

—

Pedal cyclist injured in other and unspecified transport accidents

437

1.01

0.00

1.4

7.18

6.68

g/l

0.42

303

Burns and corrosions of external body surface, specified by site

443

0.99

0.00

1.6

1.3

5.95

6.60

g/l

0.83

312

Maternal care for cervical incompetence

121

0.99

0.00

1.3

1.5

6.53

6.60

g/l

—

Single delivery by caesarean section

554

1.00

0.00

1.4

1.5

6.52

6.54

g/l

0.02

423

Malignant neoplasm of colon

435

1.01

0.00

1.1

1.4

7.35

6.86

g/l

0.39

303

Crowding of teeth, including avohilmo

354

1.00

0.00

1.3

1.4

6.47

6.25

g/l

0.29

257

Traumatic amputation of wrist and hand

123

0.98

0.00

1.4

1.3

5.53

6.88

g/l

—

Other sexually transmitted chlamydial diseases

257

1.01

0.00

1.3

1.4

6.73

6.63

g/l

0.06

169

Respiratory and cardiovascular disorders specific to the perinatal period

141

1.01

0.00

1.8

1.3

5.61

6.11

g/l

0.42

122

Respiratory distress of newborn

108

1.03

0.00

2.0

1.3

5.24

5.93

g/l

0.63

Congenital malposition of the kidney

0.00

0.0

1.0

—

5.90

—

Acne varioliformis

0.00

0.0

1.0

—

5.94

—

Burns and corrosions of multiple and unspecified body regions

0.91

-0.00

1.0

1.3

7.17

6.92

g/l

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system

0.00

-0.00

0.0

1.2

—

7.24

—

Microtia (small ears)

0.00

-0.00

0.0

1.1

—

6.22

—

Phlebitis and thrombophlebitis of other sites, drug-induced

0.00

-0.00

0.0

1.4

—

7.27

—

Hirsprung

0.00

-0.00

0.0

1.0

—

4.87

—

Staphylococcal scalded skin syndrome

0.00

-0.00

0.0

1.2

—

7.20

—

Other inherited muscular atrophy

0.00

-0.00

0.0

1.0

—

7.29

—

Congenital malformation of optic disc

0.00

-0.00

0.0

1.0

—

5.75

—

Injury of urinary and pelvic organs

0.94

-0.00

1.0

1.2

5.86

6.74

g/l

—

Exposure to other and unspecified man-made environmental factors

0.96

-0.00

1.0

1.3

6.22

6.66

g/l

—

Chondrosarcoma

0.00

-0.00

0.0

1.1

—

6.21

—

Intracranial nontraumatic haemorrhage of fetus and newborn

0.00

-0.00

0.0

1.4

—

5.17

—

Accidental poisoning by and exposure to pesticides

0.00

-0.00

0.0

1.3

—

6.83

—

Birth injury to skeleton

0.00

-0.00

0.0

1.5

—

6.99

—

Liveborn infants according to place of birth

0.91

-0.00

1.0

1.2

5.96

5.77

g/l

—

Other perinatal haematological disorders

0.00

-0.00

0.0

1.1

—

5.81

—

Cholera

0.00

-0.00

0.0

1.2

—

6.48

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

IgG subclass 1 [Mass/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS